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ABSTRACT 
A fundamental hallmark of modern neuroscience lies on the realization that, similarly to what 
happens in other tissues of our body, the adult mammalian central nervous system is endowed with 
considerable regenerative potential. This regenerative capacity is reflected in cellular processes 
defining the so-called neural plasticity, which include rapid and dynamic axo-dendritic remodelling of 
post-mitotic cells, as well as the ability of restricted brain regions to persistently generate new 
neuronal and glial cells, a process known as neuro- and gliogenesis, respectively. Together, neural 
plasticity confers to the mammalian brain a wide adaptive capability to redefine neuro-glial circuits, 
in response to every-day-life experiences and challenges. 
Reflecting the plastic nature of the adult brain, the hippocampus harbors different forms of neural 
plasticity, which have been implicated in different cognitive and emotional functions. Indeed, besides 
exhibiting forms of functional and structural dendritic plasticity, the hippocampus constitutes one of 
the two adult brain regions in which neurons are continuously generated throughout life. The 
importance of hippocampal neural plasticity extends beyond basal physiological contexts, as it serves 
as a pathological target in different neurological and psychiatric diseases. 
In particular, the hippocampus is considered a major gateway for the translation of the systemic 
stress-response into deleterious effects on neural plasticity, that are also included in the 
pathophysiology of diseases in which stress has a major etiological role, such as depression. In fact, 
not only has depression been linked to impoverished neuronal dendritic arborization and reduced 
cytogenesis within the hippocampus, but, also, antidepressant therapeutical efficacy has been 
suggested to be associated with the ability to reverse the aforementioned plastic alterations. Even so, 
the specific contribution of different forms of hippocampal plasticity in the onset and recovery from 
depression remains highly controversial. Following the initial reports claiming that hippocampal 
cytogenesis was fundamental to the antidepressant action, we and others have reported that the 
short-term improving actions of antidepressants depended on dendritic remodeling, rather than on 
cytogenesis. However, the longitudinal course of depression, as well as the full extent of the 
cytogenic process have often been neglected, since several studies have focused their analysis 
shortly after cytogenesis ablation, when newborn cells were yet to be fully differentiated and 
integrated in pre-existing circuits.  
In the work comprised in this thesis, we have arrested adult cytogenesis in naïve animals through the 
administration of the cytostatic agent methylazoxymethanol (MAM) and analyzed the long-term 
behavioral consequences four weeks after. Cytogenesis ablation was sufficient to induce core 
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symptoms of depression, such as anhedonic behavior, as well as other behavioral traits known to be 
highly comorbid in depressive patients, namely heightened anxiety and cognitive impairments. 
Moreover, work with a genetic model of cytogenesis ablation, the glial acidic fibrillary protein (GFAP) - 
tyrosine kinase (Tk) rat, revealed a time-dependent manifestation of behavioral impairments following 
cytogenesis ablation. Analysis conducted immediately after ablation in GFAP-Tk animals showed that 
while cytogenesis suppression can elicit short-term anxiety-like behavior, no alterations were 
produced in hedonic behavior or cognitive performance. Contrastingly, when conducting behavioral 
analysis 4 weeks post-ablation, the already present anxiety traits were accompanied with anhedonic 
behavior, as well as cognitive deficits related with spatial reference memory, behavioral flexibility, 
contextual fear memory and pattern separation. Interestingly, animals with ablated cytogenesis 
displayed impaired electrophysiological communication between the hippocampus and the prefrontal 
cortex, possibly contributing to the described behavioral alterations.  
Besides exploring the effects of cytogenesis ablation on the precipitation of depressive-like 
phenotype, we sought to analyze the importance of adult cytogenesis to the long-term spontaneous 
and antidepressant-induced behavioral recovery. Hence, we have submitted young-adult rats to an 
unpredictable chronic mild stress (uCMS) protocol to induce core symptom of depressive-like 
behavior. During the last two weeks of uCMS, animals were treated with the antidepressants 
fluoxetine and imipramine, either alone or co-administered with MAM, and allowed to recover during 
the four subsequent weeks. The long-term behavioral profile of rats suggests that ongoing 
cytogenesis is essential for long-term recovery from some emotional deficits (anhedonia and anxiety-
like signs) and cognitive impairments (working memory and behavioral flexibility). Furthermore, 
fluoxetine and imipramine antidepressants promoted the generation of new hippocampal cells that, 
are able to survive and successfully integrate the pre-existing circuits, counteracting the deleterious 
effects induced by cytogenesis arrest.  
Finally, and in light of evidence linking epigenetic DNA methylation with the pathophysiology of 
depression, we sought to explore whether the recently described pathway of DNA demethylation could 
be modulated by stress and antidepressant therapy and therefore participate in the pathology of the 
disease. We have detected decreased levels of DNA hydroxymethylation in the dorsal, but not in the 
ventral, hippocampus, which was correlated with decreased expression  of tet3 in the same region. 
Strikingly, monoaminergic antidepressants were able to revert these alterations. The dichotomy dorsal 
vs ventral is also evident in the pattern of genomic locci differentially hydroxymethylated by stress and 
antidepressants that differs between the dorsal and ventral hippocampal poles. 
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RESUMO 
Uma característica fundamental que timbra aquilo que é a neurociência moderna relaciona-se com 
facto de reconhecermos que, à semelhança do que acontece noutros tecidos do nosso corpo, o 
sistema nervoso central é dotado de um considerável potencial regenerativo. Esta capacidade 
regenerativa reflete-se em processos celulares que definem a chamada plasticidade neural, dentro 
da qual se incluem a rápida remodelação axo-dendrítica de células pós-mitóticas, assim como a 
capacidade de áreas restritas do cérebro gerarem continuamente novas células neuronais e gliais, 
processo este conhecido por neuro- ou gliogénese, respectivamente. Em conjunto, os fenómenos 
neuroplásticos conferem ao cérebro mamífero uma vasta capacidade adaptativa na redefinição de 
circuitos neuro-gliais, em resposta às experiências e desafios do nosso quotidiano. 
Em particular, o hipocampo assume um papel preponderante na translação da resposta sistémica 
ao stress em efeitos deletérios ao nível da plasticidade neural. Assim, este comprometimento de 
diferentes formas de plasticidade neural integra, pois, a patofisiologia de doenças nas quais o stress 
é um importante factor etiológico, como é o caso da depressão. De facto, a doença depressiva não 
só foi associada a defeitos atróficos na estrutura dendrítica e a citogénese diminuída no hipocampo, 
como também a eficácia dos fármacos antidepressivos foi relacionada com a capacidade destes de 
reverterem aqueles défices neuroplásticos. Contudo, a contribuição específica de diferentes formas 
de plasticidade hippocampal para o desenvolvimento e recuperação da doença depressiva 
permanece altamente controversa. Após estudos pioneiros que reportaram que a citogénese 
hipocampal seria fundamental para a acção dos fármacos antidepressivos, nós demonstrámos que 
os efeitos terapêuticos a curto-prazo destas drogas dependia antes da remodelação dendrítica, em 
detrimento do processo citogénico. No entanto, o curso longitudinal da depressão, assim como a 
completa extensão do processo citogénico têm vindo a ser largamente negligenciados, uma vez que 
vários estudos focaram a sua análise pouco tempo após a conclusão do tratamento cito-ablativo, 
numa altura em que as células que seriam formadas teriam ainda que completar o seu processo de 
maturação e integração nos circuitos pré-existentes.   
No trabalho que constitui a presente tese, promovemos a ablação da citogénese adulta em animais 
naíve mediante a administração do agente citostático metilazoximetanol (MAM) e analisámos as 
consequências a longo-prazo no perfil comportamental dos animais. A ablação da citogénese 
revelou-se suficiente para induzir sintomas cardinais da doença depressiva, como é o caso de 
comportamento anedónico, assim como outros traços comportamentais descritos como 
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comorbilidades frequentes em doentes depressivos, nomeadamente manifestações de ansiedade e 
défices cognitivos. A utilização de um segundo modelo genético de ablação de citogénese, ratos glial 
acidic fibrillary protein (GFAP)-tyrosine kinase (Tk),  revelou o desenvolvimento tempo-dependente de 
défices comportamentais após ablação. Análises efectuadas imediatamente após ablação em 
animais GFAP-Tk, revelaram que a supressão da citogénese induz a exacerbação de comportamento 
ansioso a curto-prazo, não se tendo verificado alterações hedónicas ou na performance cognitiva. 
Em contraste, quando realizada a análise 4 semanas após a ablação citogénica, ao comportamento 
ansioso associavam-se também anedonia e défices ao nível da memória espacial, flexibilidade 
comportamental, memória emocional e em tarefas de pattern separation. Animais com citogénese 
suprimida revelaram défices na comunicação electrofisiológica entre o hipocampo e o córtex 
prefrontal, o que poderá contribuir para as alterações comportamentais identificadas. 
Para além do estudo dos efeitos da ablação da citogénese na precipitação do fenótipo depressivo, 
procurámos ainda analisar a importância da citogénese adulta na recuperação deste fenótipo a 
longo-prazo, quer espontânea, quer induzida por fármacos antidepressivos. Submetemos ratos 
adultos ao protocolo de stress crónico imprevisível (uCMS) afim de induzirmos sintomas cardinais da 
doença depressiva. Durante as últimas 2 semanas de uCMS, os animais foram tratados com os 
antidepressivos fluoxetina e imipramina, quer isoladamente quer em co-tratamento com 
metilazoximetanol (MAM) e foram deixados a recuperar durante 4 semanas. O perfil 
comportamental dos animais sugere que a citogénese adulta é essencial para a recuperação a 
longo-prazo de défices emocionais (anedonia e comportamento ansioso) e cognitivos (memória de 
trabalho e flexibilidade comportamental). O tratamento com fluoxetina e imipramina promoveu a 
geração de novas células hipocampais que se revelaram capazes de sobreviver e integrar nos 
circuitos pré-existentes, revertendo os efeitos deletérios provocados pela supressão citogénica.  
Finalmente, à luz da evidência existente que estabelece uma associação entre a metilação do DNA e 
patofisiologia da depressão, explorámos se a recém descrita via de desmetilação do DNA poderia ser 
modelada pelo stress e tratamento antidepressivo e assim participar na patologia da doença 
depressiva. Detectámos um decréscimo nos níveis de hidroximetilação do DNA no hipocampo dorsal, 
mas não no ventral, que se correlacionava com uma diminuição na expressão de tet3 na mesma 
região. Importa notar que antidepressivos monoaminérgicos se revelaram capazes de reverter as 
alterações mencionadas. A dicotomia dorsal vs ventral parece ser também aqui evidente, uma vez 
que o padrão de locci genómicos que se detectaram ser diferencialmente hidroximetilados pelo 
stress e tratamento antidepressivo diferiam entre os pólos dorsal e ventral do hipocampo.
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THESIS LAYOUT 
Chapter 1 presents a general introduction, covering fundamental aspects of (i) 
hippocampal structure and function, along with the description of (ii) different forms of 
neural plasticity occurring within the adult hippocampus. A perspective on both of these 
topics is fundamental to address the subsequent topic of (iii) stress-induced dysregulation of 
adult neural plasticity as a pathophysiological element of depression. Finally, (iv) epigenetic 
alterations in the stressed brain are focused, with special emphasis given to DNA methylation 
and hydroxymethylation. 
Chapter 2 presents the general rationale and major scientific aims of this thesis work.  
Chapter 3 comprises the research work focusing the longitudinal impact of hippocampal 
cytogenesis pharmacological ablation on both the development and remission from 
depressive-like behavior. This chapter is presented as two sequential original papers 
published in Translational Psychiatry, in 2013 (Mateus-Pinheiro et al., 2013a) and in 
Molecular Psychiatry (Mateus-Pinheiro et al., 2013b), subsequently in the same year.  
Chapter 4 comprises work in which a transgenic rat model for specific cytogenesis ablation 
(GFAP-Tk rat model) was used to further explore the longitudinal participation of adult 
cytogenesis in the development of different short-term and long-term emotional and cognitive 
impairments. Moreover, the importance of new mature hippocampal cells to specific 
cognitive domains and to hippocampal-prefrontal cortex communication is also studied. 
Chapter 5 presents the most recently produced work, focusing the characterization of 
epigenetic alterations on DNA demethylation pathways, following chronic stress exposure, in 
the dorsal and ventral hippocampal dentate gyrus. 
Chapter 6 addresses the development of a new behavioral paradigm to assess anhedonic 
behavior in rodents. This chapter is presented as an original paper published in Frontiers in 
Behavioral Neuroscience, in 2014 (Mateus-Pinheiro et al., 2014).  
Chapter 7 encompasses this thesis general discussion, in which the major findings of the 
presented research work are debated in an integrated manner. Moreover, research 
limitations, along with future perspectives in the field are also discussed. 
Appendices  
Finally, the following appendices are presented:  
I) Submitted paper on the regulatory role of the transcription factor AP2gamma in adult 
glutamatergic neurogenesis  (Mateus-Pinheiro et al., submitted).  
II) Preliminary data on the impact of cytogenesis ablation in GFAP-Tk rats for the efficacy of 
the SSRI fluoxetine. 
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Chapter I 
INTRODUCTION 
i i1
i i2
1. INTRODUCTION
 1.1  
On Hippocampal Structure and Function 
1.1.1 PRINCIPLES OF INTRINSIC HIPPOCAMPAL ORGANIZATION 
The hippocampal formation is a medial temporal lobe structure with an heterogeneous 
topographical and functional organization. Due to its complex connectivity with numerous cortical 
and subcortical structures, the hippocampal formation integrates the neural circuitry underlying 
different cognitive and emotional functions. Besides its elaborate topographical and functional 
organization and rich connectivity, the adult hippocampal formation is endowed with considerable 
adaptive and regenerative capacity as it harbors one of the two neurogenic niches of the adult 
brain, adding an extra level of complexity both to structural and functional aspects of this region, 
as I will discuss later. Firstly, and in order to further address different functional aspects of 
hippocampal activity, it is important to briefly specify key notions on hippocampal intra-regional 
organization, as well as on its relations to other brain structures.  
The formation of the hippocampus is generated during embryonic development but most of its 
neuronal population is only produced post-natally. In fact, this structure has a prolonged 
developmental window that extends from embryogenesis to the postnatal period which is finely 
regulated to correct patterning and organization (Rolando and Taylor, 2014). The basic intra-
hippocampal circuitry has its foundations during development of the hippocampal 
neuroepithelium (HNE). The HNE is divided into three morphogenetic components arising from 
dorsal to ventral: the ammonic neuroepethilium aNE, the primary dentate neuroepithelium (dNE) 
and the fimbrial glioepithelium (fGE) (Altman and Bayer, 1990). These three contiguous regions 
constitute the germinal matrix of the intra-regional hippocampal formation circuitry, as their 
names imply: the aNE (sometimes referred simply as the hippocampal neuroepithelium) is the 
most dorsally located and the first to differentiate, giving rise to the hippocampal pyramidal 
neurons that compose the Ammons’horn (also called cornus ammonis; CA) (Figure 1); the 
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primary dNE will give rise to the dentate gyrus (DG), with the important particularity of retaining a 
pool of resident adult neural stem cells (aNSC) that will persist throughout adulthood (as further 
discussed in Section 1.2); lastly, a ventrally located fGE will be a source of glial cells that will 
populate and contribute to the formation of the fimbria, a major information outsource structure of 
the hippocampus.  
 
Once fully formed the hippocampal formation will assume a curved shape with its longitudinal axis 
extending along the brain septo-temporal axis. The pathways of signal flow of the hippocampal 
formation  (hippocampus proper and dentate gyrus) combine with parahippocampal cortical 1
regions to form the backbone of the traditional hippocampal circuitry, the trisynaptic circuit 
 Note that the definition of hippocampal formation is not consensual; while some authors define it as comprising the 1
hippocampus proper (CA1, CA2, CA3 and Subiculum) and the dentate gyrus, others extend the definition to include the pre- and 
parasubiculum, as well as the entorhinal cortex.  
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Figure 1. Hippocampal intrinsic organization. a. The hippocampal formation is a medial lobe 
structure, whose intrinsic circuit organization is relatively conserved between humans and rodents. The 
basic functional unit corresponds to the classical trisynaptic circuit, in which input from the entorhinal 
cortex (EC) is propagated by recurrent connections within the DG-CA region. b. The signal flow follows 
a DG →CA3 →CA1 sequence, to be then conveyed to the subiculum (sub) that represents a major 
signal outsource region of the hippocampal formation back to the EC (see main text for further detail). 
© Mateus-Pinheiro 2016. 
(Andersen et al., 1971) (Figure 1). In this loop circuitry, inflow signals from the entorhinal cortex 
(EC) are propagated by excitatory synaptic relays in the CA and in the DG and then redirected 
back into the EC. Most external inputs are received from the enthorinal cortex, via long axonal 
pathways called medial- and lateral perforant paths (or together simply called perforant path, PP), 
that arise from layer 2 of the EC and terminate in the CA3 and DG (Deng et al., 2010); in parallel 
to this path, there is a direct path arising from EC layer 3 to CA1, commonly called 
temporoammonic path. Within the dentate gyrus, granule cells project their axons (the so-called 
mossy fibers) to the CA3, where pyramidal neurons are interconnected via recurrent connections. 
These pyramidal neurons will convey signal input towards the ipsilateral CA1, through Shaffer 
collaterals; CA3 pyramidal neurons also project to the contralateral CA3 and CA1 regions through 
commissural connections (Neves et al., 2008). To close the loop, CA1 send their axons to the 
subiculum (or directly to deep layers of EC) where information from the CA1 projection and EC 
layer III are combined and send along the output pathways of the hippocampal formation (Amaral, 
1993). Despite one of the most studied circuits in the brain, current notions on its structuring 
connections keep being revisited. A recent example was the redefinition of the prevalent notion 
that dentate granule cells did not send projects to CA2 pyramidal cells. In fact, Kohara and 
colleagues showed that granule neurons do indeed send abundant monosynaptic projections to 
CA2 pyramidal cells (Kohara et al., 2014). This alternative trisynaptic circuit has already been 
shown to be relevant for both context learning (Wintzer et al., 2014) and social memory (Hitti and 
Siegelbaum, 2014). 
The description given above of the basic hippocampal regional organization is obviously a 
simplification of a much more complex circuit involving many recurrent collaterals and inhibitory 
interneurons that modulate hippocampal activity (Witter, 1993; McBain and Fisahn, 2001). It is 
important to bear in mind that the trisynaptic circuit gained a central role in hippocampal research 
in a time when the prevalent idea was that the hippocampus proper was the major source of 
subcortical projections from the hippocampal formation. The current well established notions that 
the subiculum is the main source of subcortical projections and the enthorinal cortex is the main 
source of neocortical projections, the trisynaptic circuit is now only considered to be a part of the 
functional circuitry of the hippocampal formation. Nevertheless, and even considering the original 
“trisynaptic circuit concept” too narrow at light of recent knowledge, this hippocampal intrinsic 
organization allows to effectively receive, process and relay multimodal information from and to 
different neural nuclei. As we will see in the next section, the hippocampal formation is one of the 
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most connected areas of the brain and although commonly referenced as “memory center”, 
during the last two decades it became increasingly regarded as an integrator of both cognitive and 
emotional functions (Small et al., 2011; Femenia et al., 2012). The participation of the 
hippocampal formation in different cognitive and emotional modalities is the functional reflection 
of its inter-regional connections. 
1.1.2 HIPPOCAMPAL INTER-REGIONAL COMMUNICATIONS 
The adult mammalian hippocampus its a long curved “banana-shaped” structure that runs across 
a dorsal-ventral axis in rodents, that corresponds to a posterior-to-anterior axis in humans (Figure 
2). As for other species, in rodents the three-dimensional disposition of the hippocampus is 
relatively complex, as its longitudinal C-shaped axis runs from the septal nuclei rostro-dorsally to 
the temporal lobe caudo-ventrally (Amaral and Witter, 1989; Squire et al., 2004). For this reason, 
the longitudinal axis is often referred as the septo (dorsal)-temporal (ventral) axis, while the 
orthogonal orientation is referred as the transverse axis. As the hippocampus is disposed along a 
long longitudinal axis, it has the capacity to establish a diverse connectivity with multiple cortical 
and subcortical structures that I will briefly address, as they are key to further understand 
hippocampal function. 
Afferent Connections 
Injections of retrograde tracers in the septal (dorsal) pole of the DG (dDG) has revealed that this 
region receives main afferent connections from the dorsolateral area of the EC (Dolorfo and 
Amaral, 1998). In turn, the temporal (ventral) DG (vDG) receives its main afferences from the 
ventromedial area of the EC (Dolorfo and Amaral, 1998). The EC receives input from the 
perirhinal (PerC) and postrhinal (PosC) cortices: while the dorsolateral EC receives afferent 
projections preferentially from the PerC, both the lateral and ventromedial areas of the EC receive 
moderate projections from the PosC originated in layers III and V, and terminating primarily in 
layers II and III (Burwell and Amaral, 1998). Together, the PerC and PosC are innervate by 
multiple uni- and polimodal cortical areas, including the retrosplenial, anterior cingulate, 
prefrontal, somatosensory, temporal, parietal and occipital cortices (Squire and Zola-Morgan, 
1991; Cenquizca and Swanson, 2007). However, the connectivity pattern with different brain 
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regions differs along the hippocampal septo-temporal axis, in a non-abrupt, but rather gradual 
manner (Cenquizca and Swanson, 2007; Strange et al., 2014). 
In particular, in the rat brain, the perirhinal cortex receives input from primary visual (17) and 
visual association areas (18a and 18b) (Deacon et al., 1983; Vaudano et al., 1991; Burwell et al., 
1995). Although the primary auditory cortex does not project to the PeriC, a small region of 
auditory association located caudo-ventrally to the primary region, projects to the PeriC (Vaudano 
et al., 1991; Mascagni et al., 1993; Burwell et al., 1995). Furthermore, somatosensory input also 
arrives to the hippocampal formation, through more dorsally-located PeriC regions, from the 
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Figure 2. Hippocampal extrinsic connectivity. a. Both in the human and rodent brain, the hippocampus 
displays a rich connectivity with different cortical and limbic regions. b. The hippocampus establishes 
connections with uni- and polimodal cortical areas, mainly through the perirhinal (periC) and postrhinal (posC) 
cortices. A monosynaptic direct connection is also established between the hippocampus and the prefrontal 
cortex. In addition, the hippocampus establish bidirectional connections with subcortical regions such as the 
amygdala (Amy), the bed nucleus of stria terminalis (BNST), the nucleus accumbens (NAc)/ventral striatum, and 
the dorsal striatum. Moreover, through the fornical system, the hippocampus establishes connections with the 
lateral septum (LS), the hypothalamic area, the mammilary body and with thalamic nuclei. c. Depiction of CA1 
(adapted from Cenquizca and Swanson, 2007) and fornical hippocampal projections in rodent brain flat-map 
(adapted from Swanson, 2004). © Through the fornix, to thalamic, hypothalamic and mammilary nuclei; © to 
septal nuclei; © to thalamic nuclei; © to the NAc; © to the Amygdala; © to the BNST; © to the hypothalamus; © 
to the prefrontal cortex; © to other uni- and polimodal cortical areas. © Mateus-Pinheiro 2016.
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insular cortex (Deacon et al., 1983). In contrast, the PosrC receives strong visual associational 
input, some afferent projections from somatosensory regions, but weak or no input both from 
auditory associational or olfactory areas. In addition, it is also through the PeriC, that input arising 
from the anterior cingulate and retrosplenial cortices, reaches the dorsolateral EC. 
Moreover, ventral areas of the PeriC, along with the PosC also receive projections from polymodal 
associational cortices including the medial prefrontal (Deacon et al., 1983; Burwell et al., 1995; 
Conde et al., 1995), ventrolateral prefrontal (Deacon et al., 1983; Burwell et al., 1995), anterior 
cingulate cortices (Conde et al., 1995), medial precentral and temporal cortices. In addition, 
PeriC and PosC also receive afferent projections from subcortical areas such as thalamic nuclei, 
lateral nuclei of the amygdala, supramammilary nuclei and dorsal raphe nuclei (Deacon et al., 
1983), as well as from the nucleus accumbens (Burwell and Amaral, 1998), altough also 
receiving some afferences from caudal portions of neocortical regions, as it is the case of the 
parietal and occipital cortices. For instance, olfactory input reaches the perirhinal cortex trough 
the periamygdaloid region and piriform cortex (Deacon et al., 1983; Luskin and Price, 1983) 
(Figure 2).   
Efferent Connections 
The hippocampus has regional recurrent efferent connections with the EC, as well as 
extrahippocampal projections (Cenquizca and Swanson, 2007). Indeed, CA1 extrahippocampal 
projections to neocortical regions can be described in terms of “three routes”, as previously 
suggested: a dorsal path, that terminates in the retrosplenial area and caudal end of the anterior 
cingulate cortex (Vogt and Miller, 1983; Tamamaki and Nojyo, 1990; van Groen and Wyss, 1990; 
Jones et al., 2005); a ventral path, originating from the ventral 2/3 of CA1 region and extends 
throught the longitudinal association bundle to the visual, auditory, somatosensory, gustatory, 
olfactory and visceral cortical areas and agranular insular and orbital areas (as well as to 
basolateral amígdala) (Cenquizca and Swanson, 2006). A third route exists, consisting in a 
cortica-subcortical-cortical pathway arising from all the extension of CA1, but progressively 
increasing in strength from the dorsal to the ventral hippocampus. This pathway goes along the 
fornix to innervate rostral brain regions, such as the anterior cingulate, prelimbic, infralimbic and 
orbital cortices (Swanson and Cowan, 1977; Swanson and Kohler, 1986; van Groen and Wyss, 
1990; Swanson, 2000; Petrovich et al., 2005). The dorsal hippocampus also sends projections 
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through the fornix to the mammillary complex, and subcortical projections to the lateral septal 
nuclei (Swanson and Cowan, 1977); contrastingly, the ventral hippocampus sends projections to 
the BNST, nucleus accumbens and to the anterior olfactory nucleus  (Swanson and Cowan, 1977).    
Moreover, besides CA1 direct projections and fornical projections, the EC cortex also sends 
projections to both PeriC and PostC, which also establish a complex map of efferent projections 
with piriform, frontal, insular, temporal, cingulate, parietal and occipital cortices (Burwell and 
Amaral, 1998). Regarding subcortical regions, the primary subcortical connections of the periC 
are sent to the amygdala (to the lateral, basal, accessory basal an the capsular region of the 
central nuclei of the amygdala), striatum (with strong projection to the caudate nucleus) and 
thalamus (perigeniculate region and midline thalamic nuclei). The postC also projects to the 
striatum and thalamus (mainly, with lateral posterior thalamic nuclei), but has little or no 
connections with the amygdaloid complex. Instead, postC also projects to the claustrum (Burwell 
et al., 1995). As can be appreciated by its anatomical connections, the perirhinal and postrhinal 
cortices are areas of major convergence for widespread neocortical efferents, thus playing an 
important role in linking neocortical areas with allocortical regions.  
1.1.3 TOPOGRAPHICAL ORGANIZATION OF HIPPOCAMPAL CONNECTIVITY: 
THE DORSAL vs VENTRAL DICOTHOMY 
Despite the fact that the already described intrinsic circuit (see Section 1.1.1) is replicated along 
the entire septo-temporal axis of the hippocampus, the dorsal and ventral hippocampal regions 
establish different connections with cortical and subcortical areas, thus contributing to an 
heterogenous functional specialization of the hippocampal longitudinal axis (Witter et al., 1989; 
Strange et al., 2014) (Figure 3).  
Dorsal Hippocampus 
When trying to define a set of biological functions that are dependent of the hippocampal 
formation, spatial processing might come ahead, specially when considering the dorsal 
hippocampus (DH). In fact, the dorsal pole of the hippocampus harbors a great density of the so-
called place cells wich are fundamental for spatial memory encoding (Moser et al., 1995), as they 
allow us to construct independent spatial representations. On the subject of spatial 
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representations, it becomes also important to mention grid cells, which reside on the entorhinal 
cortex, curiously also with greater density in its dorsal region (dorsoventral medial EC), and 
encode a periodic triangular or hexagonal array that represent the entire animal’s environment 
(Hafting et al., 2005).  
Together, place cells and grid cells are the biological encoders employed by the DH, and 
enthorinal areas in its vicinity, to encode location information in a given environment. However, to 
navigate from a point A to a point B, one needs not only information on current location, but also 
directional heading perception. Once again, the ability to perceive such information lies in a 
particular group of cells residing in the DH, known as head direction cells (HDCs). Indeed, within 
the subicular complex , HDCs have been reported only in the postsubiculum (dorsal presubicular 2
area ) and are believed to encode the animal's perceived directional heading with respect to its 3
environment (Taube, 2007). The dorsal subicular area establishes efferent connections with 
regions integrating Papez Circuit  in which HDCs have also been identified, namely the anterior 4
dorsal thalamic nucleus (Taube, 1995), which contains the highest percentage of HDCs (≈60%), 
the lateral mammillary nuclei (Stackman and Taube, 1998), retrosplenial cortex (Cho and Sharp, 
2001), and also the entorhinal cortex (Sargolini et al., 2006). Furthermore, the dorsal 
hippocampal pole establishes strong connections with the anterior cingulate cortex, that along 
with retrosplenial cortex, have also been shown to be important for spatial processing and 
memory (Frankland et al., 2004; Harker and Whishaw, 2004). 
The importance of the DH in spatial context processing and navigation, has been further 
evidenced by several spatial memory and navigation tasks. A test that has and continues to be 
classically used to assess spatial navigational memory is the Morris Water Maze (MWM), in which 
animals are placed in a swimming pool and have to find and memorize the position of a hidden 
submerged platform, with the help of landmarks placed in the test room (Morris, 1984). In fact, 
 The subicular complex is usually divided into three subdivisions, namely, the subiculum proper, the presubiculum and the 2
parasubiculum (Witter et al., 1989)
 Some researchers contend that the dorsal portion of the presubiculum is characterized by cytoarchitectonics and connectivity 3
that differ from the ventral portion of the presubiculum (van Groen & Wyss 1990). These researchers thus prefer to use a 
different name for the dorsal portion and refer to this area as the postsubiculum. Using this nomenclature, they reserve the 
term presubiculum for only the ventral portion of this area
 Papez circuit: connnects the mammillary nuclei → anterior thalamus → cingulate cortex → hippocampus → mammillary 4
nuclei  
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Figure 3. Connectivity and functional correlates of the dorsal and ventral hippocampus. a. 
The rodent hippocampus has a C-shaped structure, running across its dorsal (septal) pole to its ventral 
(temporal) pole. b. In more rostral coronal sections, (©) only the dorsal hippocampus is identifiable; more 
caudal sections, run across both dorsal and septal poles (©). c. The dorsal hippocampus establishes 
important connections with the retrosplenial and anterior cingulate cortices, septal and mammilary nuclei, 
suprammammilary and thalamic nuclei, as well as with the dorsal striatum. It has been shown to 
participate in head direction perception, spatial navigation, leaning and memory, as well as in 
hippocampal theta rythms. d. The ventral hippocampus establishes important connections with the 
amygdala and bed nucleus of the stria terminalis (BNST), the hypothalamus and the dorsal and ventral 
striatum. In addition, it also establishes a singular monosynaptic connection with the prefrontal cortex, as 
well as with othe uni- and polimodal cortical areas. It has been suggested to participate in anxiety and fear 
control, in the modulation of affective states, motivation and sexual behavior, among other suggested 
functional correlates © Mateus-Pinheiro 2016.
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lesional studies of one of these regions individually, have provided the first evidence for this 
notion, as extensively reviewed elsewhere (Moser and Moser, 1998; Fanselow and Dong, 2010). 
Moser and colleagues showed that ibotenic acid-induced lesion in the septal hippocampus, 
produced significant spatial learning deficits (Moser et al., 1995). In fact, lesions that preserved at 
least 26% of the septal pole of the hippocampus did not produced cognitive deficits, 
demonstrating that as little as this amount of the septal hippocampus is enough to ensure normal 
spatial memory. In the same line of experiments, it was also demonstrated how ventral 
hippocampal lesions did not interfere with this type of memory. Such findings have proven to be 
consistent, as several subsequent studies have endorsed them (Bannerman et al., 2002). 
Another test used to evaluate spatial memory, that is chiefly used in rats, is the radial arm maze 
(RAM), in which animals are required to distinguish positions where they have already been, from 
new positions, where food is placed (Olton and Samuelson, 1976; Hodges, 1996). In line with 
findings in water maze tasks, Pothuizen and colleagues found that excitotoxic lesions in the DH 
severely disrupted spatial reference and working memory, in the RAM test. Here again, lesions 
confined to the ventral hippocampus (VH) did not interfere with spatial memory function 
(Pothuizen et al., 2004). However, it was further shown that ventrally-confined lesions increased 
the return to arms previously associated with food (Ferbinteanu and McDonald, 2001).   
Contextual fear conditioning (CFC) is also commonly used to assess hippocampal function (Kim 
and Fanselow, 1992; Maren et al., 2013). Contexts serve the cognitive function of abstracting 
situationally informed meaning of the world (Maren et al., 2013). They allow us to match 
contigencies, spatial cenarios or emotional states to specific cues and memory traces, being for 
such reason important for our cognitive capabilities of recollection, associative learning, 
familiarity, anticipation and planning. In a commonly used CFC test setup, conditional stimuli 
(CS), such as light or a tone, are followed by a footshock (an uncoditional stimulus - US). This CS-
US pairings, that occur only in first test context, but not in a second one, will be the basis of a 
task that tests spatial (context fear) and nonspatial (cued fear memory) and that is, in part, driven 
by emotion. Lesional studies have showed that lesion in the DH produce impairments in 
contextual fear memory, but not in cued fear memory (Kim and Fanselow, 1992; Hunsaker et al., 
2008). In this test paradigm, the effects produced by ventrally confined lesions is not so linear. In 
fact, VH lesions, or transient neuronal inactivation (by muscimol infusion) cause severe deficits in 
cued fear memory, but also interfere with context fear memory (Rogers and Kesner, 2006; 
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Hunsaker and Kesner, 2008; Fanselow and Dong, 2010). This is in line with the growing notions 
that the hippocampus, although classically viewed as “memory center”, also regulates emotion, 
what should not be unexpected due to its many reciprocal connections to both neocortical and 
subcortical regions involved in numerous emotional dimensions. In this CFC paradigm, VH lesion 
are depriving the amygdala (which participates in mediating fear memory) from hippocampal 
input, which is only directly conveyed  by the VH. 
Moreover, the dorsal hippocampus proper has strong bidirectional connections with the medial 
septum, as well as with the posterior hypothalamic region, namely the supramammilary nucleus 
(Risold and Swanson, 1996; Fanselow and Dong, 2010), which are important pacemakers of 
hippocampal theta rythms (Vinogradova, 1995; Kocsis and Vertes, 1997). Hippocampal theta 
rythms (slow activity in the hippocampus) are selectively present during exploratory behavior and 
REM sleep and believed to serve a critical role in memory and navigation (O’Keefe and Nadel, 
1978; Buzsaki and Moser, 2013). 
In sum, the dorsal pole of the hippocampal formation participates in elaborate cognitive functions, 
related to spatial navigation and exploration, learning and mnemonic functions. As we will see, its 
ventral pole displays a curiously contrasting functional specialization. 
Ventral Hippocampus 
The ventral pole of the hippocampus establishes important bidirectional connnections with several 
amygdalar nuclei (Cenquizca and Swanson, 2007). Importantly, connections with lateral, 
basolateral and central amygdalar nuclei (Petrovich et al., 2001; Cenquizca and Swanson, 2007) 
are believed to be critical for the participation of the hippocampus in Pavlovian fear conditioning  5
(Maren and Holt, 2004). Here, the hippocampus is believed to play a critical role in bridging the 
gap between the conditioned stimulus (CS) and the unconditioned stimulus (US) in situations in 
which the CS and US presentations are separated by an empty interstimulus interval (i.e., a form 
of pavlovian conditioning known as trace conditioning). In agreement with this notion, is the report 
of a particular paradigm of trace conditioning - conditioned taste aversion - to be dependent on 
the VH (Koh et al., 2009). Together, the circuit composed by the VH, the amygdala and the 
prefrontal cortex (that also establishes a bidirectional monosynaptic connections with the ventral 
 Pavlovian fear conditioning: a form of classical conditioning where the CS (e.g. tone or light) is paired with an aversive US 5
(classically, a foot shock) that evokes a CR (e.g. freezing, acoustic startle response or autonomic arousal).  
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hippocampal pole) (Thierry et al., 2000) compose the neural substrate modulating fear (Mahan 
and Ressler, 2012). This is, at least in part, the reason why the hippocampus is believed to 
participate in the manifestation of stress-induced anxiety and other neuropsychiatric disorders 
(McEwen and Magarinos, 1997). 
Another important reciprocal connection of the VH that is worth analyzing, is the one established 
with the bed nucleus of the stria terminalis (BNST) (Dong and Swanson, 2006). In contrast to 
other forebrain regions (such as the hippocampus, the amygdala or the medial prefrontal cortex) 
that modulate hypothalamic neuroendocrine function, the anteromedial area of the BNST is known 
to have a direct projection to the hypothalamic perviventricular and paraventricular nuclei, where 
most secretory neurons synthesizing corticotropin-releasing hormone and thyrotropin releasing 
hormone are found (Markakis and Swanson, 1997). Indeed, BNST has an important 
neuroendocrine role in stress and anxiety (Walker et al., 2003; Sink et al., 2013; Micioni Di 
Bonaventura et al., 2014), and the activity of the the PVN is believed to be modulated by the VH, 
through the BNST (Zhu et al., 2001; Herman et al., 2004; Herman et al., 2005). Reinforcing the 
role of the VH in stress and anxiety-like behavior, is the study of Kheirbek et al., where 
optogenetically-induced activation of dentate granule cells in the VH, but not in the DH, promoted 
a significant suppression of innate anxiety, tested in several test paradigms (Kheirbek et al., 
2013). This VH-BNST-Hipothalamic circuit, may also mediate the hippocampal modulation of 
hypothalamic nuclei functions, as part of what has been designated by Swanson as “behavioral 
control column", that accounts for the elicitation of neuroendocrine and autonomic responses 
underlying ingestive (Swanson, 2000) and social behaviors, namely reproductive and defensive 
behaviors (Dong and Swanson, 2006). 
Also within the hypothalamus, the suprachiasmatic nucleus and dorsomedial nucleus receive 
ventral hippocampal projections (Kishi et al., 2000; Cenquizca and Swanson, 2007). These brain 
nuclei are involved in depressive behavior and circadian sleep-wake and corticosterone rythms 
(Bellinger et al., 1976; Chou et al., 2003; Saper et al., 2005; Nollet et al., 2011), thus regulating 
sleep and affective states (McClung, 2011; McClung, 2013). 
Another important connection of the hippocampal ventral pole to be noted is the one established 
with the ventral striatum. In particular, the ventral hippocampal and entorhinal areas send 
projections to the nucleus accumbens shell (Naber and Witter, 1998; Voorn et al., 2004), placing 
the VH in a position to modulate motivation and reward-seeking behavior (Strange et al., 2014), as 
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hippocampal projections to the NAc have already been shown to be able to control information 
processing in the NAc (O'Donnell and Grace, 1995; Goto and O'Donnell, 2001). 
Finally, and although it might not be a role that we commonly enumerate when referring to 
hippocampal functions, associations between normal hippocampal activity and motor function has 
been long known (Vanderwolf, 1969). Globally, studies have demonstrated that stimulation of the 
VH, but not of the DH, recrute NAc and dopaminergic circuits functions, resulting on increased 
locomotion (Bardgett and Henry, 1999; Legault et al., 2000; Zhang et al., 2002). Indeed, reward- 
and goal-directed functions have been attributed to the rodent ventral hippocampus, in light of the 
view of the ventral striatum and NAc as the interface between the limbic system and motor 
circuits (Mogenson et al., 1980; Pennartz et al., 2011). It should be noted, however, that the DH 
may also be important, as it seems to be the locci where encoding occurs, although the major site 
of projections is indeed in the intermediate and ventral domains of the hippocampal formation 
(Bast et al., 2009; Strange et al., 2014). 
Hence, the ventral hippocampal pole integrates brain circuits responsible for anxiety and fear, 
stress response, reward-seeking behavior, affective states, neuroendocrine functions and social 
behaviors with a strong emotional component, functions likely to be attributed to its integration in 
Papez circuit. 
Indeed, this functional segregation has contributed to a classical (and perhaps oversimplistic) view 
of hippocampal function that confers to the DH the label of “cold hippocampus”, a designation 
that refers to its role on cognitive functioning (orientation, memory, navigation and exploration), 
while the ventral “hot” hippocampus is regarded as an emotional processor (motivated behavior, 
neuroendocrine responses, stress, anxiety and fear). However, although a dorsal-ventral dichotomy 
do exist, a more in depth analysis of both the anatomical and functional organization of the 
hippocampal formation reveals that the functional segregation of these two regions is not strictly 
defined. In fact, it as long been proposed by anatomical studies, and more recently by 
transcriptomic and functional studies that despite the existence of different hippocampal domains, 
the transitions are gradual rather than strict, and intermediate hippocampal regions of the 
hippocampal septo-temporal axis may exhibit neuroanatomical and molecular aspects of both the 
septal and temporal poles (Strange et al., 2014). In fact, a ill-defined transitional area, called by 
some authors as the intermediate hippocampus, precludes the delineation of a clear anatomical 
and functional DH-VH boundary, due to its mixed connectivity and molecular signatures. This 
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“anatomical and functional hippocampal continuum” is likely to be an important source of what 
may be taken as contrasting or discrepant results that continue to emerge in several reports 
seeking to explore the still many unknowns of post-natal hippocampal function.   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 1.2  
Neural Plasticity in the Adult Hippocampus 
Similarly to what history has unfold in other fields of science, neuroscience’s notions and concepts 
have mutated and evolved along times. Contrasting to its foundations, a pivotal aspect of modern 
neuroscience is its appreciation of the extraordinary and complex mutability of the central nervous 
system (CNS). This so-called plasticity is but the mirror of the CNS’s ability to redesign neural 
pathways function and anatomy in response to everyday life experiences, but also in the advent of 
injury or disease. This plasticity can occur in many forms, ranging from simply functional 
adaptations (functional plasticity) to more anatomical and morphological reorganization of circuits 
(structural plasticity). In this section I will focus on hippocampal neural plasticity and how it 
contributes to hippocampal circuitry and function. 
1.2.1 ADULT HIPPOCAMPAL CELL GENESIS 
New cells in the adult brain 
In the beginning of the 20th century, Santiago Ramon y Cajal argued that new neurons were only 
generated during prenatal development (Ramon y Cajal, 1993). One could say that Cajal 
observations were quite accurate, if considering that at the time there were no tracing methods to 
label and determine the fate of newborn cells. As a result, Cajal’s decree of “fixed and immutable 
neural paths” prevailed for more then half a century. It was only in the late 60’s, with the recent 
development of [H3 ]-thymidine cell labelling, that Joseph Altman and colleagues were able for the 
first time to describe the generation of new neurons in various regions of the adult rat brain (Altman 
and Das, 1965; Altman and Das, 1966; Altman, 1969). At that time those studies received little 
attention, perhaps in favor of the subsequent reports by Rakic failing to detect the generation of new 
cells in the adult monkey brain (Rakic, 1985). In the late 70’s this topic was revisited, with a report 
showing that some [H3 ]-thymidine labelled cells survived for 30 days in the adult hippocampal DG 
and in the olfactory bulbs, and that these cells exhibited ultrastructural features of neurons (Kaplan 
and Hinds, 1977; and subsequently in Kaplan and Bell, 1983).  These neurons were shown to send 
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projections along the mossy fibers tract to the hippocampal CA3 region (Stanfield and Trice, 1988). 
Besides the rediscovery of the generation of new neurons in the adult rat brain, Kaplan and Hinds 
(1980) also reported the generation of new astrocytes and oligodendrocytes in the adult rat cortex. A 
major turning point in the strong resistance that adult cell genesis (a process also referred as adult 
cytogenesis) has encountered, was provided by Paton and Nottebohm (1984), in a study conducted 
in adult canaries, showing that newly generated neurons incorporated pre-existing functional circuits 
and exhibited vigorous electrophysiological responses to auditory stimuli. This study provided the first 
evidence of the functional relevance of adult generated neurons, and perhaps most importantly, 
emphasized the importance of studying and characterizing the true potential of these cells 
(Nottebohm, 2004 ). Following these breakthroughs, in the 90’s adult neural stem cells (NSCs) were 6
successful isolated from the rodent brain (Reynolds and Weiss, 1992) and subsequently from the 
human brain (Kukekov et al., 1999). Eventually, the description of Bromo- and Iododeoxyuridine 
(thymidine analogs) as a new approach for detection of DNA replication (Gratzner, 1982) fueled the 
growth of the field, and soon neurogenesis was reported in several mammal species (Ming and 
Song, 2005;Gould, 2007), including in humans (Eriksson et al., 1998).  
Adult Hippocampal Neurogenesis 
Today it is well established that adult cytogenesis, a process defined as comprising the 
generation, differentiation and integration of new cells in the pre-existing brain neuronal networks, 
occurs in the adult brain (Gage, 2000). The generation of new neurons - neurogenesis - prevails 
throughout life in discrete brain areas (Doetsch et al., 1999; Gage, 2002). Such spatially defined 
brain regions where neurogenesis occurs, known as neurogenic niches, display a permissive 
microenvironment for the maintenance and differentiation of neural stem cells and to their 
proliferation. Up to now, only two regions of the brain have been consensually labelled as 
neurogenic niches in the mammalian brain: the subependymal zone (SEZ) lining the lateral 
ventricles  and the subgranular zone  (SGZ) of the hippocampal DG. I shall focus my attention on 7 8
the latter. Within the hippocampal DG, newly-born cells are generated throughout the SGZ and 
after becoming committed to the neuronal lineage, they migrate towards the granule cell layer 
 Nottebohm (2004), provides a comprehensive view of the serie of elegant works developed in songbirds, that contributed to 6
elucidate the process of adult neurogenesis and its role in auditory processing in these animals.
 In the SEZ the precursor cells are mostly found in the anterior segment of the walls of the lateral ventricles. Here, newly-born 7
precursor cells generate neuroblasts that will migrate along the rostral migratory stream (RMS), reaching the olfactory bulb 
(OB), where they fully differentiate mostly into granule inhibitory interneurons (Chumley et al. 2007; Wu et al. 1999).
 The hippocampal subgranular zone (SGZ) corresponds to a narrow band of about 2-3 cell layers wide, lying between the 8
granule cell layer and the hilus.
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(GCL), where they mature to become granule neurons, predominantly excitatory glutamatergic 
neurons (Seri et al., 2004; Brill et al., 2009) (Figure 4) . 9
 Here, we use an inclusive definition of “cytogenesis”, encompassing the multi-potent capacity to generate new cells from 9
both neuronal and glial lineages. We refer to the process of generation of new cells specifically from neuronal, astroglial or 
oligodendroglial lineages as neurogenesis, astrogliogenesis or oligodendrogliogenesis, respectively.
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Figure 4. Cytogenesis9 in the adult mammalian brain. a. Two cytogenic niches are consensually 
accepted to exist in the adult mammalian brain, and have been identified in several species: the 
hippocampal dentate gyrus (DG) and the subpendymal zone (SEZ) - olfactory bulb (OB) system (SEZ-OB 
system). The hypothalamus is increasingly accepted as the third cytogenic niche of the adult brain. Although 
adult cytogenesis has been reported in many different areas, several contradictory reports exist. b. Within the 
hippocampal DG, neural stem cells (radial glia-like cells) are present in the subgranular zone (SGZ). From 
these cells, new progenitor cells are formed and migrate towards the granular cell layer (GCL) where they 
fully differentiate into mature granule neurons (neurogenesis). Alternatively, progenitor cells may become 
commited to the glial lineage, giving rise to new astrocytes (astrogliogenesis). c. Both cytogenic processes 
occur though a series of sequential steps (less well characterized in the astrogliogenic process), that can be 
staged using specific immunohistochemical markers (see main text for further detail). RGLs- radial glia-like 
cells. TAPs- transient amplifying progenitors. © Mateus-Pinheiro 2016.
The process of adult hippocampal neurogenesis, which in many aspects largely recapitulates 
embryonic neurogenesis (Esposito et al., 2005), can be described in 4 sequential phases: i) a 
percursor cell phase, ii) an early elimination-survival phase, iii) a post-mitotic migration and 
differentiation phase and iv) a late maturation phase. The percursor cell phase (PCP) corresponds 
to the expansion of the pool of multipotent cells residing in the hippocampus. The hippocampal 
SGZ harbors an heterogeneous precursor cell population, distinctly identifiable through particular 
cell markers that each cell type expresses (Ming and Song, 2005) (some of them listed in Figure 
4). Following similar observations made in the SEZ (Doetsch et al., 1999), Seri et al. described 
that neural stem cells (NSCs) residing in the adult hippocampus had astrocyte-like properties, 
displaying radial morphology (Seri et al., 2001). These radial glia-like cells (RGLs, alternatively 
called type-1 cells) express the glial fibrillary acidic protein (GFAP) and neural stem cell protein 
(nestin), two intermediate filament proteins (Seri et al., 2004). They present different modes of 
division, either displaying symmetric divisions to expand the type-1 progenitor cell pool, or 
undergoing asymmetric divisions to give rise to intermediate progenitor cells (type-2 cells, also 
known as transiently amplifying neural progenitors or simply TAPs). TAPs have higher proliferative 
activity and within this cell population, two subsets have been identified: type-2a cells no longer 
display radial morphology, but still display radial glial markers (GFAP and Nestin); type-2b cells, in 
the other hand, are negative for GFAP and start to present the first marks of neuronal lineage 
choice, namely the transcription factors NeuroD1 and Prox1 (the latter, specific from granule 
neurons of the dentate gyrus) (Oliver et al., 1993; Steiner et al., 2006). TAPs receive the first 
synaptic input (GABAergic input), becoming able to respond to external stimuli (Tozuka et al., 
2005) and increase cell proliferation to promote pool expansion. Among type-2b, expression of the 
microtubule associated protein doublecortin (DCX) is the first indication of neuronal lineage 
commitment. Its expression is maintained in type-3 cells, that no longer express GFAP or nestin, 
and is extended during approximately 2-3 weeks after cell-cycle exit, in a post-mitotic phase 
(Francis et al., 1999; Rao and Shetty, 2004; Plumpe et al., 2006). 
 Following the PCP, comes one of the most critical steps of adult neurogenesis, here designated 
as the early elimination-survival phase (eESP). In an initial survival checkpoint, Sierra and 
colleagues (2010) have shown that the large majority of newborn cells undergo death by 
apoptosis, within the first 4 days since birth. The  surviving cells, that had been tonically activated 
by ambient GABA released from local inter-neurons (Bhattacharyya et al., 2008), will then start 
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receiving GABAergic synaptic inputs (Ming and Song, 2011). Latter, this is also the phase were 
new cells establish synapses to the target area CA3, and when they start to receive the first 
glutamatergic synaptic input (Tozuka et al., 2005; Christian et al., 2014). In fact, a latter 
elimination-survival checkpoint occurs around week three, when survival of new neurons is 
dependent on NMDA-related synaptic activity (Tashiro et al., 2006). Quite surprisingly, at the end 
less than 25% of newborn neurons survive and integrate pre-existing circuits (Christian et al., 
2014).  
In the post-mitotic migration and differentiation phase (MDP), cells that have exited cell-cycle 
undergo a serie of developmental processes, including axonal elongation, dendrite extension and 
increased synaptic plasticity, while migrating into the GCL. During this period they start to express 
markers such as the neuronal nuclei epitope NeuN and the calcium-binding protein calbindin 
(Brandt et al., 2003). Eventually newborn neurons attain structural integration around weeks 4-5 
(Esposito et al., 2005; Zhao et al., 2006). Finally, in late maturation phase (LMP) new neurons 
undergo a phase of maturation of dendritic spines and increased synaptic plasticity, and 
according to some authors, only become electrophysiologically indistinguishable from the 
remaining pre-existing mature neuronal population some weeks later (van Praag et al., 2002; 
Ambrogini et al., 2004). Importantly, all above mentioned steps are finely tuned by a serie of 
epigenetic and transcriptional mechanisms, extensively reviewed elsewhere (Mateus-Pinheiro et 
al., 2011; Hodge et al., 2012).  
 In addition to the hippocampal DG and the SEZ-OB system, some authors have presented 
evidence for adult mammalian neurogenesis to occur in other brain regions, including cortex 
(Gould et al., 2001; Tamura et al., 2007), hypothalamus (Kokoeva et al., 2005; Perez-Martin et 
al., 2010), the striatum (Dayer et al., 2005; Cho et al., 2007), amygdala (Rietze et al., 2000; 
Bernier et al., 2002), cerebellum (Ponti et al., 2010), substantia nigra (Zhao et al., 2003), 
brainstem (Bauer et al., 2005), among others (see Bonfanti and Peretto, 2011 for review). Indeed, 
many of these studies provide compelling evidence supporting the idea that adult neurogenesis 
may be more regionally widespread than what was initially believed. However, this is still a matter 
of debate, as many conflicting reports exist and caution is needed in the interpretation of some 
findings that might be the direct result of experimental manipulations. In humans, hippocampal 
neurogenesis occurs in an comparable extent in middle-age individual and rodents (Eriksson et al.,
1998; Spalding et al., 2013) and, curiously, appears to show a much less pronounced decline 
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with aging (Spalding et al., 2013). In addition, human neuroblasts are also formed in the lateral 
ventricles, but do not populate the olfactory bulbs (Bergmann et al., 2012). Instead, it has been 
quite recently shown, by a carbon-14 dating approach, that these neuroblasts integrate in the 
human striatum (Ernst et al., 2014).    
Adult Hippocampal Gliogenesis 
While neurogenesis prevails throughout life in discrete brain areas, the generation of new glial 
cells (a process known as gliogenesis) is not regionally restricted in the adult brain (Kriegstein 
and Alvarez-Buylla, 2009; Ninkovic and Gotz, 2013). Most of the proliferating progenitors detected 
outside the neurogenic niches, are NG2 and Olig2 (Dimou et al., 2008; Simon et al., 2011), 
although they have also been found in the hippocampal SGZ  (Encinas et al., 2011). They generate 
glial cells, mostly from the oligdendroglial lineage, a gliogenic process therefore called 
oligodendrogliogenesis. Curiously, while most of Olig2-positive cells generate mature myelinating 
oligodendrocytes in white matter regions of the adult cerebral cortex, in the gray matter they give 
rise mostly to NG2-positive glia, that persists in these regions (Dimou et al., 2008). Reports of 
widespread NG2/Olig2-positive proliferating cells were also reported in humans (Geha et al., 
2010), but functional correlates of adult oligodendrogliogenesis are still scarce. 
Another form of gliogenesis occuring in the adult hippocampus proceeds from the duality of cell 
fate choices of hippocampal RGLs. In fact, RGLs generate not only new neurons through TAPs, but 
also astrocytes - astrogliogenesis (Bonaguidi et al., 2012) (Figure 4). Indeed, through in vivo 
clonal analysis it has been shown that RGLs undergo multiple rounds of self-renewal and 
differentiation to produce both neurons and astrocytes (Bonaguidi et al., 2011; Dranovsky et al., 
2011; but see Encinas et al., 2011 for a contrasting RGL proliferation-differentiation model). The 
process of  adult hippocampal astrogliogenesis and its regulation has merited much less attention 
when compared with its neurogenic counterpart. Tanigaki et al. (2001) proposed that Notch1 and 
Notch3 promoted the irreversible commitement of progenitor cells towards astroglial fate. More 
recently, using adult DG derived neural percursor cells, it has been suggested that glial cell line-
derived neurotrophic factor (GDNF) can promote astrogliogenesis, through the activation of the 
signal transducer and activator of transcription 3 (STAT3; Boku et al., 2013).  
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In respect to the functional importance of hippocampal astrogliogenesis, until now there are no 
studies specifically addressing the role of this form of adult plasticity in physiological and 
behavioral responses. However, and also according to data that I will present and discuss later on 
this thesis, hippocampal RGLs can be the source of both newborn neurons and astrocytes, 
supporting the consequent notion that the existing studies using cytogenic ablation approaches 
are likely to affect unselectively these two cell lineages. Hence, it becomes licit to believe that the 
presumably “neurogenesis functional correlates” described so far are (with few exceptions) more 
likely to be cytogenesis functional correlates, encompassing the contribution of both newborn 
neuronal and astroglial populations.  
Functional correlates of adult hippocampal cytogenesis 
Understanding how new cells in the adult hippocampus can reshape brain circuits and affect 
different behavioral functions is a remarkably complex and demanding task. This complexity 
emerges primary from the difficulty to precisely segregate the function of newborn cells from the 
preexisting neuron-glia cell network in which they are integrated. When attempting to construct an 
integrative view of evidence gathered so far, the second major source of entropy lies in the 
diversity of models and approaches that have been used to study this topic. In fact, there is 
sufficient evidence to support the notion that cytogenesis functional roles are variable according to 
(i) factors that are intrinsic to the studied animals (eg. young adult vs old; female vs male), (ii) 
experimental interference (eg. physiological/basal conditions vs disease states or pharmacological 
interventions) and (iii) the time-window of the analysis (eg. newly-formed cells vs 6-weeks old, 
fully integrated new cells). Hence, I will begin by summarizing key findings associating 
hippocampal cytogenesis with cognitive functions in the mammalian brain, focusing mainly on 
evidence gathered by studies that have used cytogenesis ablation approaches (Figure 5). 
Memory and Forgetting. Impaired hippocampal cytogenesis has been implicated in spatial memory 
deficits in several studies (Snyder et al., 2005; Dupret et al., 2008; Imayoshi et al., 2008; Garthe 
et al., 2009; Lemaire et al., 2012). In particular, Snyder and colleagues (2008) have shown that 
irradiated animals presented deficits in the Morris Water Maze (MWM) task. However, irradiation 
just before testing did not produce memory deficits, again supporting the current view that the 
reported implications of hippocampal cytogenesis are highly variable according to the adopted 
experimental timeframe. The importance of considering a longitudinal perspective was again 
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recently supported by showing that cytogenesis ablation 1 week prior testing produced no effects 
on spatial memory, whereas the same analysis 2 and 4 weeks post-ablation revealed significant 
deficits post-ablation (Denny et al., 2012). Importantly, cytogenesis ablation has been suggested 
to impact specifically in spatial reference memory in the water maze, without having effects on the 
cue-guided or egocentric orientation versions of the test (Dupret et al., 2008). Although still 
controversial, the diversity of approaches and time-points of analysis may account for the reason 
why some authors describe no alterations in spatial memory upon hippocampal cytogenesis 
ablation (Shors et al., 2002; Saxe et al., 2006; Wojtowicz et al., 2008; for discussion see Leuner 
et al., 2006). Moreover, it was recently proposed that hippocampal cytogenesis is also relevant in 
forgetting (Akers et al., 2014). The authors propose that increasing neurogenesis after memory 
formation, either by voluntary running or by memantine or fluoxetine administration, is sufficient 
to induce forgetting in adult animals.  
i i24
Figure 5. The plastic hippocampus and functional correlates of hippocampal cytogenesis. 
a. The hippocampus harbors different forms of neural plasticity, ranging from functional synaptic 
plasticity (e.g. long-term potentiation or long-term depression) to different types of structural plasticity, 
namely neuro-glial morphological remodeling and hippocampal cytogenesis. b. Adult hippocampal 
cytogenesis has been implicated in different cognitive domains, such as reference memory, behavioral 
flexibility and pattern separation/completion. The participation of adult hippocampus in emotional 
behavior (e.g. depressive- and anxiety-like behavior) have also been suggested, although this is still a 
topic of controversy. © Mateus-Pinheiro 2016.
Behavioral Flexibility and Spatial Search Strategies. In behavioral neuroscience, behavioral flexibility 
is the adaptive ability to favor or ignore the use of familiar associations when either intrinsic or 
extrinsic contingencies change (Burghardt et al., 2012). As it was also proposed before through 
computational network simulations (Wiskott et al., 2006;Gage et al., 2008), several authors have 
reported impaired behavioral flexibility after cytogenesis ablation (Garthe et al., 2009; Burghardt 
et al., 2012; Garthe et al., 2014). Indeed, 12 weeks after irradiation mice showed no deficits in 
learning the position of the shock zone in an active place avoidance task. However, animals 
presented deficits in learning to avoid the shock zone if its position was changed over trials, when 
compared with animals with active cytogenesis (Burghardt et al., 2012). Another form of cognitive 
process that has been suggested to be dependent on ongoing hippocampal cell genesis, is related 
to the adopted search strategies in the classical water maze (Garthe et al., 2009; Gu et al., 2012; 
Garthe et al., 2014). In fact, it has been suggested that although typically analyzed parameters 
(such as path length or latency to escape) reflect how efficiently spatial memory is consolidated, 
information related with the animal’s cognitive spatial representation and the consequent 
efficiency of spatial navigation is usually overlooked (Garthe and Kempermann, 2013). Through a 
series of works, the authors advocate and present evidence showing that performance in the 
water maze depends on the successful integration of egocentric route-base information into 
allocentric representations, the latter depending on the ability to encode new information through 
the generation of new neurons (and presumably also astrocytes) in the adult hippocampus 
(Garthe and Kempermann, 2013; Garthe et al., 2014).  
Pattern Separation and Pattern Completion. The concept of pattern separation (PS) and how it 
relates to underlying neural networks is still controversial. In computational and behavioral terms, 
PS corresponds to the neural mechanism of storing successive patterns of input stimuli into 
distributed networks. It is considered a form of counteracting catastrophic memory interference , 10
thereby avoiding that recent memory traces conflict with and degrade previously consolidated 
ones (Wiskott et al., 2006; Abrous and Wojtowicz, 2015). In both animals and humans, 
hippocampal cytogenesis deficits have been associated with the long-term manifestation of pattern 
separation impairments (Leutgeb et al., 2007; Leutgeb and Leutgeb, 2007; Bakker et al., 2008; 
Clelland et al., 2009; Arruda-Carvalho et al., 2011; Denny et al., 2012; Niibori et al., 2012). 
 Catastrophic interference: is the phenomenon in which successive patterns of incoming stimuli overwrite the existing patterns 10
to the point of the latter being unrecognizable (McClelland et al. 1995; Abrous and Wojtowicz, 2015)
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Interestingly, Nakashiba and colleagues (2012) have proposed that adult born neurons in different 
maturation stages are important not only to PS but also to Patter Completion (PC). Contrastingly 
to PS, PC is the neural mechanism in which a degenerated recent input pattern is resolved 
through the retrieval of an intact previously stored pattern (Leutgeb and Leutgeb, 2007). In fact, 
the authors show that while young newborn neurons contribute to pattern separation, older 
newborn granular neurons switch their function, becoming important for pattern completion 
(Nakashiba et al., 2012).  
Before discussing how hippocampal cytogenesis has been related to emotional behavior, a 
conceptual disambiguation is needed. Growing evidence has been supporting the prevalent notion 
that rodents can express different emotional states (Ben-Ami Bartal et al., 2011; Wohr and 
Schwarting, 2013; Decety et al., 2016). However, these are naturally extremely difficult to 
characterize or quantify with currently available methods, and impossible to precisely model in 
rodents (Cryan and Holmes, 2005). In this perspective, it is impossible to be sure wether we are 
(or will ever be) able to evaluate mood and anxiety in animals, as this evaluation depends chiefly 
from the individual self-examination of his inner state and how he conveys the information to the 
observer. However, within the fields of pharmacological and behavioral neurosciences, there is a 
large bulk of evidence supporting the construct and face validity of behavioral test paradigms that 
are believed to translate “emotional status” of the animals. Such examples include mood-related 
dimensions such as behavioral despair or anhedonic  behavior or anxious-like behavior, as for 11
instance neophobic  behavior (see Section 1.3). Hence, I will briefly summarize findings 12
relating hippocampal cytogenesis impairments with deficits found in those test paradigms (for a 
more in depth review see Petrik et al., 2012 and Tanti and Belzung, 2013).  
Mood-related behavior. One of the first hints on the potential association between adult cytogenesis 
and mood disorders, were provided by the demonstration that corticosterone suppressed the 
generation of new neuronal and glial cells in the adult DG (Gould et al., 1992). This notion was 
further supported by later studies showing that activation of serotonergic receptors promoted 
hippocampal cytogenesis (Gould, 1999), while serotonin depletion in the adult rat brain was 
associated with decreased cytogenesis (Brezun and Daszuta, 1999).  
 Anhedonia: the inability to enjoy pleasure from a formerly pleasurable experience. It is core symptom in the clinical 11
presentation of depressive spectrum disorders. 
 Neophobia: is the persistent or heightened fear/anxiety in face of something new. In rodents, neophobic behavior is typically 12
assessed in test paradigms where animals approach a new and unknown environment.
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In cytogenesis ablation studies it is difficult to establish whether cytogenesis ablation per se is 
sufficient to induce behavioral deficits in emotional dimensions such as anhedonic behavior. In 
fact, anhedonic behavior has been reported after cytogenesis suppression in rodents (Snyder et 
al., 2011) and also in non-human primates after bilateral hippocampal irradiation (Perera et al., 
2011). However, other works, including from our lab have found no association (Bessa et al., 
2009; Jayatissa et al., 2009; Surget et al., 2011). The same holds true for increased immobility in 
the forced swim test (FST), after cytogenesis ablation in naïve animals. While Snyder and 
colleagues (2011) report deficits in FST, several other authors present contrasting results (Holick 
et al., 2008; Bessa et al., 2009; Revest et al., 2009). Another critical aspect is the question of 
whether hippocampal cytogenesis is required for the action of pharmacological or somatic 
treatments, such as antidepressants or for instance electroconvulsive therapy (ECT). I will tackle 
this topic in the next section. 
Anxious-like behavior. The participation of hippocampal cytogenesis in the control of anxiety-related 
behavior is another topic of much controversy. Anxiety-like behavior after cytogenesis ablation in 
naïve animals has been reported in several test paradigms, namely the novelty supressed feeding 
(NSF) (Bessa et al., 2009), the elevated plus maze (EPM) (Revest et al., 2009) and the light/dark 
test (Revest et al., 2009; Fuss et al., 2010). Again, several studies that followed various ablation 
approaches and experimental timeframes presented apparently discordant results (Santarelli et 
al., 2003; Saxe et al., 2006; Surget et al., 2008).  
To conclude, several ablation studies have implicated hippocampal cytogenesis in different 
cognitive and emotional behavioral dimensions, in naïve animals. When reviewing current 
literature, contrasting results and views are evident, but the major source of incongruence lies on 
the still debatable participation of adult hippocampal cytogenesis in emotional behavior control. In 
section 1.3, I will further explore this topic adding evidence gathered from animal models of 
disease and pharmacological treatments. 
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1.2.2 ADULT HIPPOCAMPAL DENDRITIC PLASTICITY 
Although adult cytogenesis encloses great potential to modulate neural circuits and brain 
functions, another much massive phenomenon, occurring virtually all over the brain, is also 
responsible for the plasticity of the adult CNS. Such phenomenon refers to the highly dynamic 
dendritic plasticity that, theoretically, has the potential to occur in every single neuronal unit in the 
adult brain. Structural dendritic plasticity, along with dendritic functional plasticity , have been 13
intensively studied both in the developing and mature brain, and a systematic review of this topic 
is not within the scope of this introductory preamble. Instead, I will briefly highlight the 
importance of this form of plasticity in the adult brain, giving special emphasis to dendritic 
plasticity occurring within the hippocampus and its functional repercussions. 
Dendritic Plasticity in the Adult Brain 
Rewiring of neural networks is achieved either by collapsing (Bastrikova et al., 2008) and/or 
creating new synapses (Knott et al., 2006). This redesign of the synaptic scheme can be the 
result of the highly dynamic dendritic spines turnover (Trachtenberg et al., 2002) and re-routing of 
axonal projections (De Paola et al., 2006; as reviewed in Butz et al., 2009). Indeed, neural 
networks are profoundly plastic in the adult brain (Majewska et al., 2006) and have raised the 
interest of both experimentalists, but also computational neuroscientists (Verzi et al., 2005). 
Furthermore, adding to the long known notion that axon terminals contribute to structural 
plasticity in the adult brain (Wolf et al., 1989), the simplistic classical view that dendrites function 
as synaptic input collectors and conveyers of information to the soma has been revisited (Branco 
and Hausser, 2010). In fact, recent years have provided evidence demonstrating that the single 
dendritic branch may act as a fundamental unit of signaling in the mammalian brain (Branco and 
Hausser, 2010; Jia et al., 2010). This view exponentially increases the complexity and potential of 
this form of plasticity, as it massively increases the computational capacity of a single neuron in 
normal physiological conditions. Furthermore, within the mammalian brain dendritic structural 
plasticity can assume even a greater proportion in reactive conditions. In fact, even areas that are 
considered relatively stable, such primary sensory cortices (Grutzendler et al., 2002; Mizrahi and 
Katz, 2003) can undergo profound reactive neuroplastic changes in face of extrinsic insults (Jain 
 Disambiguation - Structural Dendritic Plasticity vs Functional Dendritic Plasticity. Theoretically, the concept of functional 13
plasticity considers synapses as variable amplification factors (synaptic strengths) within a hardwired network structure. In 
contrast to any forms of functional plasticity that change synaptic strengths without changing the anatomical connectivity 
between neurons, structural plasticity comprises changes in synapse numbers, axonal fibre densities, axonal and dendritic 
branching patterns, synaptic connectivity patterns (Butz et al., 2009).
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et al., 2000). This also holds true for the hippocampus. In fact, it has long been known that the 
hippocampal formation can express alternative forms of structural plasticity as a response to a 
structural lesion (Lynch, 1974; Butz et al., 2009). Indeed, the hippocampus seems highly prone to 
experience-dependent axonal and dendritic structural reconfigurations, such as environmental 
enrichment or voluntary exercise (Redila and Christie, 2006), as well as it is vulnerable to structural 
reconfiguration induced by deleterious stimuli, such as stress (Watanabe et al., 1992; Magarinos et 
al., 1996), or pathological conditions such as schizophrenia (Garey, 2010), autism spectrum 
disorders (Raymond et al., 1996; Durand et al., 2012) or depression (Duman et al., 1997; Bessa et 
al., 2009).  
Hippocampal Dendritic Plasticity in Learning and Memory 
Early studies using the sea slug Aplysia have provided the grounding evidence for the remodelling of 
synaptic architecture after non-associative learning and long-term facilitation (Bailey and Chen, 
1983; Glanzman et al., 1990). Today, there are several lines of evidence associating structural 
alterations within the hippocampus and its role in learning and memory formation (Lamprecht and 
LeDoux, 2004). A paradigmatic example is the correlation between the mossy fiber pathway (MFP) 
configuration and behavioral performance in several test paradigms (Rekart et al., 2007). This is 
shown by the positive correlation between the amount of CA3 that is innervated by the MFP in the 
rat hippocampus and performance in MWM (Prior et al., 1997). The association between the 
structural complexity of the MFP with learning and memory in a radial arm maze task (Crusio et al., 
1987) and a reversal learning task have also been reported (Schopke et al., 1991). Curiously, this 
association is bidirectional, as besides being possible to predict some dimensions of cognitive 
behavior from the structural richness of intrahippocampal circuits, these same circuits seem to be 
reshaped by experience-dependent mechanisms during cognitive tasks (Crusio et al., 1987; Lipp et 
al., 1988; Prior et al., 1997). Indeed, learning-induced growth of intra-hippocampal circuits has been 
reported in several studies (Ramirez-Amaya et al., 2001; Holahan et al., 2006). It is important to 
emphasize that in many aspects structural plasticity is indissociable from functional plasticity. 
Learning and memory consolidation are one of such examples, where many evidences exist showing 
the association between memory formation and a Hebbian  strengthening of existing synapses 14
(Melamed et al., 2004; Massey and Bashir, 2007; Raymond, 2007). In this context, structural 
 The most frequently postulated mechanism for synaptic plasticity is based on Hebb’s rule, which states that strengthening of 14
a connection between two neurons occurs, if both cells are simultaneously and repeatedly active (Hebb, 1949).  
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dendritic plasticity may hardwire those functional changes, as in the case of the generation of new 
synapses in close apposition induced by long-term potentiation (LTP), or when synapses are lost as a 
result of long-term depression (LTD) (Raymond, 2007; Becker et al., 2008; Butz et al., 2009). 
The participation of hippocampal structural dendritic plasticity in the control of emotional behavior is 
still an open question. However the correlation between the neuronal atrophy occurring in different 
cortico-limbic areas following chronic exposure to stress with mood- and anxiety-related deficits, 
together with the correlation between the reestablishment of structural dendritic morphology by 
antidepressant treatment and the improvement in the aforementioned behavioral deficits (Pittenger 
and Duman, 2008; Bessa et al., 2009) are one of the most consistent findings in literature that 
support the role of axonal and dendritic plasticity in emotional homeostasis.  
What about astrocytes? 
I will conclude this chapter with a final remark whose major purpose is to invigorate the need to 
revisit concepts and views in post natal plasticity, that have been classically neuron-centric. When 
referring to dendritic plasticity we are implicitly referring to neuronal cells, but these cells are not 
alone in the adult brain when it comes to the ability to rapidly adapt and change their morphological 
architecture. In fact, astrocytes, that best neurons in the adult brain in the proportion of 3 to 1, are 
also key players in redesigning adult neuroglial networks (Slezak et al., 2006). This is achieved via 
two general mechanisms. First, astrocytes are in close contact with synapses and control neuronal 
morphology by releasing factors that enhance or inhibit synaptic transmission (Zhang et al., 2003). 
Under the principles that we have already discussed, this can lead to the activity-dependent 
formation or elimination of new synapses. The same outcome is also achieved by the astrocytic 
secretion of a variety of factors that regulate dendritic and axonal growth, such as laminins (Liesi et 
al., 1983), neurotrophins (Althaus and Richter-Landsberg, 2000) or S100β (Donato, 2001). Second, 
astrocytes themselves are highly plastic and have the ability to change their morphology in a variety 
of contexts. There is evidence showing that astrocytes show altered morphology in response to 
environmental complexity (Jones and Greenough, 2002), as well as hypertrophy in relation to motor 
skills learning in rats (Anderson et al., 1994). Hippocampal LTP-induction has also been shown to 
promote morphological alteration in hippocampal astrocytes (Wenzel et al., 1991). Insight on how 
these astrocytic morphological alterations are molecularly regulated has been growing, and the 
association of impaired learning and memory performance with defects in astrocytic cytoarchitecture 
supports the hypothesis that astrocytes operate conjointly with neuronal assemblies to encode 
engrams in the adult brain (Slezak et al., 2006; Gibbs et al., 2008).      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 1.3 
Dysregulation of Adult Neural Plasticity in the 
Stressed Brain: a road to Depression? 
“Neither the prestige of your subjects and the power of your instruments, nor the extent of your 
planning can substitute for the originality of your approach and the keenness of your observation.”  
               Hans Selye  
So far, we have seen how hippocampal structure and topographical organization allow this brain 
region to integrate the neural circuits responsible for different cognitive processes and emotional 
behaviors. In addition, I have highlighted evidence supporting the importance of different forms of 
neuro- and glioplasticity, persisting in the adult brain, as the structural and functional substrates 
of some behavioral outputs. Understanding hippocampal function and how it is modulated by 
neuro-glial plasticity is the comprehensional basis to explore the question of how disruption of 
adult neural plasticity may integrate mechanisms of disease and recovery in the CNS.          
1.3.1 STRESS, NEURAL PLASTICITY & DEPRESSION: JOINING THE DOTS 
Starting point: Stress and the HPA axis  
The mundane use of the word “stress” in current days has its origins in the wealth of scientific 
work that Hans Selye’s pioneer research has propelled, in the beginning of the 20’s century. Using 
Selye’s own words, stress may be defined as “the non-specific response  of the body to any 15
demand for change” (Selye, 1936) and, in its physiological and adaptive essence, serves to 
promote the constancy of the “milieu intérieur” (as Selye would write as a reference to the work of 
the french physiologist Claude Bernard), that is to say, to maintain homeostasis, as we now prefer 
to term it (Selye, 1950). With the prolonged over-recruitment of the adaptive mechanisms elicited 
by stress exposure, the adaptive response is worn-out, triggering multi-systemic maladaptive 
 Selye originally alluded to the sum of all non-specific, systemic reactions of the body which ensue upon exposure to stress as 15
the general adaptation syndrome, later to be gradually replaced by the now common stress response.
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by stress exposure, the adaptive response is worn-out, triggering multi-systemic maladaptive 
effects (Selye, 1976; Tsigos and Chrousos, 2002). Such effects are related to both central and 
peripheral immune (Chrousos, 1995), metabolic and endocrine (Benker et al., 1990) 
disturbances, as well as the eventual installation of different systemic, neurodegenerative and 
psychiatric conditions (Herman and Cullinan, 1997; Dinan, 2005; Baumeister et al., 2014). 
In both adaptive and maladaptive responses, endogenous corticosteroids are one of the major 
effectors of the stress response. These steroid hormones are produced by the adrenal cortex and 
participate in many different systemic physiological processes (de Kloet, 2003). Their 
predominant role in either kidney water and ion transport, or carbohydrate metabolism allows for 
their classification in either mineralocorticoids or glucocorticoids, respectively. Aldosterone is the 
major endogenous mineralocorticoid, and although regional production of aldosterone in the brain 
has been reported, its functional repercussions in the CNS, beyond hemodynamic regulation, 
remain to be fully comprehended (Gomez-Sanchez et al., 2005). Hence, in light of current 
knowledge, circulating glucocorticoids - cortisol in humans, and corticosterone (CORT) in rodents - 
are the prime effectors of stress response. 
Corticosteroids, as lipophilic steroids, are long known to act on the brain (McEwen et al., 1968; Reul 
and de Kloet, 1985) and the harmful effects that ensue upon prolonged or excessive levels of 
corticosteroids, such as neuronal degeneration and cell loss, have also been early reported (Muhlen 
and Ockenfels, 1969; Sapolsky, 1985). Indeed, high secretion of corticosteroids is until now 
considered the major molecular signature of stress response (Sapolsky, 1996; Sapolsky, 2015).  
A key neuroendocrine system that translates an environmental threat or challenge  into a series of 
coordinated physiological responses that are part of the stress response is the so-called HPA axis 
(from hypothalamus-pituitary-adrenal axis) (Herman and Cullinan, 1997; Lupien et al., 2009) 
(Figure 6). Briefly, HPA axis stimulation upon stress exposure leads to the engagement of stress-
responsive brain regions, that include the hypothalamus, the hippocampus, the septal nuclei, the 
amygdala, the BNST and the PFC, among others (Cullinan et al., 1995; Lopez et al., 1999). 
Activation of these areas will then prompt neurons in the medial parvocellular region of the 
hypothalamic paraventricular nucleus to release corticotropin-releasing hormone (CRH) and 
arginine vasopressin (AVP). Within the pituitary gland, CRH will trigger the secretion of 
adrenocorticotropic hormone (ACTH), leading to the production of corticosteroids by the adrenal 
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The HPA axis, also elicits the activation of the sympathetic nervous system, the release of 
inflamatory cytokines and metabolic responses, all of which also encompass the overall stress 
response (de Kloet, 2003; Leonard, 2006). Importantly, the responsiveness of the HPA axis is 
largely determined by the ability of corticosteroids to regulate ACTH and CRH secretion, by binding 
to both glucocorticoid (GRs , also called type II corticosteroid receptors) and mineralocorticoid 16
receptors (MRs, also called type I corticosteroid receptors) in key areas such as the hippocampus 
and the PFC (Jacobson, 2005). In fact, once the stressor has subsided, negative feedback 
regulatory loops executed by glucorticoids in these areas will promote HPA downregulation. By 
contrast, brain regions such as the amygdala and some brainstem locci act as HPA activators 
when facing a challenge (Lupien et al., 2009).  
 GRs have about 10 times lower affinity than MRs for corticosterone, but display the highest affinity for the synthetic 16
glucocorticoid dexamethasone, which is often use to study the selective activation of GRs.
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Figure 6. Stress response: the sympatho-adrenomedulary system and the hypothalamic-
pituitary-adrenal (HPA) axis. a. Stress triggers a response by the sympathetic nervous system, which 
will stimulate the adrenal medulla to produce cathecolamines (adrenaline and noradrenaline) and 
inflammatory cytokines , that in turn will mediate the most immediate physiological alterations of stress 
response. b. In turn, the HPA axis will be responsible of triggering a long-term stress response. Briefly, 
limbic brain areas, such as the amygdala, promote the activation of the hypothalamic paraventricular 
nucleus to release corticotropin-releasing hormone (CRH). Within the pituitary gland, CRH will trigger the 
secretion of adrenocorticotropic hormone (ACTH), leading to the production of corticosteroids 
(mineralcorticoids and glucocorticoids). Corticosteroids will impact both peripherally and in the central 
nervous system, exerting a negative feedback control on the hypothalamus and pituitary, as well as in brain 
areas suggested to participate in the “shutting-down” of the HPA axis (e.g. hippocampus and prefrontal 
cortex). © Mateus-Pinheiro 2016.
CRH
The physiological activity of the HPA axis in many vertebrate follows a circadian rhythm (Herman 
et al., 1993), with a diurnal secretion peak coinciding with the begining of the active phase of the 
organism’s sleep-wakefulness cycle (light-phase in human, dark-phase in rodents), after which 
circulating corticosteroids rapidly decay to basal levels. As pointed before, this circadian pattern of 
activity is often disrupted in the context of maladaptive stress, leading to several deleterious 
effects in the brain. In relation to what we have been discussing in previous chapters, different 
forms of adult structural plasticity are often compromised following HPA axis dysregulation and 
hypercorticosteronemia.   
From stress to impaired plasticity 
As summarized above, there is a group of cortical and limbic regions, sometimes referred as 
stress-responsive areas, whose topographical organization and functional properties will determine 
their action in HPA axis regulation (as reviewed in Herman et al., 2005). Areas such as these 
include the amygdala, the hippocampus, the PFC, the BNST or the Striatum and structural and 
functional alterations in these regions are thought to be associated with glucocorticoid 
hypersecretion (or in some contexts, hyposecretion) seen upon chronic stress exposure or 
different neuropsychiatric disorders (Jacobson and Sapolsky, 1991; Pittenger and Duman, 2008). 
It is today also widely recognized that the mediation of synaptic remodeling and cytogenesis 
alterations in these brain regions is not a solo agent mission carried out by corticosteroids. 
Instead, they operate jointly with excitatory amino acids (Venero and Borrell, 1999), as well as 
with trophic factors such as brain-derived neurotrophic factor (BDNF) (Patterson et al., 1996; 
Govindarajan et al., 2006; Revest et al., 2014) and vascular endothelial growth factor (VEGF) (Cao 
et al., 2004), signaling molecules, as for instance protease tPA (Pawlak et al., 2005) and synaptic 
remodeling proteins such as neural adhesion molecule (NCAM) and synapsin (Syn) (Wellman, 
2001; Cook and Wellman, 2004). This complex regulatory and inter-dependent pathways are likely 
the source of contrasting plastic alterations observed in different brain regions upon chronic 
stress exposure, that will be summarized next (Figure 7). 
Hippocampus. Initial studies revealing how chronic stress and CORT induced loss of dendritic 
complexity in hippocampal CA3 were the spearhead of research that led to our current 
understanding on how stress has the ability to induce structural remodeling events in the adult brain 
(Watanabe et al., 1992; McEwen, 1999; Sousa et al., 2000). Within the hippocampus, stress 
exposure has also been shown to produce dendritic atrophy in apical dendrites of CA1 and granular 
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dentate neurons (McEwen, 1999). Besides dendritic shortening, spine density and spinogenesis have 
been reported to be decreased in hippocampus following stress exposure (Chen et al., 2008; Chen et 
al., 2010) (Figure 7). Moreover, in a recent study, Maras and colleagues showed that while the 
number of CA3 synapses was reduced both in the septal and temporal hippocampal poles, in CA1 
this effect was restricted to the septal hippocampus (Maras et al., 2014). These effects of chronic 
stress on structural hippocampal neural plasticity are largely reversible, as the mentioned 
morphological alterations are resettable to basal levels after the cessation of stress (McEwen et al., 
2016). As highlighted before, structural plasticity alterations are many times coupled with changes in 
functional plasticity. Indeed, never is this more true than in the hippocampus. Both in vitro and in vivo 
studies have demonstrate that stress and CORT impair LTP, and that repeated stress could mediate 
the switch from LTP to LTD (Diamond and Rose, 1994; Kim and Diamond, 2002). Notably, and 
supporting the functional heterogeneity of the hippocampal longitudinal axis (see Section 1.2), a 
recent work from our lab showed how stress produces contrasting effects on dendritic plasticity in the 
dorsal and ventral hippocampal poles. In fact, whereas in the DH, chronic stress triggered a 
volumetric reduction as a result of atrophy of CA3 and CA1 apical dendrites, in the VH there was an 
increase in hippocampal volume concurrent with the increase of CA3 apical dendrites (Pinto et al., 
2015). Furthermore, in the hippocampus, brain-derived neurotrophic factor (BDNF) has been the 
most widely studied molecular regulator of neural plasticity. Stress has been linked to reduced levels 
of BDNF, which in turn have not only been linked to impoverished dendritic arborization, but also to 
reduced hippocampal cytogenesis (Schaaf et al., 2000; Sairanen et al., 2005; Magarinos et al., 
2011; Lakshminarasimhan and Chattarji, 2012). Indeed, the DG appears to be highly vulnerable to 
the deleterious effects of stress, as impaired generation of new granule neurons (impaired 
neurogenesis), has been shown to be accompanied by loss of older pre-existing granule neurons 
(Pham et al., 2003), as also mimicked by CORT administration (Sousa et al., 1999). In addition, 
hippocampal glioplasticity appears also to be targeted by stress, as chronic stress was shown to 
decrease both the number and somal volume of astroglia (Czeh et al., 2006). These findings in 
animal models correlate and provide a possible explanation for the reduced hippocampal volume 
found in patients with disorders often accompanied by hypercortisolemia, such as PTSD or Cushing’s 
disease (Starkman et al., 1992; Bremner et al., 1995; Starkman et al., 1999).  
mPFC. Similarly to what happens in the hippocampus, chronic stress significantly reduces both 
structural and functional plasticity in the medial PFC (mPFC) (Figure 7). Stress exposure has been 
shown to reduce spinogenesis and dendritic complexity in layer II/III and layer V pyramidal neurons 
(Cook and Wellman, 2004; Radley et al., 2004; Cerqueira et al., 2007). These alterations have also 
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been reproduced by CORT administration (Watanabe et al., 1992; Wellman, 2001; Cerqueira et al., 
2005) and, as in the hippocampus, are reversible after subsiding stress exposure (Radley et al., 
2005; Liston et al., 2006). Molecular regulators mediating these alterations include TrkB and 
excitatory amino-acids  (Martin and Wellman, 2011), while it is still difficult to conciliate inconsistent 
findings regarding BNDF expression with the observed morphological alterations. Moreover, 
structural alterations are associated with functional plasticity effects, namely with the blunting of LTP 
response (Goldwater et al., 2009), as well as decreased LTD elicitation in brain slices of animals that 
had been exposed to stress (Zhong et al., 2008), the last being an apparent difference between the 
hippocampus and the PFC, whose functional importance remains to be unveiled. In addition, glial 
cells are also targeted by stress, as shown by the CUS-induced decrease in GFAP mRNA levels and 
impaired glial metabolism (Banasr et al., 2010). Accordingly, in humans the severity of PTSD 
symptoms is inversely correlated with the volumetric variation of the anterior cingulate region of the 
PFC (Woodward et al., 2006), and loss of gray matter has been documented as a result of exposure 
to adverse experiences (Ansell et al., 2012). 
Amygdala. The amygdala paradigmatically reflects how the effects of stress in adult plasticity are 
region-specific. In contrast to other limbic structures, chronic stress exposure is able to enhance 
synaptic plasticity in the amygdala (Vyas et al., 2002; Vyas et al., 2003; Drevets et al., 2008; but see 
also Banasr and Duman, 2007) (Figure 7). In fact, expanded dendritic branching and increased 
spinogenesis have been reported in spiny neurons of the basolateral amygdala (BLA) after 
prolongued stress (Roozendaal et al., 2009). These hypertrophic effects have been reported to be 
long-lasting, as they persist several weeks after stress (Vyas et al., 2004), which represents an 
unique feature of the temporal dynamic of structural plastic changes promote by stress, as in other 
areas these alterations are reversed some time after stress cessation. Interestingly, the levels of 
dendritic spine density in the BLA have been shown to be a good predictor of the anxiety state of 
animals (Rao et al., 2012). Stress-induced neuro-structural alterations have been recently shown to 
be accompanied by enhanced LTP in lateral amygdala (Suvrathan et al., 2014). Although the 
molecular regulation of structural plasticity in the amygdala is yet to be fully understood, studies 
have linked glucocorticoids action, the neurotrophic factor BDNF (Govindarajan et al., 2006) and the 
proteinase tPA (Bennur et al., 2007) to the increased dendritic spines densitiy and synaptic 
connectivity in this region. These neuroplastic alterations found in rodents are the likely effect of the 
over activation of the neural circuit responsible for fear and anxiety, and are translatable to humans, 
where both volume and activation have been found associated to stress-related disorders such as 
PTSD (Rauch et al., 2000; Shin et al., 2005). In addition, studies have found decreased glial cell 
i i36
i i37
Figure 7. Stress, antidepressants and adult structural plasticity. Chronic stress has been shown to 
impact different forms of structural plasticity in the adult brain. In the hippocampus (Hip), chronic stress 
promotes dendritic atrophy, along with astroglial somal atrophy and cytogenic impaiments. Different classes of 
antidepressant drugs were shown to revert these neuroplastic alterations. In the medial prefrontal cortex 
(mPFC), stress-induced dendritic atrophy is accompanied by alterations in glial metabolism and glial cell death. 
Drugs with antidepressant action have been shown to revert these neuro-glioplastic deficits. Contrastingly, in 
the amygdala (Amy), the bed nucleus of the stria terminalis (BNST) and the nucleus accumbens (NAc), chronic 
stress was shown to elicit hypertrophic effects on dendritic neuronal structure, that are reverted by 
antidepressants. The modulation of glioplasticity by stress or antidepressants in these regions remains 
unknown. © Mateus-Pinheiro 2016.
numbers in the amygdala of patients with PTSD, and depression, making glioplasticity a likely target.  
BNST. The activation of the BNST has been described to side with the amygdala in the response to 
stress and anxiety behavior (Walker et al., 2003; Hammack et al., 2009). Indeed, similarly to what 
happens in the amygdala, both CORT and chronic stress have been shown to increase dendritic 
lenght in anteromedial division of the BNST, as well as increased volume (Vyas et al., 2003; Pego et 
al., 2008) (Figure 7). These alterations have been associated to increased BDNF and TrkB receptor 
expression (Hammack et al., 2009). The effects of stress in functional plasticity have also been 
shown to be pronounced, as in the BNST stress has been shown to trigger the transition of LTD to 
LTP (Glangetas et al., 2013). To the best of our knowledge there are no reports addressing 
gliopasticity alterations in the BNST, or studies studying volumetric changes in this brain region in 
humans.  
Striatum. Although not typically included in the “stress-response neurocircuitry”, a brief reference to 
the striatum is mandatory, as striatal neuroplasticity have also been reported following stress 
exposure  (Pittenger and Duman, 2008; Dias-Ferreira et al., 2009). Briefly, several lines of evidence 
have provided insights on how chronic stress can produce neuronal remodelling in corticostriatal 
circuits, affecting decision-making and habit formation (in the dorsal striatum), as well as reward-
related behavior (in the ventral striatum) (Dias-Ferreira et al., 2009; Sousa and Almeida, 2012) 
(Figure 7). Regarding the latter, chronic stress can modulate synaptic strength of synapses in 
midbrain dopaminergic neurons (Saal et al., 2003), possibly leading to NAc dysregulation. 
Impaired neural plasticity as pathophysiological connector to depression  
Major depression (or Major Depressive Disorder, MDD) is a highly prevalent chronic psychiatric 
disorder, estimated to affect 350 million people worldwide (WHO, 2012), with a pooled anual 
incidence of 3.0% (Ferrari et al., 2013). Depression alone accounts for 4.3% of the global burden 
of disease and is among the largest single causes of disability worldwide (11% of all years lived 
with disability globally) (World Health Organization, 2013). According to the Diagnostic and 
Statistical Manual of Mental Disorders V (DSM-V; American Psychiatry Association, 2013), major 
depression symptoms include depressed mood and anhedonia, both considered core features of 
depression (Nelson and Charney, 1981) often accompanied by neurovegetative symptoms (such 
as asthenia and anorexia), feelings of despair, guilt and suicidal ideation (Hasler et al., 2004; 
American Psychiatry Association, 2013). The complexity of its clinical presentation is also 
reflected in the high comorbidity with anxiety, which has led to the suggestion of a common 
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pathophysiology for both conditions (Hettema, 2008). Also, cognitive dysfunction, namely changes 
in executive function, attention deficits, and memory impairments, have been reported in 
depressed patients (Castaneda et al., 2008; Gonda et al., 2015). The complexity and high 
heterogeneity of this clinical entity probably accounts for the fact that MDD neurobiological basis 
remains a difficult conundrum.  
 Several lines of evidence gathered both from clinical and preclinical studies have associated 
different pathophysiological mechanisms in the aetiology of the disease (see BOX 1), ranging 
from the more classical neurochemical unbalances (Castren, 2005), to include 
neuroimmunological responses (Maes, 2011),  and impairments in neural plasticity (McEwen et 
al., 2016). 
BOX 1. Pathophysiological elements suggested to be associated with Depression
Neurochemical 
Systems
Monoaminergic depletion has classically been associated with depression (Berton and 
Nestler, 2006). In addition, increased glutamate levels in depressed patients have also led 
to the assumption of glutamate excitoticity as a contributing factor to the neurobiological 
basis of the disease (Kucukibrahimoglu et al., 2009). Both views are supported by the 
observations that antidepressants can counteract these neurochemical unbalances (Milan 
et al., 2015).
Immune System Inflammation and cell-mediated immune activation have been linked to depression (Maes, 
1995, 2011). This neuroimmune etiological component of depression has been associated 
with immune response mediators such as interleukin-4 (IL-4) interleukin-6 (IL-6) and tumor 
necrosis factor alfa (TNF-α) (Dowlati et al., 2010).
Cell Signalling & 
Neurotrophins
Neurotrophins are important regulators of cell growth, proliferation and differentiation. 
Decreased levels of neurotrophins have been associated to stress exposure and 
depression (Duman, 2004, Duman and Monteggia, 2006). Moreover, neurotrophins, such 
as BDNF or VEGF have been associated with antidepressant action (Warner-Schmidt and 
Duman, 2007), further supporting the so-called neurotrophic hypothesis of depression.
Neural Plasticity Different forms of neuroplasticity, such as dendritic plasticity and hippocampal 
cytogenesis, have been linked to the pathogenesis of depression (McEwen et al., 2015). 
Moreover, glioplasticity has been also implicated as pathological target of the disease 
(Banasr et al., 2008). Several antidepressant classes have been shown to reverse 
impairments in adult neural plasticity (Patricio et al., 2015), substantiating the view o 
adult neural plasticity as fundamental pathological pilar of depression (see main text for 
further detail).
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Among the different ethiological factors of major depression, chronic stress exposure has been 
widely associated to the precipitation of the disease symptomatology (Pittenger and Duman, 
2008). Similarly to the deleterious effects of chronic stress exposure on structural and functional 
neural plasticity, dif ferent imaging and post-mortem studies repor t volumetric, 
neuromorphological and cytogenic alterations in patients diagnosed with major depression 
(Lorenzetti et al., 2009). In the amygdala, MRI studies suggest that amygdala size may vary with 
illness duration (Lange and Irle, 2004; Weniger et al., 2006; Monkul et al., 2007) and while in 
earlier stages of the disease patients tend to present increased amygdalar volumes (Lange and 
Irle, 2004; Weniger et al., 2006), with the progression and recurrence of depressive episodes, 
patients exhibit a reduction in amygdala volumes (Caetano et al., 2004; Hastings et al., 2004; 
Monkul et al., 2007), but different studies reporting volumetric variations in opposite direction are 
still difficult to conciliate (Campbell et al., 2004). Also, in the PFC, imaging studies suggest 
negative volumetric variations in MDD patients (Lacerda et al., 2004; Monkul et al., 2007), 
although other studies have failed to found this correlation (Bremner et al., 2000). Supporting 
neuroimaging studies, histopathological data shows lower cortical thickness and decreased 
neuronal size and density in prefrontal cortical regions (Rajkowska et al., 1999). Furthermore, the 
neuroplastic alterations caused by stress in the ventral striatum that affect the excitatory input into 
the NAc are likely to modulate the function of this brain region, whose dysfunction in depression is 
believed to be associated with anhedonic behavior (as reviewed in Nestler and Carlezon, 2006). 
The hippocampus is the most extensively studied region in the context of MDD and the associated 
structural alterations. Albeit some contradictory findings, several studies support the association 
between hippocampal volumetric reductions and MDD (Bremner et al., 2000; Shah et al., 2002; 
Sheline et al., 2003; Caetano et al., 2004; Frodl et al., 2004; Lange and Irle, 2004; Weniger et 
al., 2006). In addition, illness duration and severity appear to influence the reported finding 
(Lorenzetti et al., 2009), as decreased hippocampal volumes have been more frequently 
described in patients with history of multiple episodes, longer illness or more severe 
symptomatology (Sheline, 1996; Vakili et al., 2000; MacQueen et al., 2003; Caetano et al., 
2004). Accordingly, hippocampal neuronal atrophy have also been described in post-mortem 
brains of MDD patients (Stockmeier et al., 2004; Pittenger and Duman, 2008), but again some 
studies report no alterations in cell integrity or neuronal morphology in both MDD or bipolar 
disorder patients (Lucassen et al., 2001; Muller et al., 2001).  In addition, as it happens following 
chronic stress exposure, post-mortem studies revealed that MDD appears to be not only 
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associated with dendritic/ neuromorphological remodeling but also with decreased adult 
hippocampal cytogenesis (Jacobs et al., 2000; Miller and Hen, 2015). The theory that propounds 
that hippocampal cytogenesis is associated with the precipitation and treatment of depression has 
been named neurogenic hypothesis of depression (NHD) (Jacobs et al., 2000). Initially, this theory 
has stemmed from two main correlations relating hippocampal cytogenesis and depressive illness. 
First, the already discussed reduction of hippocampal volume in depressed patients and the ability 
of high levels of glucocorticoids to reduce hippocampal cytogenesis (Cameron and Gould, 1994). 
Second, the observation that serotonergic antidepressants can re-establish normal levels of 
hippocampal cytogenesis in the mammalian brain (Malberg et al., 2000), as further discussed 
bellow.  
In humans, due to technical limitations of directly labelling new cells, the full extent of the 
hippocampal cytogenic process has not been analyzed, but three studies have evaluated 
hippocampal neural progenitors in post-mortem brains of patients with depression, as a proxy 
measurement. While Reif and colleagues described no differences (Reif et al., 2006), a study by 
Boldrini et al. found a non-significant trend towards a decrease in hippocampal NSCs in 
depressed patients (Boldrini et al., 2009). In contrast, Lucassen et al., reported a significant 
reduction of precursor cells in non-treated depressed patients, comparing to age and sex-matched 
controls (Lucassen et al., 2010).  
In light of the limitations to directly measure the birth of new cells in humans, animal models of 
depression have been widely used to test the arguments in which the neurogenic hypothesis of 
depression is grounded. In most cases, the link between chronic stress and impaired 
neuroplasticity is used to model a depressive-like phenotype in rodents (Willner et al., 1992; 
Willner, 2005; Chattarji et al., 2015). Chronic stress exposure appears to recapitulate the 
association between psychosocial stressors and the precipitation of depression in susceptible 
individuals (Kendler et al., 1999; Caspi et al., 2003; Heim and Binder, 2012). The unpredictable 
chronic mild stress (uCMS)  protocol, originally developed by Paul Willner and colleagues, has 17
been commonly used and refined for more than 25 years to model depressive-like behavior in 
rodents (Willner, 1997). The uCMS protocol induces multi-dimensional behavioral deficits in 
rodents, that are arguably translatable to the human disease (Bessa et al., 2009; Hill et al., 
Consists on the continuous exposure to a set of mild stressors in an unpredictable fashion, over a relatively prolonged period 17
of time. The duration of the protocol is variable and usually ranges from 10 days to 8 weeks (Hill et al., 2012). A diversity of 
stressors is used to prevent habituation of the animals; this has been reported to occur when a single stressor is used over time 
(Willner, 2005). Unpredictability is another important feature of this model, acting as a reinforcing factor of the stress effect.
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2012). Not only they display mood-related deficits, such as anhedonic behavior, as they do present 
anxiety-like phenotype and different cognitive impairments (Bessa et al., 2009). Furthermore, the 
behavioral phenotype is accompanied by several neurobiological alterations, in HPA activation, 
neurotransmitter systems, neurotrophin levels and in neural plasticity, alike those that have been 
reported in patients with MDD (Willner, 2005; Hill et al., 2012). 
The use of these preclinical models of Depression has allowed to address two fundamental 
questions concerning the putative role of hippocampal cytogenesis in depression, whose answers 
remain debatable even if we stand more than 15 years past the initial proposal of the NHD. First, 
to explore the importance of hippocampal cytogenesis in etiology of the disease, which must still 
be clarified. In spite of several studies reporting the correlational findings of decreased 
proliferation in the hippocampus of both patients and animal models of depression, many 
contradictory reports exist (Tanti and Belzung, 2013). As discussed previously (see Chapter 2), 
cytogenesis ablation in rodents has been shown to produce cognitive deficits, which can be 
translatable to the cognitive dysfunctions often observed in MDD patients (Saxe et al., 2006; 
Clelland et al., 2009). However, in spite of studies reporting anxiety-like behavior and anhedonia 
following cytogenesis suppression, these results are apparently at odds in many other  works that 
have failed to find this association (see the following works for contrasting results, Santarelli et al., 
2003; Bessa et al., 2009; David et al., 2009; Revest et al., 2009; Fuss et al., 2010; Snyder et al., 
2011). In a previous work from our lab, treatment with the cytostatic drug methylazoxymethanol 
(MAM) in naïve animals to ablate cytogenesis produced short-term anxiety-like behavior, while not 
producing depressive-like behavior (Bessa et al., 2009). The different cytogenesis ablation 
procedures together with different experimental time-frames and analysis time-points are likely to 
account for the observed discrepancies, thus precluding the formulation of an unifying view of 
evidence gathered so far. Second, the putative relationship between the pro-cytogenic effect of 
antidepressants and their therapeutic efficacy must be further explored. 
1.3.2MODULATION OF HIPPOCAMPAL PLASTICITY BY ANTIDEPRESSANTS 
The second pillar supporting the importance of neural plasticity in depression derives from the 
reported effects of most antidepressant classes tested to date in both functional and structural 
adult plasticity (Figure 7). Neuroimaging studies conducted in MDD patients have shown that 
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treatment responders have larger hippocampal volumes than non-responders, although this was 
only observed in female patients (Vakili et al., 2000; Vythilingam et al., 2004). In another study, 
Sheline and colleagues (2003) found an inverse correlation between hippocampal volume in 
depressed patients and the duration of untreated illness, again supporting the role of a successful 
antidepressant treatment in the reversal and/or protection from hippocampal atrophy observed in 
unipolar depression. To the best of our knowledge, no post-mortem studies in humans have 
reported the correlation between increased hippocampal volume and the increase variation in 
neuronal dendritic lenght.  
Contrastingly to the lack of data available in humans, there is substantial evidence showing that 
chronic, but no acute, administration of antidepressants to animal models of depression do 
enhance both functional and structural hippocampal plasticity (McEwen et al., 2016). Indeed, 
several classes of antidepressants have been described to increase LTP in the DG (Stewart and 
Reid, 2000; Levkovitz et al., 2001). A similar enhancement of LTP has been described in CA1 
upon antidepressant treatment, blocking the blunt of LTP and the promotion of LTD both induced 
by stress (Vouimba et al., 2006;Holderbach et al., 2007). Moreover, the effects of antidepressants 
in functional plasticity appear not to be regionally confined to the hippocampus, but to modulate 
the communication of the hippocampus with other brain regions. Accordingly, the administration 
of the Selective Serotonin Reuptake Inhibitor (SSRI), Fluoxetine, and the atypical tricyclic, 
Tianeptine, are able to reverse stress-induced deficits in PFC LTP upon stimulation of 
hippocampal outflow (Rocher et al., 2004). At the structural level, different antidepressant classes 
have been shown to increase the number of synapse, spines and dendrites in the hippocampus, 
such as SSRIs (e.g. Fluoxetine, Escitalopram) (Bessa et al., 2009; Li et al., 2015), Tricyclics (e.g. 
Amitriptyline, Imipramine) (Norrholm and Ouimet, 2001; Bessa et al., 2009; Chen et al., 2010), 
NRIs (e.g. Reboxetine) (Baj et al., 2012), MAOIs (e.g. Pirlindol) (Morais et al., 2014) and atypical 
antidepressants (e.g.Tianeptine, Vortioxetine) (Watanabe et al., 1992; Chen et al., 2016). 
Accordingly, we have recently conducted a comparative study, to test different classes of 
antidepressants in hippocampal plasticity. Interestingly, all antidepressants, except a more 
recently developed atypical antidepressant, Agomelatine, rescued the stress-induced dendritic 
atrophy in granule neurons (Patricio et al., 2015). In addition, antidepressants have been shown to 
also promote dendritic structural recovery in other stress-responsive areas of the brain (Pittenger 
and Duman, 2008)(Figure 7). 
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Furthermore, chronic treatment with antidepressants also impact on the generation of new 
hippocampal cells. In fact, the ability of chronic antidepressant treatment to bolster hippocampal 
cytogenesis is now well recognized and, notably, this pro-cytogenic effect is promoted by most 
pharmacological classes tested to date, such as SSRIs (e.g. Fluoxetine, Paroxetine)(Qiu et al., 
2007; Bessa et al., 2009), Tryciclics (e.g. Amytriptiline, Imipramine)(Caldarone et al., 2004; 
Surget et al., 2008; Bessa et al., 2009), MAOIs (e.g. Tranylcypromine, Moclobemide)(Malberg et 
al., 2000; Li et al., 2004), Tetracyclics (e.g. Maprotiline) (Jhaveri et al., 2010), SNRIs (e.g. 
venlafaxine)(Mostany et al., 2008), NRIs (e.g. reboxetine) (Malberg et al., 2000) and NDRIs (e.g. 
Bupropion) (Onoue et al., 2014). It is important to note that it is still not clear whether this pro-
cytogenic action affects differentially the DG along its septo-temporal axis, as different reports 
exist describing increased proliferation only in the dorsal, only in the ventral or in both 
hippocampal poles (as reviewed in Tanti and Belzung, 2013). Nevertheless, the fact that this pro-
cytogenic action is shared by a multitude of antidepressant classes was one of the arguments 
supporting the hypothesis of hippocampal cytogenesis being a key form of neural plasticity 
necessary to the therapeutical effects of these drugs. A second compelling argument lies on the 
fact that antidepressants commonly used in clinical practice, typically take 2 to 4 weeks to 
manifest therapeutical efficacy (Miller and Hen, 2015), a lag period that is somewhat coincident 
with the period of mammalian neurogenesis. 
Curiously, increased hippocampal cytogenesis is not an effect solely achieved by antidepressant 
drugs, as other therapeutical interventions have evidenced parallel action. This is the case in 
electroconvulsive therapy (ECT), where a single ECT seizure has been shown to be sufficient to 
increase the number of newborn cells in the DG (Madsen et al., 2000). 
However, and as in the case of the pathophysiology of depression, the role of adult cytogenesis in 
the therapeutical action of antidepressants is a matter of much controversy (Petrik et al., 2012). In 
humans,  studies have been restricted to post-mortem analysis, where correlational analysis are 
possible but to establish causality between cytogenesis and therapeutic actions is currently 
unfeasible. Lucassen and colleagues found no effect of different antidepressant treatments in the 
number of progenitor cells, despite observing a significant decrease in non-treated patients 
(Lucassen et al., 2010). Other studies revealed increased numbers of neural progenitors in 
antidepressant-treated patients (Boldrini et al., 2009), as well as an increase in the total number 
of granule cells in treated patients (Boldrini et al., 2013), although the latter finding may be 
related to non-cytogenic effects. In animal models of depression, the most substantial results have 
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emerged from cytogenesis ablation studies. In 2003, Santarelli and colleagues published the first 
evidence of blunted antidepressant response following cytogenesis ablation by x-ray irradiation 
(Santarelli et al., 2003). However this initial proposal was subsequently challenged in several 
works that have either failed to observe an association between cytogenesis supression and 
antidepressant efficacy, or supported the notion that ongoing cytogenesis was not responsible for 
all the behavioral improving effects of antidepressants (Holick et al., 2008; Surget et al., 2008; 
David et al., 2009). Accordingly, Bessa et al. have showed that cytogenesis supression by MAM 
did not preclude short-term monoaminergic antidepressant efficacy, rather suggesting the initial 
mood-improving effects to rely more on the recovery from hippocampal and PFC neuronal 
dendritic atrophy (Bessa et al., 2009).  
Hence, as in the few existing human studies, animal studies appear to have conflicting data 
regarding the participation of hippocampal cytogenesis in the onset of depression, but also in the 
therapeutical action of antidepressants. As discussed in the previous chapter in relation to studies 
seeking to characterize the functional roles of adult cytogenesis in naïve animals, also in this 
research context many sources of potential variability become clear when reviewing available 
literature. First, although we tend to analyze data emerging from rats and mice indiscriminately, 
there are several indications at the neuroanatomical level (Andersen, 2007) and even in terms of 
hippocampal cytogenesis (Snyder et al., 2009) that differ between these two species, and that 
may therefore account for some discrepancies. Second, the chosen paradigm to model 
depression, and factors such as duration and severity may differentially affect neural plasticity, so 
that the potential of recovery by antidepressant treatment through non-cytogenic plasticity may 
vary. Third, different cytogenesis ablation procedures have specific limitations, such as 
exacerbated immunological response (irradiation) or generalized anti-mitotic action (cytostatic 
drugs), that may undermine a clearer interpretation of the therapeutic efficacy of the tested 
antidepressants. Finally, a major factor that is been largely undervalued is the temporal dimension 
of experimental planning and analysis time-points. Indeed, and due to the different structural and 
functional properties characteristic of progenitor, immature and mature cells, it should be 
expectable that studies that analyze both consequences of cytogenesis ablation or treatment 
efficacy at different time-points post-ablation yield distinct results.  
To sum up, the triad stress-plasticity-depression is well supported by both animal and human 
studies, but a closer look into available literature points out how the specific role of different forms 
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of plasticity to the pathophysiology and treatment of depression remains highly debatable. Most 
likely such complex, but exhilarating, debate may only be solved by combining a renewed and 
critical interpretation of available data with additional studies, designed to address this matter in a 
longitudinal perspective, while also controlling the possible confounding effects emerging from the 
sources of discrepancy, already discussed above.   
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1.4 
New forms of epigenetic regulation in the adult 
brain: a focus on DNA hydroxymethylation
Part of the work included in the present thesis has focused on epigenetic mechanisms in the 
context of the stressed brain, latter to be discussed (see Chapter 5). This section, rather than 
configuring an exhaustive review on epigenetic regulatory mechanisms within the CNS (for review, 
see Mehler, 2008; Mateus-Pinheiro et al., 2011), is intended to provide a brief introductory 
overview on epigenetic regulation, with emphasis given to DNA methylation and 
hydroxymethylation, as the work here presented has focused on these epigenetic marks.  
1.4.1 DNA METHYLATION AND HYDROXYMETHYLATION IN THE CNS 
DNA methylation  
The field that we now call epigenetics stemmed from the early observations that heritable 
mechanisms could regulate phenotypic expression without implicating alterations on DNA 
sequence. Globally, epigenetic regulation is accomplished through four cardinal and 
interdependent mechanisms: (i) DNA methylation, (ii) histone modifications and higher order 
chromatin remodeling, (iii) non-conding RNAs and (iv) RNA and DNA editing/recoding (Mehler, 
2008). All of these have been implicated in multiple molecular and cellular processes essential for 
higher nervous system functions (Feng et al., 2007; Mehler and Mattick, 2007; Taniura et al., 
2007; Tsankova et al., 2007; Mehler, 2008). In particular, DNA methylation in the fifth position of 
the cytosine residues (5mC) is a well known epigenetic mark that has been widely studied. 
Originally, DNA 5mC was thought to occur specifically within CpG context and act exclusively as a 
transcriptional repressive mark (Jones, 2012). This classical view has been revisited following the 
description of DNA 5mC occurring at non-CpG regions in embryonic stem cells (ESC) and 
neurons, where it can lead, instead, to transcription activation (Jones, 2012). This epigenetic 
modification is achieved through the transfer of methyl groups from S-adenosyl methionine to DNA 
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cytosine residues, which is catalyzed by a family of DNA methyltransferases (DNMTs) responsible 
for both the “maintenance” of methylation (DNMT1) or de novo methylation (DNMT3A, DNMT3B, 
DNMT3L) (Klose and Bird, 2006). The functional repercussions of DNA 5mC on the CNS have 
long become evident, with the early descriptions of the importance of this epigenetic mark in the 
adult brain for learning  and  memory (Day and Sweatt, 2010). Indeed, DNMT3A  and  DNMT1 
deletion  in  the  mouse  forebrain impairs synaptic plasticity and  compromises learning and 
memory (Feng et al., 2010). Accordingly, pharmacological  inhibition of these enzymes in the 
hippocampus has been shown to produce memory deficits (Miller and Sweatt, 2007). Moreover, 
profiles of DNA methylation display an intricate relation with patterns of histone protein post-
translational modifications conducted by methyl CpG-binding proteins (MBDs) that are recruited to 
methylated DNA and, in association with large protein complexes, regulate gene repression and 
orchestrate DNA replication and repair (Klose and Bird, 2006; Mehler, 2008). Several studies 
addressing the role of DNA methylation and the associated MDBs, such as MeCP2 and MDB1, 
have provided important insights into how these epigenetic mechanisms are modulated by 
different physiological or pathological states (Klose and Bird, 2006; Ooi et al., 2007). In fact DNA 
methylation has been linked to neuronal identity and neuronal functional specialization (Ladd-
Acosta et al., 2007), neuronal survival, plasticity and also stress response (Klose and Bird, 2006; 
Ooi et al., 2007). Furthermore, the process of astrocyte differentiation has also been shown to be 
tuned through DNA methylation mechanisms (Kondo, 2006).  
DNA hydroxymethylation  
Until recently the reverse mechanism of DNA methylation was poorly comprehended (Wu and 
Zhang, 2010). In 2009 a novel DNA mark was unveiled at the fifth position of cytosine - the 5- 
hydroxymethylation (5hmC) (Kriaucionis and Heintz, 2009; Tahiliani et al., 2009). DNA 5hmC was 
found to be an alteration catalyzed the TET family of methylcytosine dioxygenases (TET1/TET2/
TET3) which oxidizes 5mC to 5hmC and subsequently to 5-formylcytosine (5fC) and 5-
carboxylcytosine (5caC), in a reaction that is both Fe(II) and 2-oxyglutarate dependent (Kriaucionis 
and Heintz, 2009; Tahiliani et al., 2009; Ito et al., 2010) (Figure 8). These 5fC and 5caC are 
substrates of the thymine-DNA glycosylase (Tdg), representing what are believed to be transient 
epigenetic marks that will be converted in non-methylated cytosine (Maiti and Drohat, 2011; 
Piccolo and Fisher, 2014).  
Most differentiated tissues present very low levels of TET1 and high levels of TET3, with the 
exception of the zygote, while undifferentiated embryonic stem cells show the opposite pattern 
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(Szwagierczak et al., 2010). Importantly, the high levels of TET3 expression in several brain 
regions indicate that it might play an important role in post-mitotic neurons (Santiago et al., 2014). 
Even so, TET1 function in the central nervous system has been the most studied so far. It has 
been shown that Tet1-KO mice display a decrease in hippocampal progenitor cells, while also 
having impairments in spatial reference memory test in the Morris Water Maze (Zhang et al., 
2013). Moreover, mice lacking Tet1 have been showed to have memory extinction defects, 
accompanied by an abnormally enhanced hippocampal LTD. These studies also revealed that 
NSCs isolated from the DG of Tet1-KO mice present an enrichment of hypermethylated genes that 
are downregulated, many of which participate in neurogenesis regulation. TET2 and TET3 
functions in the adult CNS are less characterized. In particular, the study of TET3 function in the 
brain has been delayed due to the neonatal lethality of the Tet3-KO mice. Recently, a study 
revealed a dramatic genomic redistribution of 5hmC within the infralimbic PFC in response to fear 
extinction learning, and that fear extinction leads to TET3-mediated accumulation of 5hmC (Li et 
al., 2014). Altogether these studies highlight that TET proteins may play critical roles in the adult 
CNS which remain to be elucidated. This aspect might be of particular interest in a stress 
exposure context, which is generally associated to hypermethylation alterations in the CNS. 
Therefore a better characterization of TET enzymes function and the demethylation pathways 
could provide important cues on the mechanisms underlying cognitive and emotional disabilities 
after chronic stress exposure.  
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Figure 8. TET enzymes and DNA hydroxymethylation. The conversion of 5-methylcytosine to 5-
hydroxymethylcytosine is catalyzed by the TET family of methylcytosine dioxygenases (TET1/TET2/TET3) which 
oxidize 5mC to 5hmC and further to 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC), in a Fe(II) and 2-oxyglutarate 
dependent reaction. 5fC and 5caC can subsequently operate as substrates for thymine-DNA glycosylase (Tdg), which 
eventually results in the generation of a non-methylated cytosine, representing an active DNA demethylation pathway. 
Adapted from Nabel and Kohli, 2011 .
1.4.2 DNA 5mC/5hmC, STRESS AND MENTAL HEALTH: IS THERE A LINK? 
Different studies have already linked epigenetic mechanisms to the molecular and cellular basis of 
stress and depression, as well as to the action of antidepressants (Schroeder et al., 2007; 
Tsankova et al., 2007; Krishnan and Nestler, 2008).  
Regarding DNA 5mC, there are several indications supporting the role of this epigenetic mark in 
stress response and the concomitant development of depressive behavior. Among these, early-life 
stress in mice has been shown to control DNA 5mC levels, and MeCP2 DNA binding, in post-
mitotic neurons in the hypothalamic PVN, leading to increased arginine vasopressin (AVP) 
expression (Murgatroyd et al., 2009). Epigenetic-induced changes in AVP expression were 
associated with neuroendocrine and behavioral responses typical from those following stress 
exposure or seen in animal models of depression, such as corticosterone hyper secretion or 
increased latency to immobility in the FST. In the other hand, a latter work has suggested that 
variations in DNA 5mC of the corticotropin releasing-factor (CRF) could mediate resilience to 
chronic social stress in adult mice (Elliott et al., 2010). Also, Nuber et al. used a Rett syndrome 
mouse model and put forward evidence supporting the role of MeCP2 as a modulator of 
glucocorticoid function, a finding that is of particular relevance to stress-induced psychiatric 
disorders, such is the case of depressive spectrum disorders (Nuber et al., 2005; Klengel et al., 
2014).  
Another argument favoring the view of DNA 5mC epigenetic regulation as a key pathological mark 
in depression is the translational validity of the stress-induced increase in DNA 5mC in the 
hippocampus and other brain regions in rodents (Miller and Sweatt, 2007; Zhang et al., 2010), as 
increased DNA 5mC levels have also been described in specific genomic locci at the hippocampus 
of suicide completers (McGowan et al., 2008; Poulter et al., 2008; McGowan et al., 2009). Also 
important, is the evidence provided by two works were antidepressant action has been linked to 
the modulation DNA 5mC levels within the NAc (LaPlant et al., 2010) and the hippocampus (Sales 
et al., 2011). 
Although the lines of evidence presented above allow to establish a connection between 5mC and 
the pathophysiology of stress-related disorders, such as depression, the role of active DNA 
demethylation remains to be unveiled. Although still sparse, some works reported data supporting 
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the need to better explore this form of epigenetic regulation in psychopathological contexts: Wei et 
al. reported decreased TET1 expression in a genetic rat model of depression and a decrease in 
hydroxymethylation of bdnf (Wei et al., 2015). The administration of sodium butyrate had 
antidepressant-like effects, reversing the depressive-like behavioral phenotype, while also restoring 
normal levels of TET1 expression, and bdnf hydroxymethylation. Furthermore, a recent study has 
put forward a new rat model of Gulf War, combining stress with neurotoxin exposure (Pierce et al., 
2015). Although it is impossible to dissociate the environmental effects of stress from the 
neurochemical consequences of neurotoxin exposure, the authors report variations in global levels 
of 5mC and 5hmC, differentially affected according to the brain region analyzed. Accordingly, a 
recent report also found variation in genomic 5hmC levels following acute stress, again proposing 
that this epigenetic mark may constitute an important mediator in the translation of environmental 
effects into physiological and pathological responses (Li et al., 2016). 
Together, data implicating DNA 5mC in stress response, depression pathology and antidepressant 
action, combined with the yet sparse indication that hydroxymethylation and the associated 
enzymatic regulators are targeted in the exact same biological contexts, are compelling arguments 
to further investigate the role of this epigenetic mark in both the development an treatment of 
stress-related disorders. 
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2. RESEARCH AIMS
Despite the correlated findings of stress-induced impaired adult neural plasticity and the 
development of different emotional and cognitive deficits evidenced by animal models of 
depression, the importance of hippocampal plasticity for the development and remission of this 
disease remain highly controversial, as several authors presented what appears to be 
contradictory data. 
In this thesis we sought to explore the longitudinal participation of hippocampal cytogenesis in the 
pathophysiology and treatment of depressive-like behavior, as the neglected aspect of the 
temporal dynamics of the disease course and the cytogenic process are likely source of 
discrepancy between several reported studies. For that, we used an unpredictable chronic mild 
stress (uCMS) animal model of depression in association with different cytogenesis ablation 
strategies. Furthermore, we treated animals with two monoaminergic antidepressants (ADs), 
fluoxetine and imipramine, to ascertain the modulatory effect of these drugs on hippocampal 
plasticity. Complementarily, we also characterized dendritic structural alterations occurring in 
hippocampal granule cells. 
Within this research context, 3 major research aims were defined: 
1. Evaluate the importance of both immature and mature newly-formed hippocampal cells for 
the development and remission from depressive-like behavior (initially addressed in Chapter 
3, and latter in Chapter 4).  
2. Explore how uCMS exposure and chronic AD treatment modulate epigenetic alterations in the 
adult hippocampus, specifically at the level of the more recently described DNA demethylation 
pathways (addressed in Chapter 5).  
3. Refine current methods to characterize and measure hedonic behavior in rodents, as the lack 
of sensitivity and high output variability of current methods may contribute to aforementioned 
incongruences  (Chapter 6). 
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Sustained remission from depressive-like behavior
depends on hippocampal neurogenesis
A Mateus-Pinheiro1,2,4, L Pinto1,2,4, JM Bessa1,2, M Morais1,2, ND Alves1,2, S Monteiro1,2, P Patrı´cio1,2, OFX Almeida3 and N Sousa1,2
Impairment of hippocampal neurogenesis has been associated with the expression of depressive-like symptoms and some
studies have suggested neurogenesis as a critical factor in the normalization of behavior by antidepressant (AD) drugs. This
study provides robust evidence that ongoing neurogenesis is essential for the maintenance of behavioral homeostasis and that
its pharmacological arrest precipitates symptoms commonly found in depressed patients. Further, the incorporation of newly
born neurons and astrocytes into the preexisting hippocampal neurocircuitry is shown to be necessary for the spontaneous
recovery from the adverse effects of stress and for long-term benefits of AD treatments.
Translational Psychiatry (2013) 3, e210; doi:10.1038/tp.2012.141; published online 15 January 2013
Introduction
Major depression is a highly prevalent disorder that imposes a
significant social burden. While the pathophysiology of the
disease is still poorly understood, growing evidence suggests
that impaired neuroplasticity may be a key underlying
mechanism. Surrogate markers of impaired neuroplasticity,
such as reduced neuroproliferation and impoverished den-
dritic arborization in the hippocampus, have been implicated
in the onset, progression and remission of depressive
symptoms.1–4 Several antidepressants (ADs) tested to date
stimulate hippocampal neurogenesis,5–7 but it is unclear as to
whether these pro-neurogenic effects are responsible for their
mood-, emotional- and cognitive-improving actions. Recent
studies indicate that ADs exert their short-term therapeutic
effects by inducing remodeling of dendrites and synapses in
mood-regulating limbic brain regions rather than by stimulat-
ing neurogenesis per se;8–11 however, considering the long-
itudinal course of depression, the debate on whether the long-
term benefits of AD treatments result from altered hippocam-
pal neurogenesis and gliogenesis remains open.
In this study, we examined whether and how the neurogenic
process, from cell birth to integration of newly born cells into
the existing circuitry, influences the development of and
remission from depressive-like symptoms. Astrogliogenesis
was included in the present analysis in light of evidence that
astroyctes have a role in preventing of the expression of
depression-like behaviors in laboratory animals.12–14 A vali-
dated unpredictable chronic mild stress (uCMS) paradigmwas
implemented to induce core symptoms of depressive-like
behavior in rats; during the last 2 weeks of the uCMS protocol,
animals were administered imipramine or fluoxetine. To
assess the role of hippocampal neurogenesis and gliogenesis
in the long-term effects of ADs, cell proliferation was artificially
blocked through the coadministration of methylazoxymethanol
(MAM) with the ADs. After 1 month of recovery from the
experimental procedures, the behavioral dimensions com-
monly affected on depression were assessed and correlated
with hippocampal neuroplastic alterations.
Materials and methods
Animals and treatments. Male Wistar rats (200–250 g,
aged 2 months; Charles-River Laboratories, Barcelona,
Spain) were maintained under standard laboratory conditions
(12 h light: 12 h dark cycles, 22 1C, relative humidity of 55%,
ad libitum access to food and water). Groups of rats (n¼ 10–
12 per group) were randomly assigned to the following eight
experimental groups: non-stress controlþ saline or MAM;
stress (uCMS)þ saline or MAM; uCMSþ fluoxetine or imipra-
mine alone, or coadministered with MAM. All procedures were
carried out in accordance with EU Directive 2010/63/EU and
NIH guidelines on animal care and experimentation.
A validated uCMS protocol was applied for 6 weeks as
previously described.8,15 The ADs fluoxetine (10mgkg# 1;
Kemprotec, Middlesborough, UK) and imipramine
(10mgkg# 1; Sigma-Aldrich, St Louis, MO, USA) were
administered intraperitoneally (1ml kg# 1); MAM (7mgkg# 1;
MRIGlobal Chemical Carcinogen Repository, Kansas City,
MO, USA) was administered subcutaneously (0.45ml kg# 1).
All drugs were dissolved in dimethyl sulfoxide (5%) and saline
(0.9%) and administered daily, during the 2 last weeks of the
uCMS protocol. Pilot studies showed that MAM did not
adversely influence general health parameters, such as
locomotor activity (ambulation in an open field, swimming
speed in a water maze) and fur quality.8,16,17 Here, we found no
significant alterations induced by MAM in appetite drive
(Supplementary Figure S1), in swimming performance in the
water maze (Supplementary Figure S2), as well as in weight
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variation (Supplementary Figure S3). BrdU was injected
intraperitoneally (50mgkg! 1) for 5 days at the cessation of
uCMS in order to evaluate neurogenesis by immunocytochem-
istry (see below).
Subsequently, animals were allowed to recover for 4 weeks
and behavioral analyses were carried out at weeks 11 and 12,
during the daily light phase (09:00–18:00 h).
Behavioral analysis
Sucrose consumption test. Anhedonia was assessed on a
weekly basis by the sucrose consumption test, throughout
the experimental procedures. Baseline sucrose preference
values were established during a 1-week habituation period
during which animals were presented with two pre-weighed
drinking fluid bottles, containing water or 1% (m/v) sucrose.
Before each recording of sucrose preference, rats were food-
and water-deprived for 20 h and exposed to the test drinking
solutions for 1 h. Sucrose preference was calculated as
described previously.8
Elevated-plus maze. Anxiety-like behavior was examined
through the elevated-plus maze (EPM) test, in a 5-min
session, as previously described.15 The percentage of time
spent in the open-arm was used as an index of anxiety-like
behavior and the number of entries in the closed-arms was
taken as an indicator for locomotor activity (Supplementary
Figure S4).
Novelty suppressed feeding test. Anxiety-like traits were
further assessed through the NSF paradigm. After a 18-h
period of food-deprivation, animals were placed in an open-
field arena, as previously described,8 where a single food
pellet was positioned in the center. After reaching the pellet,
animals were individually returned to their home cage, where
pre-weighted food was available, and were allowed to feed
during 10min. The latency to feed in the open-field arena
was used as an anxiety-like behavior measurement, whereas
the food consumption in the animal home cages provided a
measure of appetite drive. No differences were observed in
the appetite drive between the experimental groups that
could lead to a misinterpretation of the results
(Supplementary Figure S1).
Forced swimming test. Learned-helplessness was assessed
through the forced swimming test. Assays were conducted
24 h after a 5-min pretest session, by placing the rats in
transparent cylinders filled with water (25 1C; 50 cm of depth)
during 5min. Trials were video-recorded and the immobility
time, as well as the latency to immobility were measured
using an automated video tracking system (Viewpoint,
Champagne au mont d’or, France). Learned-helplessness
was considered as an increase in the immobility time.
Results were complemented with the analysis of latency to
immobility, as a second measure of learned-helplessness
(Supplementary Figure 5).
Cognitive assessment. Cognitive function was evaluated in
a spatial working memory task and in a behavioral flexibility
task, performed in a black circular tank (170 cm diameter)
filled with water (23 1C; 31 cm of depth) placed in dimly lit
room with extrinsic clues. The water tank was divided in four
quadrants by imaginary lines and a black platform (12 cm
diameter; 30 cm high), invisible to rodents, was placed in one
of the quadrants. Trials were video-captured by a video-
tracking system (Viewpoint). Animals were habituated to the
test room, during the 2 days preceding the tests, being kept
in the room for 1 h in each day. These tests were conducted
as it follows:
Working memory task
The working memory task was used to evaluate the cognitive
domain that relies on the interplay between the hippocampal
and prefrontal cortex functions.18 The goal of this task, a
modification of the original spatial reference memory test, is to
assess the ability of animals to learn the position of the hidden
platform and to retain this information during four consecutive
trials. An escape platform was placed in one of the quadrants,
and was maintained in the same position during the four daily
trials. The test was performed during four days, and in each day
the platform was repositioned in a new quadrant in a clockwise-
fashion. In each of the daily trials animals were positioned in
a different starting point (north, east, west and south) and a trial
was considered as concluded when the platform was reached
within the time-limit of 120s. If the animals were unable to
find the platform during the trial time they were guided to the
platform and allowed to stay in it for 30s. The time of escape
latency was recorded for each trial.
Behavioral flexibility task. Following working memory
assessment, tests were conducted for 4 days maintaining
the platform in the same quadrant. At the fifth day, the beha-
vioral flexibility performance of animals, a prefrontal cortex-
dependent function, was tested by positioning the platform in a
new (opposite) quadrant. Animals were tested in four trials
according to the same procedure previously described. Besides
the time of escape latency, the time spent in both new and
old quadrants were recorded. Analysis of memory acquisition in
the 4 days preceding was conducted in order to assess whether
the different animal groups had equivalent memory for the
old platform position (Supplementary Figure 6).
To confirm that differences observed in the escape latency
were not due to distinct locomotor performance, wemeasured
the average swimming velocities during trials. No differences
were found among the groups in this parameter (Supple-
mentary Figure S2).
Immunostaining procedures. Animals were deeply anaesthe-
tized with sodium pentobarbital (20%; Eutasil, Sanofi) and
were transcardially perfused with cold 4% paraformaldehyde.
Brains were removed and post-fixed in 4% paraformaldehyde.
Coronal cryosections (20 mm) and vibratome sections
(40mm) were firstly stained for BrdU (1:50; Dako, Glostrup,
Denmark), followed by staining for DCX (for neuroblasts,
1:500; Abcam, Cambridge, UK), NeuN (for mature neurons;
1:100; Chemicon, Temecula, CA, USA) or GFAP (for glia;
1:200; Dako). Finally, all sections were stained with 4’,6-
diamidino-2-phenylindole (1mgml! 1). For each animal, BrdU-
positive cells within the subgranular zone of the dentate gyrus
were analyzed after double staining with neuronal (DCX or
NeuN) or glial (GFAP) markers and cell counts were
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performed by confocal microscopy (Olympus FluoViewTM
FV1000, Hamburg, Germany). Hippocampal proliferation at
the end of the recovery period was assessed by Ki67 staining
(1:200; Leica Microsystems, Wetzlar, Germany). Estimation
of cell density in the dentate gyrus was obtained by crossing
the cell number values with the corresponding dentate gyrus
areas, determined using a Olympus BX51 optical microscope
and the Newcast software (Visiopharm, Horsholm, Denmark).
Three-dimensional morphological analysis. To assess the
three-dimensional dendritic morphology of characterized
hippocampal neurons, we developed a new technique that
combines Golgi-Cox impregnation with immunofluorescence
staining. Briefly, brains were immersed in Golgi-Cox solution
for 21 days and then transferred to a 30% sucrose solution
and cut on a vibratome. Coronal sections (200 mm thick) were
collected in 6% sucrose and blotted dry onto gelatin-coated
microscope slides. They were subsequently alkalinized in
18.7% ammonia, developed in Dektol (Kodak, Rochester,
NY, USA), fixed in Kodak Rapid Fix, dehydrated and xylene
cleared. An adapted optimized BrdU immunostaining proce-
dure was then applied in order to identify newly born
neurons. Dendritic arborization, spine numbers and shape
were, therefore, analyzed specifically in newborn BrdUþ
cells and compared with non-BrdUþ neurons. The detailed
method has been described in detail elsewhere.19
Statistical analysis. Statistical analyses were done using
SPSS software (SPSS, Chicago, IL, USA). After confirmation
of homogeneity, data was subjected to appropriate statistical
tests. Analysis of variance repeated measures was used to
analyze cognitive-learning tasks performance. One-way ana-
lysis of variance was used to evaluate the remaining
behavioral and molecular results. F-values and P-values
derived from the between groups analysis of variance
analyses are properly indicated along the text. Differences
between the groups were determined by Bonferroni’s post-hoc
multiple comparison test, and the corresponding P-values are
indicated in the figures. A t-test was used two evaluate
differences among the two groups where appropriate.
Statistical significance was accepted for Po0.05.
Results
Blockage of hippocampal proliferation triggers depres-
sive-like symptomatology in naive rats. We first analyzed
the long-term behavioral effects of neuro- and gliogenesis
pharmacological suppression in naive animals (non-stressed
animals), 4 weeks after the cessation of MAM treatment.
Administration of MAM to naive rats, severely decreased the
generation of neurons (BrdUþ /NeuNþ cells, t8¼ 6.024;
P¼ 0.0003) and astrocytes (BrdUþ /GFAPþ cells,
t8¼ 2.889; P¼ 0.020) (Figures 1a and b) and induced
sustained deficits in hippocampal proliferation (Ki-67þ cells,
t8¼ 8.229; Po0.0001) (Figure 1c). As all neurons had
matured 4 weeks after BrdU injections, we did not find
DCXþ /BrdUþ cells. Treatment with the antimitotic drug
MAM produced increases in two surrogate measures of
depressive-like behavior (reduced sucrose preference, a
reflection of an anhedonic state, t18¼ 1.941; P¼ 0.034,
Figure 1d; increased immobility in the FST, t18¼ 3,889;
P¼ 0.001, Figure 1e). MAM administration also elicited signs
of increased anxiety, as measured in the EPM (t18¼ 4.069;
P¼ 0.0007, Figure 1f) and in the NSF (t18¼ 4.324; P¼
0.0004, Figure 1g and Supplementary Figure S1), an inter-
esting finding in light of the fact that a sizeable subpopulation
of depressed human subjects exhibit hyperanxiety. In addi-
tion, MAM treatment was associated with impaired spatial
working memory (F1,22¼ 5.726; P¼ 0.026, Figure 1h and
Supplementary Figure S2) and behavioral flexibility (t18¼ 4.158;
P¼ 0.0006, Figure 1i). Interestingly, new neurons (BrdUþ
neurons), that escaped mitotic blockade, were found to have
markedly reduced spine densities (t28¼ 6.412; Po0.0001,
Figure 1j) and altered spine morphology (Supplementary
Figure S7), as compared with neurons that had matured
before the experimental manipulations (Figure 1j).
Hippocampal neurogenesis and gliogenesis are funda-
mental for sustained spontaneous and pharmacological
recovery from depressive-like behavior. The importance
of active neurogenesis in the precipitation of depressive-like
behavior in animals exposed to uCMS, a validated animal
model of depression,15,20 was examined next. While most
studies only report on immediate, possibly transient, recov-
ery from stress, we here assessed ‘extended recovery’ by
evaluating the display of depressive-like behavior 4 weeks
after the cessation of stress (Figure 2a). In these experi-
ments, MAM was administered during the last 2 weeks of AD
treatment, allowing the examination of whether uninterrupted
neurogenesis is necessary for long-term—spontaneous and
AD treatment-associated—recovery from stress-induced
depressive-like behavior. Like MAM, stress attenuated
hippocampal neurogenesis and gliogenesis (F6,28¼ 17.35,
Po0.0001, post-hoc Po0.001 for neurons; F6,28¼ 6.079;
P¼ 0.0004, post-hoc Po0.01 for glia; Figures 3a–d) and
elicited signs of anhedonia in an AD-reversible manner.
However, the AD actions occurred independently of ongoing
neuroproliferation (Figures 2b and c). Animals exposed to
uCMS only showed partial spontaneous recovery, as
measured by the sucrose consumption test, but such
behavioral recovery was absent in animals exposed to
uCMS and MAM (F6,63¼ 4.005; P¼ 0.0019, post-hoc
Po0.001, Figures 2b and c). The latter animals showed
significantly reduced levels of neurogenesis (F6,28¼ 26.80;
Po0.0001, post-hoc Po0.001, Figure 3b) and proliferation
(F6,28¼ 26.80; Po0.0001, post-hoc Po0.001; Figures 3e
and f) for up to 4 weeks after cessation of uCMS and MAM
treatment. Strikingly, recovery during AD treatment was
insensitive to the arrest of neurogenesis (Figures 2b and c).
When tested in the forced swimming test (a test which
measures reversal of learned helplessness within 24 h of AD
treatment21), rats showed spontaneous and pharmacologi-
cally-induced recovery from the effects of uCMS, indepen-
dently of ongoing neurogenesis (Figure 2d).
Anxiety traits frequently form part of the symptomatic profile
of depressed patients and animal models of depression.8,22–24
Ablation of hippocampal neurogenesis was here found to
prevent the spontaneous reinstatement of baseline emotional
states in animals previously exposed to uCMS; this
was evident in two tests of anxiety-like behavior, EPM
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(F6–63¼ 4.122; P¼ 0.0015, post-hoc Po0.01, Figure 2e) and
NSF (F6–63¼ 8.932; Po0.0001, post-hoc Po0.001,
Figure 2f). Both imipramine and fluoxetine normalized the
anxious phenotype induced by uCMS, but whereas the
therapeutic effects of fluoxetine were compromised by MAM
administration (t18¼ 1.739; P¼ 0.0495 in the EPM, Figure 2e;
and t18¼ 1.893; P¼ 0.0373 in the NSF, Figure 2f), those of
imipramine were not (P40.05 in both tests, Figures 2e and f).
Complaints of cognitive impairment are common among
depressed subjects. Stress is known to dysregulate a
number of cognitive functions that depend on the structural
integrity of the hippocampus, prefrontal cortex and reciprocal
connections between these two regions. Here, we show that
arrest of neurogenesis prevents spontaneous improvements
in spatial behavioral flexibility (F6–63¼ 2.309, Po0.0445,
post-hoc Po0.05, Figure 2g) and spatial working memory
Figure 1 Neurogenesis arrest induces long-term emotional and cognitive changes typical of depression. (a) Neurogenesis was arrested by methylazoxymethanol (MAM)
administration and the effects on behavior were assessed after 4 weeks. MAM treatment decreased the number of BrdU-positive cells in the hippocampal dentate gyrus (b),
that underwent neuronal (BrdU/NeuN) and astroglial (BrdU/GFAP) differentiation. (c) Deficits in proliferation were sustained 4 weeks after MAM treatment cessation.
Behavioral phenotype was evaluated using a battery of tests to assess distinct behavioral domains affected in depression. (d, e) Long-term mood impairments were observed
in the sucrose consumption test (SCT) (d), and in the forced swimming test (FST) (e) 4 weeks after MAM treatment. (f, g) Increased anxiety-like behavior was detected in the
elevated plus maze test (EPM) (f) and in the novelty-suppressed feeding test paradigm (NSF) (g) in animals previously treated with MAM. (g, h) Cognitive performance was
also affected 4 weeks after neurogenesis arrest, as both (h) working memory and (i) behavioral flexibility were impaired 4 weeks after MAM administration. MAM treatment did
not affect the dendritic length of neither preexistent or newly born granule neurons (j), but there was a decrease in spine density in the dendrites of newly born neurons after
MAM exposure. Error bars denote s.e.m. *Po0.05, **Po0.01, ***Po0.001; n¼ 10–12 per group.
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(F2–33¼ 3.768, P¼ 0.034, post-hoc Po0.05, Figure 2h) for up
to 4 weeks after cessation of the uCMS paradigm. Impair-
ments induced by uCMS were reversed by both imipramine
and fluoxetine (post-hoc Po0.05 in both tests; Figures 2g
and i), but interestingly, whereas fluoxetine failed to restore
working memory when it was coadministered with MAM, the
cognition-improving efficacy of imipramine did not depend on
active neurogenesis (F3–31¼ 3.081, P¼ 0.041 post-hoc
Po0.05, Figure 2j). Imipramine treatment elicited a strong
pro-gliogenic effect (F6–28¼ 6.079; P¼ 0.0004, post-hoc
Po0.01, Figure 3b), as compared with fluoxetine which was
more effective at promoting differentiation of newly born cells
into neurons rather than astroglia (F6–28¼ 17.35, Po0.0001,
post-hoc Po0.001). Consistently, blockade of neurogenesis
with MAM did not interfere with the ability of imipramine to
improve working memory (post-hoc P40.05, Figure 2j).
Figure 2 Neurogenesis arrest prevents long-term recovery from depression. (a) The relevance of neurogenesis for long-term recovery from depression was evaluated in
animals exposed to an unpredictable chronic mild stress (uCMS) protocol 4 weeks before behavioral assessment. (b, c) Stress exposure triggers anhedonic behavior, that was
reverted by fluoxetine and imipramine. Neurogenesis arrest with mehylazoxymethanol (MAM) in stressed animals precluded recovery from anhedonic signs in the sucrose
consumption test (SCT). (d) Learned helplessness behavior, assessed in the forced swimming test (FST), was normalized after 4 weeks of spontaneous or antidepressant-
induced recovery from stress. (e, f) The long-term recovery from anxiety-like behavior was prevented by neurogenesis arrest; fluoxetine anxiolytic effects were attenuated by
MAM administration, while imipramine action remained unaffected. (g–j) Neurogenesis arrest prevented the recovery form cognitive deficits in (g) behavioral flexibility and in
(h) working memory of animals exposed to uCMS; (i, j) the therapeutical action of fluoxetine on working memory was suppressed by MAM administration, while imipramine
effect was maintained after neurogenesis arrest. Error bars denote s.e.m. *Denotes the effect of MAM;}Denotes the effect of uCMS; #Denotes the antidepressants effect, by
comparison of the antidepressants-treated animals with uCMS animals. *,}, #Po0.05, **,}}, ##Po0.01, ***,}}}, ###Po0.001; n¼ 10–12 per group. EPM, elevated plus
maze test; NSF, novelty-suppressed feeding test paradigm.
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uCMS induces sustained neuromorphological changes
in newly born hippocampal neurons. Mood, anxiety and
cognitive performance are regulated by dynamic alterations
in synaptic and dentritic structure and function.8,25,26 The
present study shows that the neuromorphological changes
that we previously observed immediately after uCMS
Figure 3 Pro-neurogenic and pro-gliogenic actions of the antidepressants fluoxetine and imipramine are associated with emotional and cognitive long-term recovery from
depression. (a, b) Micrographs depict examples of (a) BrdU/NeuN double-labeled neurons and (b) BrdU/GFAP double-labeled glial cells in the hippocampal dentate-gyrus (DG) of
control animals. (c, d) Graphs show the density of (c) total BrdU labeled cells and of (d) BrdU/NeuN, to evaluate neurogenesis, and BrdU/GFAP double-labeled cells, to evaluate
gliogenesis, in the hippocampal DG. Unpredictable chronic mild stress (uCMS) animals, with or without methylazoxymethanol (MAM) treatment, have significantly lower levels of
neurogenesis and gliogenesis when compared with control animals. Fluoxetine and imipramine treatment leads to a recovery in the levels of neurogenesis and gliogenesis,
respectively. (e) Proliferation analyses, assessed at the end of the 4-weeks recovery period, by Ki67 staining, showed that uCMS and antidepressant-treated animals have similar
proliferation levels to control animals. The uCMS effect on proliferation was prevented by neurogenesis arrest with MAM administration. (f) Micrograph depicts Ki67 labeled cells in
the hippocampal DG of a control animal. *Denotes the effect of MAM;}Denotes the effect of uCMS; #Denotes the antidepressants effect, by comparison of the antidepressants-
treated animals with uCMS animals. *,}, #Po0.05, **,}},##Po0.01, ***,}}}, ###Po0.001; n¼ 5 per group. DAPI, 4’,6-diamidino-2-phenylindole.
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exposure8 are fully reversed after a 4-week period of
recovery (Figure 4a). In fact, no differences were observed
in the dendritic morphology and spine density of mature
dentate gyrus neurons between controls and animals
previously submitted to uCMS (Figure 4a). However, using
the novel Immuno-Golgi method to distinguish between
newly born and preexisting neurons,19 we observed that
uCMS affects neither dendritic extension (Figures 4b and c)
nor overall spine density (Figure 4d) in newborn neurons;
rather, our analysis revealed that new cells generated during
spontaneous and AD-induced recovery from uCMS have an
unusually greater density of thin spines (F4–70¼ 5.103,
Figure 4 Exposure to unpredictable chronic mild stress (uCMS) causes long-term neuromorphological alterations in newborn granule neurons. (a) Structural changes in
the dendritic arborization of preexisting granule neurons in the hippocampal dentate gyrus (DG), analyzed with the Golgi-Cox impregnation method, induced by uCMS
exposure are reverted at long-term (4 weeks after uCMS exposure). (b–d) uCMS exposure does not have long-term impact on the dendritic arborization (b, c), neither in the
global spine density of newborn neurons in the hippocampal DG (d), analyzed with the Immuno-Golgi method (co-labeling of BrdU and Golgi-Cox staining). (e, f) Newborn
granule neurons of rats exposed to uCMS 4 weeks before, present increased percentage of thin spines; these alterations are attenuated in the animal groups treated with both
antidepressants (e, f). }Denotes the effect of uCMS; }Po0.05; n¼ 10–15 per group.
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P¼ 0.0011, post-hoc Po0.05; Figures 4e and f). As thin
spines are a common feature in conditions of reduced
cognitive function,27,28 these findings indicate that uCMS
leaves persistent morphological and behavioral scars. Inter-
estingly MAM treatment mimicked sustained spines altera-
tions in BrdUþ neurons produced by uCMS exposure, which
were reversed by ADs coadministration (Supplementary
Figure S7).
Discussion
Overall, the present results show that the appropriate
incorporation of newly born hippocampal cells in preexisting
neural networks is essential for spontaneous recovery from
depression-associated emotional and cognitive impairments
in rats; moreover, these processes are important for long-term
maintenance of the behavioral homeostasis achieved through
the use of ADs.
Indeed, hippocampal cell proliferation arrest by MAM on
untreated animals caused a 70% reduction on neurogenesis
and gliogenesis, similarly to the anti-proliferative effects
produced by uCMSexposure, which were causally associated
with long-lasting emotional and cognitive disabilities. Remark-
ably, MAM treatment in naive animals produced behavioral
deficits resembling those manifested after chronic exposure
to stress. In this regard, it is important to note that such
emotional and cognitive impairments emerged only 4 weeks
after cessation of MAM treatment and were not manifested
shortly after neurogenesis ablation, as we have showed
previously.8 Considering the late manifestation of these
behavioral disabilities, it is inferable that continuous prolifera-
tion and complete circuitry integration of new neurons and
glial cells, a process that takes 4–6 weeks in rodents, is
necessary for the maintenance of emotional and cognitive
homeostasis.
In line with the idea that continuous hippocampal cell
proliferation is relevant for the spectrum of depressive
symptoms, is the present observation that the ability of ADs
to reverse emotional and cognitive impairments relies on their
potential to restore hippocampal neuro- and glio-genesis. An
interesting finding is that different classes of ADs have distinct
impact on newborn cells-fate, that are reflected in different
behavioral effects. As data suggests, noradrenaline reuptake
inhibitors (imipramine) can ameliorate anxiety and cognitive
deficits induced by stress independently of ongoing neuro-
genesis, whereas the anxiolytic and pro-cognitive efficacy of
serotonin reuptake inhibitors (fluoxetine) require uninter-
rupted neurogenic processes.
These findings are consistent with earlier demonstrations of
the essential role of neurogenesis in the regulation of anxiety
behavior8,9,24,29 and cognitive function30,31 although the distinct
contributions of serotoninergic and noradrenergic pathways to
this regulation have not been previously reported. In light of
recent data suggesting that astrocytic dysfunction and glial
pathology have an important role in the regulation of emotional
and cognitive behavior,12,32,33 our observation that imipramine
treatment promotes the generation and differentiation of new
hippocampal cells into astrocytes may explain its strong ability
to counteract MAM treatment; this is consistent with the fact
that, norepinephrine, in contrast to serotonin, can directly
activate the resident pool of progenitor cells and stimulate
neurogenic, as well as gliogenic processes.34
In addition, the present results indicate that reestablishment
of synaptic connections in hippocampal networks is a likely
prerequisite for the spontaneous and pharmacological
restoration of normal emotional and cognitive states. Studies
demonstrating the fast behavioral actions of ketamine, an
NMDA receptor antagonist, support this view.35 However, we
also reveal, for the first time, the occurrence of persistent
alterations in spine morphology in neurons that escaped the
stress- or MAM-induced hippocampal arrest that might be of
relevance for future exposures to stressful conditions. Overall,
our findings suggest that slower neuroplastic changes,
involving neurogenesis and complex dynamic remodeling of
neuro-glial networks, appear to have an important role in
determining the extent of recovery from, and eventual relapse
of, depressive symptoms.
In summary, this work suggests that cytogenic alterations
are relevant but cannot account for the entire behavioral
phenotypic recover after the remission from depressive-like
behavior, as some behavioral alterations do not correlate with
variations in neuro- and glio-genesis. Thus, most likely the
incorporation of newly born cells into preexistent circuits
impact, in combination with complementary neuroplastic and
neuroendocrine alterations, on cortico-limbic circuitries
involved in the remission from depressive symptomatology.
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Supplementary Figure S1. Appetite drive (in a 10min period) in the novelty suppressed feeding 
test. Error bars denote SEM. *P<0.05, **P<0.01, ***P<0.001; n=10 to 15 per group. 
 
Supplementary Figure S2. Average swimming velocity in the water maze trials. Error bars denote 
SEM. *P<0.05, **P<0.01, ***P<0.001; n=10 to 15 per group. 
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Supplementary Figure S3. MAM effect on weight variation. Error bars denote SEM. *P<0.05, 
**P<0.01, ***P<0.001; n=10 to 15 per group. 
 
Supplementary Figure S4. Closed-arms entries in EPM test. Error bars denote SEM. *P<0.05, 
**P<0.01, ***P<0.001; n=10 to 15 per group. 
 
Supplementary Figure S5. Latency to immobility in FST. Error bars denote SEM. *P<0.05, 
**P<0.01, ***P<0.001; n=10 to 15 per group. 
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 Supplementary Figure S6. Performance on memory acquisition trials on the 4 days preceding the 
behavioral flexibility test (5th day). (a) Depicts the effect of MAM in memory acquisition performance of 
control and uCMS rats; (b) depicts the ADs effect; (c) depicts the effect of MAM co-administration along 
with ADs. Error bars denote SEM. *P<0.05, **P<0.01, ***P<0.001; n=10 to 15 per group. 
 
Supplementary Figure S7. Effects of MAM on density and morphology of spines from 
newborn neurons. (a) Effect of MAM administration on spine density in newborn neurons (Golgi/
BrdU+ cells); (b) MAM administration mimics the increase of thin spines produced by uCMS 
exposure, which is reversed by ADs administration. Error bars denote SEM. ✧*P<0.05, ✧ ✧; **P<0.01, 
✧ ✧ ✧; ***P<0.001; n=10 to 15 per group. 
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PERSPECTIVE
Cell genesis and dendritic plasticity: a neuroplastic pas de deux in
the onset and remission from depression
A Mateus-Pinheiro1,2, P Patrı´cio1,2, JM Bessa1,2, N Sousa1,2 and L Pinto1,2
Brain neuroplasticity is increasingly considered to be an important component of both the pathology and treatment of depressive
spectrum disorders. Recent studies shed light on the relevance of hippocampal cell genesis and cortico-limbic dendritic plasticity
for the development and remission from depressive-like behavior. However, the neurobiological significance of neuroplastic
phenomena in this context is still controversial. Here we summarize recent developments in this topic and propose an integrative
interpretation of data gathered so far.
Molecular Psychiatry advance online publication, 28 May 2013; doi:10.1038/mp.2013.56
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INTRODUCTION
The potential to respond to environmental stimuli through
dynamic rearrangements of synapto-dendritic networks, as well
as by regulating the generation of new neuronal and glial cells,
renders the brain highly mutable. These phenomena, collectively
known as neuroplasticity, are critical to promote neuronal
adaptations; its failure is now increasingly considered to be a
major component in many neuropsychiatric conditions. Among
these, depressive spectrum disorders are a paradigmatic example
of the importance of neuroplastic alterations in the adult brain.
Recent studies provide a comprehensive picture of the effects of
stress, a major trigger factor in depression, in the (de)regulation of
neuroplasticity;1–4 the latter is, in turn, related to the emergence
of physiological and behavioral alterations comprised in the
symptomatic profile of depressive disorders. Although these
molecular and physiological mechanisms regulating neuroplastic
processes are relevant for the onset of depressive symptoms, they
have also been implicated in the action of antidepressants (ADs).
So far, and although there is still much to be elucidated, it is
becoming evident that the triad stress-neuroplasticity-depression
constitutes fertile ground for new findings.
NEW CELLS AND DENDRITES: IMPORTANCE FOR THE
TREATMENT AND REMISSION FROM DEPRESSION
Although different forms of neuroplasticity are affected in
depression, a debate endures concerning the exact neurobiolo-
gical significance of postnatal hippocampal cell genesis, both for
the development of depressive pathology and for the therapeutic
action of ADs. From the bulk of evidence gathered so far, it is
increasingly appreciated that alterations in cell genesis are
involved in the pathology and treatment of depression; however,
there are several conflicting reports regarding its relevance. Three
factors are likely to contribute to these controversies. First, there is
a ‘necessary’ difficulty to approach this question in humans
suffering from depression; postmortem studies in humans and
animal models of depression have, nevertheless, provided
important insights. Second, it seems to exist a major prevalence
of studies focusing on the functional implications of neurogenesis,
in disregard of gliogenesis, a parallel cell-genesis process likely to
be of relevance in this context. Lastly, because these events are
highly dynamic, the adoption of different experimental models
and time frames when analyzing the participation of cell genesis
in the pathology and treatment of depression is critical to have a
complete perspective of the topic. On account of these
experimental dissimilarities, an integrative, and careful, interpreta-
tion of data published in the last years is required when
attempting to put the pieces of the puzzle together.
Suppression of hippocampal cell proliferation in naive animals
through irradiation, pharmacological approaches or through the
use of transgenic models of cytogenesis ablation has been shown
to be associated with the development of deficits in different
behavioral dimensions commonly affected in depression.2,5,6
Strikingly, most of the studies in which analyses were performed
shortly after cytogenesis ablation did not reveal significant
deficits in most behavioral domains normally assessed in the
characterization of animal models of depression (Figure 1).7,8
However, recent reports in which abrogation of cytogenesis is
maintained for long periods (over 4 weeks)6 or in which the
behavioral analysis was conducted only 4 weeks after the
cessation of cytogenesis suppression,4 reported multidimen-
sional behavioral deficits that emerged only weeks after the
antiproliferative insult. Importantly, the specific late manifestation
of depressive-like behavior and cognitive disabilities in animals in
which cytogenesis had been suppressed illustrates how mani-
pulating lengthy neuroplastic phenomena is associated with the
non-immediate development of behavioral impairments, which
are only fully manifested once newborn cells are expected to be
incorporated in local neuroglial circuits. This view has been
recently supported by the demonstration that the specific
inhibition of 4-week old new hippocampal neurons causes
deficits in memory retrieval in mice; remarkably, inhibiting the
activity of either younger or less-plastic older neurons does not
produce effects in this cognitive domain.9
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Figure 1. The participation of dendritic plasticity and hippocampal cell genesis in the development and treatment of depression. (a) In animal
models of depression, chronic exposure to stress, one major trigger factor of depression, leads to the dendritic atrophy of hippocampal and
prefrontal cortex neurons and compromises the generation of new cells. These neuroplastic impairments are associated with the
development of multidimensional deficits manifested in behavioral dimensions such as mood, anxiety behavior and cognitive performance.
Treatment with typical SSRIs allows for the fast reestablishment of dendritic neuronal architecture, which is associated with the fast remission
from depression-like behavior. The slow generation of new neuronal and glial cells, potentiated by antidepressant (AD) treatment will be
fundamental to maintain this remission and to promote a sustained long-term recovery from depression. (b) Suppression of hippocampal cell
genesis, using X-ray irradiation, the cytostatic agent methylazoxymethanol or transgenic animal models of cytogenesis ablation, does not
seem to have an impact on the mood-improving effects of ADs, but rather to preclude AD’s efficacy in reversing anxiety behavior and
impairments in some cognitive modalities (blue line); other cognitive functions remain unaffected (dashed blue line). (c) Ablation of
cytogenesis in naive animals, while maintaining dendritic morphology intact, leads to the short-term manifestation of hyperanxiety behavior;
deficits in mood and cognitive modalities are only evident later on, when newborn cells are expected to be fully matured and incorporated in
the local neurocircuitry. SSRIs, selective serotonin reuptake inhibitors.
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An exception must be made in respect to anxiety behavior,
because disruption of hippocampal cytogenesis is associated to
the immediate development of heightened anxiety, which is
commonly comorbid in depressed patients. In fact, it has been
demonstrated that immature newborn neurons display a major
role in anxiety behavior control.10–12
In contrast with the slow reconfiguration of neuroglial networks
promoted by the addition of new cells in the adult brain, are the
rapid synaptic and dendritic morphological changes. These
underlie the short-term impacts on distinct emotional and
cognitive processes observed in the onset of depressive
symptoms. Indeed, defects on neuronal cytoarchitecture have
been documented in postmortem analysis of brain tissue from
depressive patients, which seem to be ameliorated by chronic AD
treatment.13,14 These structural defects include cortico-limbic
dendritic atrophy in depressed subjects,15 accompanied by
abnormalities in glial cell structure. Importantly, in animal
models of depression, these changes are associated with
hallmarks of depressive behavior, such as anhedonic behavior,
behavioral despair and cognitive disabilities.2
Besides this common participation of slow cytogenesis pro-
cesses and rapid dendritic rearrangements in the pathology of
depressive spectrum disorders, these two neuroplastic phenom-
ena, with very different temporal dynamics, constitute the
substrate by which ADs (partially) exert their therapeutic actions.
Thus, the reestablishment of normal neuroglial networks seems to
be achieved in a biphasic manner (Figure 1): in a short-term
context, AD actions rely on rapid modulatory effects upon genes
involved in the restructuring of the synaptic network; later on, the
generation of new fully matured neuronal and glial cells will have
an impact on the long-term remission from emotional and
cognitive disabilities manifested during a depressive episode. In
fact, despite triggering an immediate pro-proliferative response,
this early effect corresponds only to the onset of a slow
neuroadaptation whose neurobiological importance can only be
fully appreciated later on, once new cells attain complete
maturation and functionality, and are integrated in the local
neurocircuitry. Taken together, and because mammalian neuro-
genesis is described to take 4–6 weeks, the overall outcome of AD’s
therapeutic action upon neuroplasticity may only be entirely
manifested after this period. Remarkably, this period correlates
with the time latency that typically prescribed ADs take to fully
manifest their action in depressive patients.
Although the neuroplastic alterations occurring during the onset,
treatment and remission from depression are being increasingly
characterized, comprehension of the processes (namely genetic
and epigenetic programs) that orchestrate these alterations is still
limited. Future research focusing on these processes should also be
extended to the still underexplored glioplastic component of this
disorder. Furthermore, local neuroplastic adaptations are likely to
occur in articulation with systemic neuroendocrine and immuno-
logical alterations, which are still to be integrated in the complex
puzzle of mechanisms implicated in depression.
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Chapter IV 
HIPPOCAMPAL CYTOGENESIS ABLATION IMPAIRS INTER-
REGIONAL COMMUNICATION BETWEEN THE HIPPOCAMPUS 
AND PREFRONTAL CORTEX AND PROMOTES BEHAVIORAL 
DEFICITS 
Hippocampal cytogenesis ablation impairs inter-regional communication between the 
hippocampus and prefrontal cortex and promotes the time-dependent manifestation of 
behavioral deficits 
   _________A. Mateus-Pinheiro, P. Patricio, N.D. Alves, V. Sardinha, A.R. Machado-Santos, J. Correia, J. Flint, J. Oliveira, 
N. Sousa and L. Pinto. 
To be submitted 
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ABSTRACT 
Impaired ability to generate new cells in the adult brain has been linked to deficits in multiple 
emotional and cognitive behavioral domains. However, the mechanisms by which the abrogation 
of post-natal neural stem cells impacts on brain homeostasis and function remains controversial. 
Here, we used one of the first transgenic rat lines available, the GFAP-Tk line, to selectively 
eliminate neural stem cells and assess the repercussion on different behavioral domains. We 
adopted two parallel experimental timeframes, to study both short-term and long-term effects of 
cytogenesis ablation (1 week post-ablation and 4 weeks post-ablation, respectively).  Moreover, we 
conducted in vivo electrophsyiological analysis to assess the effects of cytogenesis ablation on the 
electrophysiological signatures of the hippocampal and prefrontal cortex regions. Our results show 
that the short-term repercussions of post-natal cytogenesis ablation are restricted to anxiety 
behavior. Contrastingly, cytogenesis abrogation promoted the late manifestation of anhedonic and 
anxiogenic deficits, along with multi-dimensional cognitive impairments. Furthermore, we found 
that cytogenesis ablation impaired electrophysiological function between the hippocampus and the 
prefrontal cortex, which are likely to contribute to the described cognitive alterations. Altogether, 
we describe a progressive time-dependent manifestation of emotional and cognitive impairments 
following cytogenesis ablation, supporting a differential role of immature vs mature cells in the 
modulation of different behavioral dimensions within the adult brain. 
Keywords: Post-natal cytogenesis; GFAP-Tk; Hippocampus; Anhedonia; Anxiety; Memory; LTP  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INTRODUCTION 
In mammals, new cells are generated, throughout life, in the hippocampal subgranular zone 
(SGZ). Importantly, these cells have been shown to be able to differentiate, migrate radially 
towards external granular cells layers and to functionally integrate the local neuro-glial circuitry1-3. 
It is now known that this ability of generating new cells after birth, a process called post-natal 
cytogenesis, is influenced by a myriad of every-day-life experiences4,5 and affected as pathological 
target in some neuropsychiatric disorders, as well as by different classes of drugs6-8. Such 
observations led to the early assumption that these newly-generated cells could participate in 
pivotal brain functions, but the initial inability to experimentally dissociate the contribution of  new 
cells from the post-mitotic cell population undermined the attempt to understand the specific role 
of these cells. During the last 15 years, three types of strategies have been adopted to abrogate 
post-natal cytogenesis and study its impact on brain homeostasis: i) the use of x-ray irradiation9, 
which is a regionally restricted procedure, but that lacks cell-specificity as it affects also mature 
cells and elicits a significant inflammatory response; ii) the use of cytostatic drugs6,7, which are 
able abrogate cytogenesis in all cytogenic niches of the brain, but that again do not spare other 
mitotic cell populations and may trigger dose-dependent collateral effects difficult to control; iii) 
the use of transgenic mice lines10,11, that allow for the specific (promoter-directed) ablation of 
neural stem cells, without interfering with other cell types or having known systemic effects. This 
last approach has proven to be useful during the last years in order to elucidate the 
neurobiological role of cytogenesis in the adult brain. 
Indeed several studies that used either Glial Fibrillary Acidic Protein (GFAP)-Thymidine kinase 
(Tk) mice or Nestin-Tk mice lines, that allow for specific ablation of progenitor cells upon chronic 
administration of ganciclovir, have provided evidence for the requirement of new cells for a 
specific subset of  high-level neural processes that rely on hippocampal function. In particular, 
ablation of cytogenesis using both GFAP-tk and Nestin- tk mice has been shown to impair 
contextual fear conditioning, but not cued conditioning memory10,12. The fact that other behavioral 
parameters, such as the overall spatial reference memory performance in the Morris water maze 
(MWM) and Y-maze were kept intact, demonstrates how restrict and specific the role of newly-born 
cells is10,12.  Interestingly, although the latency to reach the escape platform in the MWM is not 
significantly affected upon cytogenesis ablation, a more detailed analysis has shown that Nestin-
Tk mice display long-term retention deficits on subsequent probe trials, showing no preference for 
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the quadrant in which the platform was positioned12. The findings that LTP induction in DG is 
compromised in mice without hippocampal cytogenesis, has led to the hypothesis that the 
observed deficits are related with deficits in hippocampal synaptic plasticity10. In addition, It has 
been reported that in GFAP-Tk mice, cytogenesis ablation promoted a reduction in the efficacy of 
perforant path inputs, thus leading to an increase in the magnitude of γ-frequency bursts in the 
attempt to overcome this impairment13. Moreover, behavioral flexibility has also been shown to be 
impaired in GFAP-tk mice, reflected as impaired avoidance in an active place avoidance task14. 
More recently, a GFAP-Tk rat model was generated15. Curiously, authors did not found alterations 
in spatial working  memory in radial maze, neither on the learning or reversal phases of spatial 
reference memory task in the water maze15. These findings conflict with previous data, although 
several studies exist where no alterations were found upon cytogenesis ablation, rendering this 
topic quite controversial.  
Hence, in this work we promoted cytogenesis ablation after chronic ganciclovir (GCV) 
administration (18 days). To address the importance of both immature and mature new 
hippocampal cells, we adopted two analysis time points: one “short-term” analysis, in which 
behavioral tests were conducted immediately after the cessation of GCV treatment; a second 
“long-term” analysis was performed in second subset of animals, only 4 weeks post-ablation. 
METHODS  
Animals  
GFAP-Tk transgenic rat line was perviously generated as described before15. 2 female GFAP-Tk 
founders were used to establish an in-house colony, since male rat were shown to be infertile and 
thus breeding is restricted to female heterozygous rats and wt animals. Genotyping identified 18 
transgenic pups and 20 wt littermates, that were used in this study. Animals were grouped-housed 
in polypropylene cages (2 animals per cage) under 12h light: 12h dark cycles, at 22°C, relative 
humidity of 55% and  with food and water ad libitum.  
All procedures were carried out in accordance with EU Directive 2010/63/EU and NIH 
guidelines on animal care and experimentation and were approved by the Portuguese 
Government/Direcção Geral de Alimentação e Veterinária (DGAV) with the project reference 
0420/000/000/2011 (DGAV 4542). 
i i  109
Ganciclovir (GVC) treatment and experimental timeline 
Ganciclovir (GCV) (Kemprotec, UK) was dissolved in hydroxyethilcellulose at 20 mg.ml-1, and 
10 mg.Kg-1 was injected intraperitoneally once a day, for 18 consecutive days, in 2 month-old 
animals. Both hemizygous (+/-) and littermate wilde-type controls (wt) were divided in two 
subgroups and subjected to behavioural testing either in the day following GCV treatment 
cessation (“short-term analysis”), or 28 days after the end of treatment (“long-term analysis”). In 
all animals, 5-Bromo-2-Deoxyuridine (BrdU), a thymidine analog, was injected daily (50 mg.Kg-1/ 
day; i.p.), during the last 5 days of GCV treatment.  
Behavioral analysis 
Sucrose Consumption Test (SCT) 
Baseline sucrose preference values were established during a 1-week habituation period (1 
week prior the beginning of GCV treatment) during which animals were presented with two pre-
weighed drinking fluid bottles, containing water or 1% (m/v) sucrose. A single SCT trial was 
performed in each established analysis time-point.  Before each recording of sucrose preference, 
rats were food- and water-deprived for 12h and exposed to the test drinking solutions for 1h. 
Sucrose preference was calculated as described previously.  
Sweet Drive Test (SDT) 
The SDT test was additionally used to measure anhedonic behavior, as previously described 
(Mateus-Pinheiro et al, 2014) . Briefly, each animal was allowed to explore the SDT box for 10 min, 1
where sweet (Cheerios, Nestle) or regular pellets (Mucedola 4RF21-GLP) were available. After each 
trial, preference for sweet pellets was calculated as already described. Three SDT trials were 
conducted during the last week of the uCMS protocol (1 trial every 48h). The number of entries into 
each chamber was used as a measure of exploratory behavior. Data from the last trial is shown. 
Forced Swimming Test (FST) 
Depressive-like behavior was assessed through the forced swimming test. A FST trial was 
conducted 24h after a 5-min pretest session, by placing the rats in transparent cylinders filled 
with water (25 1C; 50 cm of depth) during 5 min. Trials were video-recorded and the immobility 
time, as well as the latency to immobility were measured using an automated video tracking 
system (Viewpoint, Champagne au mont d’or, France). Learned-helplessness was considered as 
an increase in the immobility time. 
 Please see Chapter 7, for details on the Sweet Drive Test (SDT).1
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Novelty Suppressed Feeding (NSF) test 
Anxiety-like traits were further assessed through the NSF paradigm. After a 18-h period of food-
deprivation, animals were placed in an open- field arena, as previously described where a single 
food pellet was positioned in the center. After reaching the pellet, animals were individually 
returned to their home cage, where pre-weighted food was available, and were allowed to feed 
during 10min. The latency to feed in the open-field arena was used as an anxiety-like behavior 
measurement, whereas the food consumption in the animal home cages provided a measure of 
appetite drive. No differences were observed in the appetite drive between the experimental 
groups that could lead to a misinterpretation of the results (not shown). 
Water Maze Tests 
Water maze tests were used to test the performance in both spatial reference memory and 
working memory tasks as described previously16. Briefly, these tests were conducted in a 
circular black pool (170 cm diameter) filled with water at 22ºC to a depth of 34 cm in a room with 
extrinsic clues (triangle, square, cross and horizontal stripes) and dim light. An invisible platform 
was placed in one of four quadrants. Trials were video-captured by a video-tracking system 
(Viewpoint, Champagne au mont d’or, France). Animals were habituated to the test room, during 
the two days preceding the tests, being kept in the room for 1h in each day.  
Working Memory Task. The working memory task was used to evaluate the cognitive domain that 
relies on the interplay between the hippocampal and PFC functions. An escape platform was 
placed in one of the quadrants, and was maintained in the same position during the four daily 
trials. The test was performed during four days, and in each day the platform was repositioned in 
a new quadrant in a clockwise-fashion. In each of the daily trials animals were positioned in a 
different starting point (north, east, west and south) and a trial was considered as concluded 
when the platform was reached within the time-limit of 120s. The time of escape latency and the 
path described to reach the platform (distance swam) were recorded for each trial.  
Reference Memory Task. With the reference memory task the hippocampal- dependent cognitive 
function was evaluated. For five days the platform remained on the same quadrant and animals 
were tested in four daily trials according to the same procedure previously described. The time of 
escape latency and the path described to reach the platform (distance swam) were recorded for 
each trial.  
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Swimming Strategies Analysis  
Swimming analysis was performed specifically in the long-term analysis time-point. Data 
collection and analysis of Morris Water Maze spatial reference trials were performed using a video 
tracking system (Viewpoint, Champagne au mont d’or, France). Search strategies were defined as 
previously described17. Quantitative analysis and strategy classification was performed with data 
collected by the Viewpoint software, using an algorithm that we developed for automatic strategy 
attribution based on pre-defined parameters.  For strategy blocks analysis, we defined two blocks 
of strategies: Block1, comprising the “non-hippocampal dependent strategies” (Thigmotaxis, 
Random Swim and Scanning) and Block2, comprising the “hippocampal dependent 
strategies” (Directed Search, Focal Search and Direct Swim); “chaining” was considered a 
transitional strategy and thus was not included in any of the blocks. Strategy blocks were defined 
as a sequence of at least three trials with the strategies from the same class. For block lengths, a 
maximum of two-trial interruptions were tolerated but not counted. 
Contextual Fear Conditioning (CFC) 
CFC behavioral analysis were conducted specifically in the long-term analysis time-point. 
Contextual Fear Conditioning  was conducted in white acrylic chambers with internal dimensions 
of ︎20 cm wide, 16 cm deep and ︎ 20.5 cm high (Med Associates), with an embedded light bulb 
mounted directly above the chamber to provide illumination. Each chamber contained a stainless 
steel shock grid floor inside a clear acrylic cylinder, where animals were placed. Animals were 
subjected to two probes, a context probe and a cue (light) probe. The CFC procedure was 
conducted over 3 days (please refer to Fig. 5), as follows: 
Day 1. Rats were placed in the conditioning white chamber (Context A) and received 3 pairings 
between a light (20 s) and a coterminating shock (1 s, ≈0.7 mA). The interval between pairing 
was set as 180 s, and the first tone presentation commenced ︎180 s after the rat was placed 
into the chamber. Freezing was defined as the complete absence of motion, including motion 
of the vibrissae, for a minimum of 1s. At the end of the three pairings, rats remained in the 
chamber for a further 30 s before being returned to their home cage. The chambers were 
cleaned with 10% ethanol solution between each trial.   
Day 2.  For the context probe, animals were placed in the white chamber (Context A), where they 
were originally shocked, 24h after the light-sock pairings. Freezing behavior was measured 
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during 3 minutes. Two hours later, animals were put in a modified version of the chamber 
(Context B) that was sheeted with a black plasticized cover that was previously sprayed with 
vanilla oil, in order to alter both spatial and odor references; the ventilation fan was not 
operated; the experimenter wore different colored gloves and lab coat. Again, freezing was 
measured during 3 minutes.  
Day 3. For the cued probe, animals were replaced in Context B, and at the end of variable period 
of 2 to 3 minutes a light was turned on (20s). Freezing was measured in the subsequent 
minute. 
Novel Object Recognition Task  (modified version to assess pattern separation) 
We developed a variation of the classical Novel Object Recognition (NOR) task, in which 
memory assessment is based on the rodents object recognition  is based on pattern separation; 
all used objects were made of the same material (plastic foam), had the same shape and were 
only distinguishable by different black and white patterns on their surface (please refer to Fig. 5). 
Briefly, in day 0 animals were placed in an empty arena and allowed to freely explore it for 5 
minutes, for context habituation. In the following day (day 1), animals were exposed to two 
identical objects, with the same patterns, (object A) and allowed to explore the arena during 10 
minutes (acquisition phase) . One hour after (short-term retention assessment), one of the objects 
was replaced by an object with a different surface pattern (object B). Twenty-four hours later (day 
2; long-term retention assessment), animals were exposed to the original object A along with a 
new object with a different pattern (object C). To increase the level of interference on pattern 
separation, the walls of the arena were covered with different black and white patterns, in order to 
increase the requirements of intact pattern separation to recognize the familiar object. Sessions 
were video-recorded and exploration times were assessed automatically with Ethovision software 
(Noldus). 
Immunohistochemical Analysis of Cell Proliferation and Long-term Survival 
Animals were deeply anaesthetized with sodium pentobarbital (20%; Eutasil, Sanofi) and were 
transcardially perfused with cold 0.9% NaCl. Brains were carefully removed, frozen and preserved 
at -20ºC. Coronal cryosections (20 mm) were firstly stained for BrdU (1:50; Dako, Glostrup, 
Denmark), to assess short-term hippocampal cell proliferation and survival both in the dorsal and 
ventral dentate gyrus (dDG and vDG, respectively). For long-term cell survival analysis, sections 
from animals injected with BrdU 4 weeks before were co-stained with BrdU (1:50; Dako, Glostrup, 
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Denmark), followed by sequential staining for NeuN (for mature neurons; 1:100; Chemicon, 
Temecula, CA, USA) or GFAP (for glia; 1:200; Dako). Finally, all sections were stained with 4’,6- 
diamidino-2-phenylindole (1 mg.ml ︎ -1). For each animal, BrdU- positive cells within the subgranular 
zone of the dentate gyrus were analyzed after double staining with neuronal (NeuN) or glial (GFAP) 
markers and cell counts were performed by confocal microscopy (Olympus FluoViewTM FV1000, 
Hamburg, Germany). Estimation of cell density in the dentate gyrus was obtained by crossing the 
cell number values with the corresponding dentate gyrus areas, determined using a Olympus 
BX51 optical microscope and the Newcast software (Visiopharm, Horsholm, Denmark).  
Electrophysiological Recordings 
Surgery 
Experimental procedures for implantation and recording extracellular field potentials were 
performed according to previously described protocols16. Testing animals were anesthetized using 
sodium pentobarbital (selected since it acts through GABA receptors activation, thus minimizing 
the impact on the glutamatergic transmission). After anesthesia induction, animals were placed 
over a homoeothermic blanket (Stoelting, Ireland) and the rectal temperature kept at 37°C. 
Animals head was fixed to a stereotaxic frame, with a gas anesthesia platform linked to a rat mask 
(Stoelting, Ireland). From their coordinates (rostrocaudal, mediolateral and dorsoventral), the 
localization of the areas of interest, mPFC (coordinates, 1.94 mm anterior to bregma, 0.4 mm 
lateral to the midline, 2.54 mm below bregma), and ventral hippocampus (vHIP) (coordinates, 3.8 
mm posterior to bregma, 3.3 mm lateral to the midline, 3.4 mm below bregma) was determined 
according to the rat brain atlas (Paxinos, 2001). A platinum/iridium recording electrode (Science 
Products, Germany) was placed in the mPFC and a concentric bipolar tungsten/stainless-steel 
electrode (WPI, USA) positioned into either the ipsilateral CA1/subicular region of the dHIP or 
vHIP.  
A set of 10 animals (5 GFAP-Tk transgenic and 5 wt) were used to perform the 
electrophysiological recordings of local field potentials (LFPs) and synaptic plasticity, over a period 
of 6 days. 
Synaptic plasticity evaluation  
Synaptic plasticity between the PFC and the vHIP was measured as previously described 
(Cerqueira et al., 2007). Briefly, LTP was induced through the electrode inserted in the vHIP 
promoting a characteristic monosynaptic field excitatory postsynaptic potential (fEPSP) in the PFC. 
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Every 30 seconds it was invoked a test pulse (100 ms) at an intensity enough to promote a 
potential around 70% of its maximum amplitude (250–500 μA; S88X Grass Stimulator, Astro-Med, 
Germany). The evoked potential to such stimulation is likely to reflect summated post-synaptic 
potential (PSP). The induction of LTP was obtained through a high frequency stimulation (HFS) 
protocol, performed by two series of 10 trains (250 Hz, 200 ms) at 0.1 Hz, 6 min apart, delivered 
at test intensity. Signals were recorded every 30 seconds during 30 minutes before (basal 
recordings) and 45 minutes after stimulation.  
LTP response was assessed by measuring the differences in fEPSP slopes between responses 
prior (baseline) and post HFS. fEPSP slopes were analyzed using Signal software (CED, UK; 
sampling rate, 10 KHz) and expressed as a percentage change of the mean responses to normal 
stimulation before and after HFS.  
At the completion of the electrophysiological protocols, a biphasic 1 mA stimulus was delivered 
to both electrodes in order to mark the local of recording. Afterwards, rats were deeply 
anesthetized with sodium pentobarbital and brains carefully removed and emerged in 
paraformaldehyde (PFA) 4%.  
Brain sectioning and electrodes position confirmation 
Rat brains were processed in the vibratome (50 μm thick sections), and the resulting sections 
were stained with Cresyl Violet to confirm electrodes positioning.  
Data analysis and Statistics 
Statistical analyses were done using SPSS and Graphpad softwares. After confirmation of 
homogeneity, data was subjected to appropriate statistical tests. ANOVA repeated measures was 
used to analyze spatial reference memory, working memory and LTP data. Unpaired T-test was 
used in the remaining analysis. F-values and P-values are properly indicated along the text. 
Statistical significance was accepted for P<0.05. 
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RESULTS 
Ganciclovir treatment significantly abolished short-term hippocampal proliferation, 
and long-term neuronal and glial survival  in GFAP-Tk animals 
In the short-term analysis (following a period of 7 days of behavioral analysis, after the 
cessation of GCV treatment) we analyzed hippocampal proliferation in both the dorsal and ventral 
hippocampus (Fig. 1a, b). GCV treatment promoted a significant reduction in the number of 
BrdU-positive cells in both the dDG (t4=3.340, P=0.014) and the vDG (t4=2,147, P=0.049). 
Regarding 4 weeks cell survival, GCV effectively abrogates total cell (total BrdU-positive cells) in 
both hippocampal poles (dDG: t4=8.055, P< 0.0001; vDG: t4=2,578, P=0.031) (Fig. 1c). 
Specifically, both hippocampal neurogenesis and gliogenesis were markedly supressed, as shown 
by the reduced survival of new neuronal (BrdU/NeuN double-positive cells; dDG: t4=6,209, 
P=0.002; vDG: t4=5,330, P=0.003) and glial cells (BrdU/GFAP double-positive cells; dDG: 
t4=4,395, P=0.006; vDG: t4=3,646, P=0.003)  (Fig. 1d). 
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Figure 1. Short-term proliferation and long-term cell survival in the ventral and dorsal dentate gyrus, following GCV 
treatment. (a) Depiction of the experimental timeline for the “short-term analysis” (behavioral tests conducted 
immediately post-ablation and sacrificed 7 days later) and the “long-term analysis” (behavioral analysis conducted 4 
weeks post-ablation). (b-d) BrdU was administered at the end of GCV treatment for subsequent analysis of 
hippocampal 7-day (b) and 4-weeks cell survival (c). (d) Hippocampal neuro- and gliogenesis were assessed 4 weeks 
post-ablation. Error bars denote s.e.m. *P<0.05, **P<0.01, ***P<0.001; n = 3 per group.
Adult hippocampal cytogenesis ablation promotes short-term anxiety-like behavior, 
but has no effect on depressive/ anhedonic behavior or spatial reference memory 
Immediately after the cessation of GCV treatment, GFAP-TK+/- animals did not present signs of 
anhedonic behavior in the SCT (P=0.39; Fig. 2a) or SDT (P=0.41; Fig. 2b). Moreover, 
cytogenesis ablation did not produce the short-term  precipitation of depressive-like behavior, as 
both GFAP-TK+/- and wt animals presented similar immobility time in the FST (P=0.19; Fig. 2c). 
Interestingly, suppression of adult cytogenesis was sufficient to induce short-term anxiety-like 
behavior, manifested as a increase in the latency to feed  in the NSF paradigm (t16=3.696, 
P<0.001; Fig. 2d). In this time-point, we also tested animals in spatial reference memory task 
and found no interference of cytogenesis ablation in the animals performance (P=0,52; Fig. 2e). 
  
Deficits in hedonic behavior emerge 4 weeks after adult cytogenesis ablation, along 
with heightened anxiety  
While we have not found short-term behavioral deficits upon cytogenesis ablation, beyond 
those of heightened anxiety, the long-term behavioral profile of GFAP-Tk+/- animals encompasses 
additional impairments. In particular, GCV treatment elicited the long-term manifestation of 
anhedonic behavior, manifested as decreased consumption preferences in both the SCT 
(t16=1.796, P=0.045; Fig. 3a) and the SDT (t16=2.020, P=0.030; Fig. 3b). While no differences 
were observed in the FST (P=0.34; Fig. 3c), this anhedonic profile was further accompanied by 
anxious-like signs, evidenced in the NSF (t16=2.454, P=0.013; Fig. 3d). Together with the short-
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Figure 2. Short-term impact of adult cytogenesis ablation on rodent behavior. (a,b) Anhedonic behavior was 
measured in the (a) SCT and in the (b) SDT. (c, d) The presence of depressive-like behavior was assessed by the (c) 
FST, while the (d) NSF paradigm was used to measure anxious-like behavior. e. Cognitive performance was evaluated 
in a spatial reference memory task. Error bars denote s.e.m. *P<0.05, **P<0.01, ***P<0.001; n = 9-10 per group.
term behavioral characterization, this behavioral pattern suggests that adult cytogenesis 
suppression elicits a time-dependent manifestation of anxiety and anhedonic impairments. 
 
Adult cytogenesis does not impact on spatial reference memory overall performance, 
but produces alterations in the adopted cognitive strategies and working memory 
Our results show that chronic GCV abolishment of cytogenesis did not produce significant 
alterations in the distance taken to reach the escape platform during the learning phase of the 
spatial reference memory task in the water maze (Fig. 4a). However, analysis of the strategies 
adopted to reach the escape platform showed that GFAP-Tk rats are able to maintain test 
performances comparable to wt littermate controls by delaying the switch from non-hippocampal 
dependent strategies (“Block 1”) to hippocampal dependent strategies (“Block 2”) (Fig. 4b). In 
fact, the majority of wt animals initiates strategies Block 2 by test day 2, while GFAP-Tk rats do it 
so mainly during days 3 and 4, presenting an increased mean duration of Block 1 in relation to wt 
rats (Block1: wt = 6.0 ± 0.5 vs GFAP-Tk+/- = 11.7 ± 1.1; t18 = 4.616; P = 0.0001; Block2: wt = 
11.6 ± 1.8 vs GFAP-Tk+/- = 4.0 ± 2.0; t18 = 1.970; P = 0.0032; Fig. 4c - f). 
Moreover, 4 weeks post-ablation we also measured working memory in a water maze test 
paradigm in which the position of the escape platform was repositioned in a new quadrant in a 
clockwise-fashion. Hence the ability of animals to retain the platform position in each trial along 4 
days was assessed. Ablation of cytogenesis in GFAP-Tk+/- rats produced long-term deficits in this 
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Figure 3. Long-term impact of adult cytogenesis ablation in emotion-related behavioral categories . (a,b) Anhedonic 
behavior was measured in the (a) SCT and in the (b) SDT. (c, d) The presence of depressive-like behavior was 
assessed by the (c) FST, while the (d) NSF paradigm was used to measure anxious-like behavior. Error bars denote 
s.e.m. *P<0.05, **P<0.01, ***P<0.001; n = 9-10 per group.
cognitive domain, reflected as a significant increase in the overall distance traveled to reach the 
escape platform (F(1, 64)= 5.927; P= 0.017; Fig. 4g).     
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Figure 4. Long-term impact of adult cytogenesis ablation in water maze cognitive tasks. (a) Animals were evaluated 
in a spatial reference memory task 4 weeks post-cytogenesis ablation. (a-f) The overall test performance was 
complemented with the analysis of the swim strategies (b) adopted by each animal to reach the escape platform; the 
trial distributions of individual strategies and strategy block prevalence are shown both for wt (c, d) and GFAP-Tk+/- 
animals (e, f). Furthermore, the long-term impact of cytogenesis ablation was also tested in a working memory task 
(g). Error bars denote s.e.m. *P<0.05, **P<0.01, ***P<0.001; n = 9-10 per group.
Adult cytogenesis abrogation affects pattern separation in a variation of the classic 
NOR task  
The NOR task is a simple behavioral assessment of memory that relies primarily on a rodent’s 
innate exploratory behavior in the absence of externally applied rules or reinforcement. With the 
applied protocol, exploratory behavior of a novel object relied on intact pattern separation 
hippocampal function. Our results show that both animal groups presented identical total times of 
object exploration, discarding any possible effects of cytogenesis abrogation in exploratory 
behavior (Fig. 5a). In the short-term memory assessment, GFAP-Tk+/- displayed decreased 
percentage of exploration of the new object (wt: object A = 43.70 ± 8.42 vs object B = 63.59 ± 
5.96; t18 = 1.909; P = 0.0362; GFAP-Tk+/-: object A = 56.71 ± 4.15 vs object B = 47.18 ± 4.79; t18 
= 1.502; P= 0.0152, Fig. 5b), in comparison with wt animals. In the long-term (24h) memory 
assessment, neither wt or GFAP-Tk+/- rats were able to effectively identify the novel object, as 
reflected by evenly matched exploration times among both objects, Fig. 5c).  
Adult cytogenesis abrogation impairs contextual fear conditioning, but not cued-
conditioning 
In the contextual fear conditioning (CFC) task, animals were submitted to a context probe, aimed 
to test hippocampal-dependent memory, and a light-cued probe, aimed to assess the integrity of 
memory circuits relying at lesser extent in hippocampal function.  
First we assessed wether both animal groups presented similar percentages of freezing after the 
light-shock pairings day, so that potential divergent values in this parameter would undermine a 
clear interpretation of the results obtained in the following days. In fact, both groups had similar 
average freezing percentages after the conditioning trials (Fig. 5d). In the context probe, GFAP-Tk 
animals presented a reduction in the percentage of freezing, while wt animals presented higher 
freezing percentages when exposed to a familiar context (Wt = 78.83 ± 4.27% vs GFAP-Tk = 67.32 
± 4.46%; t18 = 1.866; P = 0.0392, Fig. 5e). Switching to a new environment, decreased freezing 
times in similar fashion for both groups (Wt = 22.66 ± 2,7% vs GFAP-Tk = 22.15 ± 2.14%; t18 = 
0.7245; P = 0.2390,  Fig. 5e).  
In the light probe, both animal groups presented higher percentages of freezing after exposure to 
the light cue (Wt = 80.07 ± 2.72 vs GFAP-Tk = 77.13 ± 2.38; t18 = 0.8112; P = 0.2139, Fig. 5f). 
Overall, CFC results show that GFAP-Tk rats display long-term specific deficits in contextual 
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hippocampal-associated memory, while cytogenesis ablation leaves associative non-hippocampal 
dependent memory intact. 
 
Adult cytogenesis abrogation produces synaptic plasticity impairments affecting 
vHIP-mPFC communication 
To assess wether the lack of generation of new hippocampal cells could determine long-term 
defects on interregional synaptic plasticity, we used an LTP paradigm to evaluate synaptic 
plasticity between the vHip and mPFC. Our results show that after HFS in the ventral hippocampal 
region, GFAP-Tk rats showed decreased LTP induction on the mPFC (P=0.0167; Fig. 6). 
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Figure 5. Long-term impact of adult cytogenesis ablation in pattern separation and contextual fear memory . (a-c) 
Animals were evaluated in modified version of the NOR test to assess pattern separation. (d-f) Furthermore, contextual fear 
memory was tested in CFC paradigm. Error bars denote s.e.m. *P<0.05, **P<0.01, ***P<0.001; n = 9-10 per group.
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Figure 6. Cytogenesis ablation blunts hippocampal-PFC LTP response. Error bars denote s.e.m. *P<0.05, **P<0.01, 
***P<0.001; n = 5 per group.
DISCUSSION 
 In this work, we have administrated GCV through daily i.p. injections, to abrogate adult 
cytogenesis. Our immunhistological analysis confirmed that this approach is effective in ablating 
subgranular cytogenesis. Similar to what other authors have found6,15, our short-term analysis 
revealed no association between the lack of new immature hippocampal cells with the 
manifestation of anhedonic or depressive-like behavior. However, immature cells seem to have an 
important role in the modulation of anxiety, as cytogenesis ablation is sufficient to produce  quasi-
immediate manifestations of anxious-like behavior.  
Following reports that show that 3 to 5 weeks old neurons, but not younger or older newborn 
cells, have an important impact on different hippocampal-associated cognitive domains12,18, we 
also chose to perform behavioral analysis 4 weeks post GCV administration. Interestingly, and in 
line with what we have found before using a pharmacological cytogenesis-ablation approach7, we 
report the late manifestation of anhedonic behavior. This time-dependent emergence of anhedonic 
behavior may be in favor of the importance of the integration of new mature hippocampal cells for 
hedonic behavior control, while supporting the neurogenic hypothesis of depression premise of 
the participation of hippocampal cytogenesis in the pathophysiology of depression. However, we 
failed to detect alterations in the FST, which has been used to characterize rodent’s “depressive-
like behavior”9. Nevertheless, and along with the abnormalities found in the expression of anxious-
like behavior, our data supports the time-dependent participation of adult cytogenesis in the 
modulation of different emotion-related behavioral dimensions. 
Furthermore, we found that cytogenesis abrogation spared the overall performance of GFAP-Tk 
rats in a spatial reference memory and a reversal learning tasks. This is in line with previous 
studies conducted in Nestin-Tk mice12, GFAP-Tk mice10,13 and more recently, in the same GFAP-Tk 
rat model that we used15. In recent years, however, attention has been paid to the cognitive 
strategies that animals employ to reach the escape platform, as well as to its relation to adult 
hippocampal cytogenesis19. Indeed, our data shows that cytogenesis blockage imposes a long-
term switch from hippocampal-dependent to non-hippocampal dependent processes during spatial 
reference memory trials. Therefore, this is a likely adaptive process that occurs in animals with 
impaired hippocampal cytogenesis in order to compensate eventual spatial memory deficits. 
Moreover, working memory was also found to be affected 4 weeks post GCV administration.  At 
this respect it is interesting to note that the test paradigm relies on the interplay between the 
hippocampal and PFC functions. Besides local field potentials alterations, and data described by 
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other authors showing impaired local LTP elicited in the hippocampal DG after cytogenesis 
ablation, we now show that synaptic communication betweeen the hippocampus and the PFC is 
compromised after cytogenesis ablation. It is possible that altogether, these defects on synaptic 
plasticity may account for the memory deficits that we observed.  
Furthermore, abrogation of cytogenesis 4 weeks before testing, produced long-term impairments 
in contextual fear conditioning and pattern separation. Although these findings are in line with 
many preceding works using similar mice models10-14, our data conflicts with a recent report using 
the same rat model that we use, in which the authors report no alterations in these domains15. In 
relation to pattern separation assessment, the employed methods differed between these two 
works, and authors hypothesize that the used radial maze paradigm could be too demanding to 
detect differences in a so particular cognitive function. In fact, we were able to detect deficits in 
pattern separation in memory retrieval test session conducted 1 hour after the acquisition trial. 
When performing the same retention test 24 hours later, a task that would imply greater pattern 
separation and retention ability, the paradigm has no longer sensibility to detect pattern 
separation alterations; indeed, neither GFAP-Tk rats or wt animals are able to recognize the new 
objects, implying their inability to separate two very similar memory inputs acquired 24 hours 
before.  
In conclusion, our work supports the view that adult cytogenesis does not participate in every 
hippocampal neural process and plays specific roles in a only subset of emotional and cognitive 
domains. Moreover, different functional roles of new immature and mature cells likely account for 
the observed time-dependent manifestation of behavioral deficits that we have described. It is 
important to note that the current ablational approach impacts on the generation of both neuronal 
and glial cells20,21 and thus do no allow to discriminate the individual contributions of these 
different cell populations for the cognitive domains studied. The detected alterations were found in 
basal conditions. However, several authors support the idea that under particular conditions, as 
for instance in conditions of stress and increased glucocorticoid levels, newly born cells may be 
recruited at a greater extent to play a role on different emotional and cognitive domains22,23. 
Therefore, future studies of stress exposure could contribute to a better understanding of the role 
of new cells in the adult brain at its full exten. Finally, designing experimental approaches that 
allow for the selective ablation of either neuro- or gliogenesis will also pave the way towards a 
comprehensional view on the differential impact of these cell lineages to higher neural processes.   
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Chapter V 
STRESS-INDUCED ALTERATIONS OF DNA 
DEMETHYLATION PATHWAYS IN THE DORSAL AND 
VENTRAL HIPPOCAMPAL DENTATE GYRUS 
Effects of chronic stress and antidepressant treatment in DNA demethylation pathways 
in the dorsal and ventral hippocampal dentate gyrus 
A. Mateus-Pinheiro, P. Patricio, J. Marinho, M. Santiago, N.D. Alves, A.R. Machado-Santos, J. Silva-Correia, J. Marques, M. 
Branco, N. Sousa and L. Pinto. 
To be submitted 
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ABSTRACT 
Exposure to chronic stress promotes several neuroplastic alterations in the adult brain, that 
contribute to emotional and cognitive unbalances. However, the molecular triggers by which stress 
exerts its neuropathological effects are still to be fully understood. Recent studies have put forward 
the hypothesis that the impact of stress on epigenetic machinery in the brain could be an important 
mechanism by which neuroplastic processes become compromised. Here, we show that the enzyme 
TET3 is downregulated in the hippocampal dentate gyrus (DG) of rats exposed to chronic stress, and 
that this alteration is accompanied by a reduction in DNA 5-hydroxymethylation (5hmC) levels. This 
effect was restricted to the dorsal DG and not observed in the ventral DG. The reduction of this 
epigenetic mark is also observed within the resident mitotic cell population, as 5hmC is significantly 
lost in proliferating neural progenitor cells of the subgranular zone (SGZ) after unpredictable chronic 
miild stress exposure (uCMS), suggesting a possible role for DNA hydroxymethylation in the 
maintenance of the neural progenitor cell pool in the dorsal DG. Furthermore, we conducted a 
genomic analysis by oxidative reduced representation bisulfite sequencing (oxRRBS) in both 
hippocampal poles. Our first results support the loss of 5hmC levels specifically in the dorsal dentate 
gyrus and the promotion of DNA hydroxymetylation upon chronic antidepressant treatment, targeting 
different locci in the dorsal and ventral DG. 
Keywords: Stress; 5-hydroxymethylation; TET3; dentate gyrus; cytogenesis; dendritic plasticity; 
antidepressant 
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INTRODUCTION 
In DNA hydroxymethylation, 5-methylcytosine (5mC) is oxidized to 5-hydroxymethylcytosine 
(5hmC) in a reaction catalyzed by the TET family of methylcytosine dioxygenases (TET1, TET2 and 
TET3). Through a set of additional oxidizing steps, 5hmC will be subsequently converted into 5-
formylcytosine (5fC) and 5-carboxylcytosine (5caC)1-5, to eventually be transformed in fully-
demethylated cytosine residues6,7.  
Until recently, the function of 5hmC within the adult brain has been poorly comprehended. 
However, reports of high levels of TET3 expression in different brain regions raised the early 
hypothesis of a putative important role of  this enzyme in post-mitotic neurons8. Even so, TET1 
function in the central nervous system has been the most studied so far. It has been showed that 
Tet1-KO mice display a decreased number of hippocampal progenitor cells, while also having 
impairments in a spatial reference memory test in the Morris Water Maze9. Moreover, mice lacking 
Tet1 have been shown to have memory extinction defects, accompanied by abnormally enhanced 
hippocampal long-term depression. These studies also revealed that NSCs isolated from the DG of 
Tet1-KO mice present an enrichment of hypermethylated genes that ate downregulated, many of 
which participate in neurogenesis regulation.   
TET2 and TET3 functions in the adult central nervous system (CNS) are less characterized. In 
particular, the study of TET3 function in the brain has been delayed due to the neonatal lethality of 
the Tet3-KO mice. Recently, a study revealed a dramatic genomic redistribution of 5hmC within the 
infralimbic prefrontal cortex in response to fear extinction learning, and that fear extinction leads to 
TET3-mediated accumulation of 5hmC10. Altogether these studies highlight that TET proteins may 
play critical roles in the adult CNS which remain to be elucidated. This aspect might be of particular 
interest in a stress exposure context, which is generally associated to hypermethylation alterations in 
the CNS. Therefore, a better characterization of TET enzymes function and demethylation pathways 
could provide important cues on the mechanisms underlying cognitive and emotional disabilities 
after chronic stress exposure.  
Hence, we have submitted animals to a 6-weeks prevalidated unpredictable chronic mild stress 
(uCMS) protocol and evaluated several cognitive and emotional domains. We then analyzed the 
expression of TET enzymes in both the dorsal and the ventral hippocampal dentate gyrus (dDG and 
vDG, respectively). Moreover, we performed immunhistochemical analysis to assess 
hydroxymethylation levels in these two regions, which were subsequently complemented with data 
from genome-wide analysis of 5hmC and 5mC by oxRRBS. 
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MATERIALS AND METHODS 
Animals and treatments 
Male Wistar rats (200–250g, aged 2 months; Charles-River Laboratories, Barcelona, Spain) 
were maintained under standard laboratory conditions (12 h light: 12 h dark cycles, 22ºC, relative 
humidity of 55%, ad libitum access to food and water). Four groups of rats were used: a control 
group (Ct) and three groups exposed to stress, and treated with either saline (sal), fluoxetine (flx) 
or imipramine (imi).  A validated uCMS protocol was used, as previously described15. Subsets of 
these animal groups (with a final n=9) were tested behaviorally and sacrificed for subsequent 
studies at three established time-points: after 4 weeks of stress, and before antidepressant 
treatment; after 6 weeks of stress and immediately after antidepressant treatment conclusion; 
and, finally, 4 weeks after stress and the cessation of antidepressant administration. All 
procedures were carried out in accordance with EU Directive 2010/63/EU and NIH guidelines on 
animal care and experimentation. 
Antidepressant Drugs and BrdU administration 
During the last two weeks of uCMS, animals were treated with either saline solution (0.9% 
NaCl), the selective serotonin reuptake inhibitor, fluoxetine (10 mg.Kg-1 per day), or the tricyclic 
drug imipramine (10 mg.Kg-1 per day).  To  perform hippocampal proliferation and cell survival 
analysis, 5-Bromo-2-Deoxyuridine (BrdU), a thymidine analog, was administered to animals, in the 
following manner: in the subset of animals sacrificed after 4 weeks of stress exposure, a single 
BrdU injection (100 mg.kg-1, i.p.) was administered 24h before sacrifice in order to evaluate 
hippocampal proliferation; the following animals groups were submitted to 5 days of BrdU 
administration (50 mg.kg-1/ day, i.p.) at the end of the uCMS protocol, in order to perform both 
early survival and long survival studies. 
Behavioral analysis  
Sucrose Consumption Test (SCT) 
Baseline sucrose preference values were established during a 1-week habituation period (1 
week prior the beginning of uCMS exposure) during which animals were presented with two pre-
weighed drinking fluid bottles, containing water or 1% (m/v) sucrose. A single SCT trial was 
performed in each established analysis time-point.  Before each recording of sucrose preference, 
rats were food- and water-deprived for 12h and exposed to the test drinking solutions for 1h. 
Sucrose preference was calculated as described previously15.  
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Sweet Drive Test (SDT) 
The SDT test was additionally used to measure anhedonic behavior, as previously described11. 
Briefly, each animal was allowed to explore the SDT box for 10 min, where sweet (Cheerios, 
Nestle) or regular pellets (Mucedola 4RF21-GLP) were available. After each trial, preference for 
sweet pellets was calculated as already described. Three SDT trials were performed at the end of 
experimental time-point (1 trial every 48h). The number of entries into each chamber was used as 
a measure of exploratory behavior. Data from the last trial is presented. 
Forced Swimming Test (FST) 
Depressive-like behavior was assessed through the FST. A FST trial was conducted 24h after a 
5-min pretest session, by placing the rats in transparent cylinders filled with water (25ºC; 50 cm 
of depth) during 5 min. Trials were video-recorded and the immobility time, as well as the latency 
to immobility were measured using an automated video tracking system (Viewpoint, Champagne 
au mont d’or, France). Learned-helplessness was considered as an increase in the immobility 
time. 
Novelty Suppressed Feeding (NSF) test 
Anxiety-like traits were further assessed through the NSF paradigm. After a 18-h period of food-
deprivation, animals were placed in an open- field arena, as previously described where a single 
food pellet was positioned in the center. After reaching the pellet, animals were individually 
returned to their home cage, where pre-weighted food was available, and were allowed to feed 
during 10min. The latency to feed in the open-field arena was used as an anxiety-like behavior 
measurement, whereas the food consumption in the animal home cages provided a measure of 
appetite drive. No differences were observed in the appetite drive between the experimental 
groups that could lead to a misinterpretation of the results (not shown). 
Novel Object Recognition Task   
We used the Novel Object Recognition (NOR) task, to assess memory function, as previously 
described. Briefly, in day 1 animals were placed in an empty arena and allowed to freely explore it 
for 5 minutes, for context habituation. In the following day (day 1), animals were exposed to two 
identical objects and allowed to explore the arena during 10 minutes (acquisition phase). We then 
performed a single long-term retention assessment, twenty-four hours later, in which animals were 
exposed to the original object along with a novel unfamiliar object. Sessions were video-recorded 
and exploration times were assessed automatically with Ethovision software (Noldus). 
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Immunostaining procedures 
Animals were deeply anaesthetized with sodium pentobarbital (20%; Eutasil, Sanofi) and were 
transcardially perfused with cold saline solution (0.9% NaCl). Four animal brains of each 
experimental group were randomly assigned to be macrodissected, so that both the ventral and 
the dorsal hippocampal dentate gyrus could be isolated as described bellow; the remaining 5 
brains were processed in the cryostat. Coronal cryosections (20 mm) were rehydrated in 
phosphate buffered saline (PBS) and post- fixed with 4% paraformaldehyde. For BrdU, 5mC and 
5hmC analyses, sections were then treated with 2N HCl in PBS (1 hour/RT). Incubation with 
primary antibodies (ABs) was done overnight at 4°C. Primary ABs used were BrdU at 1:100 
(Abcam), followed by sequential staining for 5hmC at 1:1000 (Active Motif), NeuN (for mature 
neurons; 1:100; Chemicon, Temecula, CA, USA) or GFAP (for glia; 1:200; Dako). Finally, all 
sections were stained with 4’,6- diamidino-2-phenylindole (1 mg ml-1). Appropriate Alexa-Fluor-
conjugated secondary ABs (from Molecular Probes) were used at 1:1000, incubated for 2 hours at 
RT. Images and cell counts were obtained by confocal microscopy (Olympus FluoViewTM FV1000, 
Hamburg, Germany). Estimation of cell density in the dentate gyrus was obtained by crossing the 
cell number values with the corresponding dentate gyrus areas, determined using a Olympus 
BX51 optical microscope and the Newcast software (Visiopharm, Horsholm, Denmark).  
RNA extraction and qPCR analysis  
Dorsal and ventral DG were macrodissected and collected 24h after the last stressor (n=5 
animals/group). Immediately after dissection, tissues were frozen and stored at - 80°C. Total RNA 
from dorsal and ventral DGs from the different time points and experimental groups was isolated 
using TRIzol (Invitrogen) according to the manufacturer’s instructions. The ND-100 UV-visible light 
spectrophotometer (NanoDrop Technologies®) was used to evaluate the purity of RNA/DNA 
samples, by measuring the OD 260/280, and to determine the RNA and DNA concentration of 
each sample. cDNA was generated by reverse transcription from 500ng of RNA with the qScript 
cDNA SuperMix (Quanta Biosciences). For qPCR, oligonucleotide primers for the selected genes of 
interest were designed using NCBI Primer BLAST software. Sense and antisense sequences were 
used: Tet1 Fw. 5’ACAATGGAAGCACTGTGGTTTG3’); Tet1 Rev. 5’CAGTGTCTGCAAGCCGGTAT3’; Tet2 
Fw.5’GTCGAGTTTGAACACCGAGC3’; Tet2 Rev. 5’GTGACCACCACTGTACTGCC3’;Tet3 Fw.
5’AGAACCAGGTGACCAATGAGG3’; Tet3 Rev. 5’CAGTGCACCCATTGTAGAGGT.3’ 
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Oxidative reduced representation bisulfite sequencing (oxRRBS) 
Genomic DNA extracted from both dorsal and ventral DGs from control, uCMS+saline and 
uCMS+fluoxetine animals (2 to 3 animals per group) was used to conduct a first genome-wide 
study of 5mC and 5hmC distribution, through oxRRBS, as described elsewhere21. 
Statistical Analysis 
Statistical analyses and graphic data representations were done using GraphPad Prism and 
SPSS®22 software. After appropriate normality tests, student’s t-test was used to evaluate 
differences between Control and uCMS groups. Multiple-comparison one-way ANOVA, with 
Bonferroni post-hoc analysis was used to evaluate antidepressant action; ANOVA F and P values 
are displayed in the main text, while post-hoc P values are depicted in the figures. Statistical 
significance was accepted for p<0.05. Test statistics and p-values are shown for each test. 
RESULTS 
uCMS promotes persistent anhedonic-behavior, short-term transient anxiety-signs 
and long-term memory impairments. 
We have conducted a longitudinal behavioral study, in which analysis were conducted early 
after 4 weeks of uCMS exposure, at the conclusion of uCMS and latter on, 4 weeks post-stress 
(Fig. 1a). In summary, at the end of uCMS week 4, stressed animals already evidenced 
anhedonic behavior in both the SCT (t16=5.296; P<0.001) and SDT (t16=3.502; P=0.002) 
paradigms and depressive-like behavior in the FST (t16=4.287; P=0.003), as well as anxious 
behavior in the NSF test (t16=2.320; P=0.017) (Fig. 1b,c). No memory deficits were yet installed 
(Fig. 1c). At the end of the 6 weeks of the uCMS protocol, anhedonic (SCT: t16=2.691; P=0.008; 
SDT: t16=5.354; P<0.001), depressive (t16=3.132; P=0.003) and anxious behavior (t16=3.122; 
P=0.003) were accompanied by memory retention deficits in the NOR task (t16=3.845; P<0.001) 
(Fig. 1d). Both fluoxetine and imipramine effectively reverted the installed emotional deficits in 
the SCT/SDT (SCT: F2,24=4.686; P=0.019), in the FST (F2,24=6.490; P=0.006) and in the NSF 
(F2,24=7.648; P=0.003) (Fig. 1d). In addition, both antidepressants (ADs) prevented the 
development o cognitive impairments evidenced in NOR (F2,24=12.29; P<0.001) (Fig. 1d). 
Moreover, 4 weeks after the cessation of uCMS, untreated stressed animals presented long-term 
anhedonic behavior (SCT: F2,24=7.933; P=0.002), while deficits in the FST and NST tests had 
already remitted (Fig. 1e). Along with anhedonic deficits (t16=3.146; P=0.003), untreated animals 
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also presented persistent memory deficits in the NOR test (t16=7.417; P<0.001)(Fig. 1e). Both 
ADs mediated the successful remission from anhedonic (SCT: F2,24=7.933; P=0.002) and 
cognitive impairments (F2,24=11.07; P=0.0004)(Fig. 1e). 
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Figure 1. Longitudinal behavioral Profile of uCMS exposed animals. a. Animals subsets were analyzed at 
three different experimental time-points. b. Anhedonic behavior was longitudinally evaluated in the sucrose 
consumption test (SCT). c-e. Animals ere  evaluated in the SCT, sweet drive test (SDT), forced swimming test (FST), as 
well as in the novelty supressed feeding (NSF) and novel object recognition (NOR) paradigms. A battery of behavioral 
tests was conducted in all animal subsets, specifically at the end of uCMS week4 (c), at the of uCMS week6 (d) and 4 
weeks after uCMS exposure (e). Error bars denote s.e.m. *P<0.05, **P<0.01, ***P<0.001; *denotes the effect of 
uCMS, #denotes antidepressant effect; n = 8-9 per group.
Stress has opposite effects in dendritic structural plasticity of granule neurons, in 
the dorsal vs ventral DG  
Besides the previously discussed behavioral phenotype, uCMS induced short-term body weight 
loss (Fig. 2a) and dysregulation of the circadian corticosterone secretion pattern (Fig. 2b). Both 
physiological alterations were remitted 4 weeks after stress (Fig. 2 a,b). Furthermore, uCMS 
exposure promoted neuromorphological alterations in the dendritic length of granule cells, which 
differ between the dorsal and ventral DG (dDG and vDG, respectively). While, at the end of uCMS 
week 4 and 6, dDG neurons display significant dendritic atrophy (week 4: t18=2.959; 
P=0.004 ;week 6: t18=4.141; P<0.001), those from the vDG show hypertrophic alterations, 
significantly evidenced at uCMS week 6 (t18=1.760; P=0.048)(Fig. 2 c,d). While in the dDG, AD-
mediated recovery of these structural alterations was evident (F2,27=11.73; P=0.0002), in the vDG 
this action was not so evident (Fig. 2d). Moreover, untreated animals are able to spontaneously 
revert this alterations, 4 weeks after ceasing stress exposure (Fig. 2e).  
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Figure 2. Stress induced alterations in physiological parameters and in hippocampal dendritic 
plasticity. a-b. Animal weight was monitored longitudinally (a), along with the serum corticosterone levels (b). c-e 
Furthermore, dendritic length of dentate granule neurons was evaluated, in the dDG and vDG, at the end of uCMS 
week4 (c), at the of uCMS week6 (d) and 4 weeks after uCMS exposure (e). Error bars denote s.e.m. *P<0.05, 
**P<0.01, ***P<0.001; *denotes the effect of uCMS, #denotes antidepressant effect; n = 8-9 per group. N - nadir; Z - 
zenit. 
Antidepressants restore stress-induced impairments in hippocampal proliferation, 
neurogenesis and gliogenesis 
To evaluate the short-term effects of uCMS in hippocampal proliferation, we administered a single 
BrdU pulse, 24h before sacrifice, at the end of week 4 (Fig. 3a). Our results show that at this time, 
hippocampal proliferation is already significantly decreased in both the dDG (t8=4.159; P=0.002) and 
vDG (t8=2.230; P=0.028) (Fig. 3b). Moreover, after 6 weeks of stress, uCMS also impacted on the 
early survival of newborn hippocampal cells, reflected by the abrupt drop on BrdU-positive cells labelled 
in both regions (dDG: t8=22.90; P<0.001; vDG: t8=4.790; P<0.001) (Fig. 3c). Interestingly, while both 
ADs were able to revert these alterations in the dDG (F(2,12)=127.7; P<0.001; post-hoc P<0.001, for 
both, their action on vDG was non-significant (P=0.062) (Fig. 3c). Four weeks after stress cessation we 
evaluated long-term survival, focusing either hippocampal neuro- or gliogenesis (Fig. 3 d,e). Within the 
dDG, uCMS significantly compromised the generation of new neurons (t8=2.597; P=0.016) and glial 
cells (t8=2.459; P=0.020) (Fig. 3 f,g). While both ADs were able to restore normal levels of 
neurogenesis in the dDG (F(2,12)=15.12; P<0.001), only imipramine showed the ability to reverse 
gliogenic impairments (F(2,12)=12.82; P=0.0011; post-hoc PFLX vs SAL= >0.05 and PIMI vs SAL= <0.01) (Fig. 
3 f,g). Contrastingly, the effects of AD treatment were less profound in the vDG, where only imipramine 
was able to revert neurogenic deficits (F(2,12)=4.574; P=0.033), while no effects were promoted by either 
stress or AD treatment in gliogenesis (Fig. 3 f,g).  
Stressed animals present low transcriptional levels of TET3 in the dorsal DG, but not in 
the vDG, correlated with a decrease on labelling intensity for 5hmC 
Next, we sought to explore whether uCMS induced epigenetic alterations related with DNA 
demethylation pathways within the hippocampal DG. Moreover, to explore if this putative modulatory effect 
was also mediated by ADs, we started by analyzing the effects promoted by fluoxetine treatment. 
Transcriptional analysis of TET enzymes in the hippocampus showed that uCMS exposure did not impact 
on the expression levels of tet1 or tet2, both in the dDG and the vDG (Fig. 4 a- c). However, specifically 
at the end of the 6-weeks uCMS exposure, we found a reduction on the mRNA expression levels of tet3 
in the dDG (t5= 6,191; P< 0.001; Fig. 4b). Moreover, fluoxetine was able tor revert tet3  expression to 
basal levels (t5= 2,615; P= 0.024; Fig. 4b). Contrastingly, in the vDG TET3 mRNA was comparable to 
control animals (Fig. 4c). We were also able to correlate the animals that showed higher levels of 
stress, either measured by the presence of increased levels of corticosterone or by poor performance in 
behavioral tests, with a higher reduction in tet3 expression (not shown). Since TET3 is highly expressed 
in the adult brain and in particular in the hippocampal region, we sought to assess if the alterations 
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observed in TET3 expression could have repercussions on DNA 5hmC levels in this region. Hence, in 
the same experimental time-point (at the end of uCMS week 6), we analyzed coronal brain cryosections 
of both dDG and vDG stained with an anti-5hmC antibody and analyzed the signal intensity by confocal 
microscopy (Fig. 4 d-f). Interestingly, we found that signal intensity was reduced in the dDG of animals 
exposed to chronic stress (Fig. 4e). This observation was consistent among all 4 stressed animals 
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Figure 3. Hippocampal proliferation, neurogenesis and gliogenesis are decreased by stress and 
restored by antidepressants. a. Two independent experimental approaches, based on BrdU administration, were 
used to assess hippocampal cell proliferation and early (5 to 8 days) survival. b,c. Both measurements of cell 
proliferation (b) and early cell survival (c) were performed in dDG and vDG. d-g. A 4-5 weeks hippocampal cell survival 
and cell fate (e) analysis was additionally performed. Specifically, hippocampal neurogenesis (f) and gliogenesis (g) 
were assessed. The white arrow depicts a newborn neuronal (BrdU/NeuN double-positive) cell, while the yellow arrow 
depicts a newborn glial (BrdU/GFAP double-positive) cell. Error bars denote s.e.m. *P<0.05, **P<0.01, ***P<0.001; 
*denotes the effect of uCMS, #denotes antidepressant effect; n = 5 per group.
analyzed. In order to obtain a quantitative indicator, and to better illustrate this downregulation, we plot 
the intensity profile of 5hmC channel after acquiring all the images with the same confocal settings 
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Figure 4. Stress-induced decrease of tet3 expression in the dDG, along with decreased 5hmC 
immunofluorescence labelling intensity are reversed by chronic fluoxetine treatment. a-c. As 5mC to  5hmC 
conversion is catalyzed by the TET family enzymes (a), we analyzed the expression of TET enzymes in dDG (b) and vDG 
(b). d-f. Representative confocal microscopy z-stacks of dDG showing 5hmC immunofluorescence labelling in control (d), 
uCMS+sal (e) and uCMS+Flx (f) animals (top panels). Lower panels depict labelling intensity plots of the images above. 
Error bars denote S.D.. *P<0.05, **P<0.01, ***P<0.001; *denotes the effect of uCMS, #denotes antidepressant effect; n = 
3-4 per group.
5hmC 5hmC 5hmC
tet1    tet2   tet3 tet1    tet2   tet3
Ct Sal Flx
(Fig. 4 d-e, lower panels). Here again, no alteration was found in the vDG, since signal levels for 5hmC 
in the vDG were similar between control and uCMS-exposed rats (Supp. Figure 1). 
5hmC epigenetic mark is significantly lost in proliferating neural progenitor cells of the 
SGZ after uCMS exposure 
To assess if the reduction of 5hmC in the dDG was extended to newly generated cells in the 
hippocampus, we performed cell counts of BrdU+/5hmC+ double-labelled cells (Fig. 5a). A first 
analysis indicated that animals subjected to uCMS presented lower total numbers of  BrdU+/5hmC+ 
double-labelled cells (Control= 6.6x10-3 ± 1.01x10-3 positive cells per 100µm2 DG vs  uCMS= 4.05x10-3 
± 4.1x10-4 positive cells per 100µm2 DG; t8= 2.329; P= 0.0241; Fig. 5b). However, as stress exposure 
is known to reduce hippocampal cell proliferation and cytogenesis, we were concerned that the 
observed effect was a direct consequence of the effect of stress in the reduction of the number of 
proliferating cells. Therefore, we analyzed the percentage of BrdU+ cells in each experimental group that 
co-labelled with 5hmC. Data shows that within population of proliferating cells (BrdU+), animals exposed 
to stress present a significant decrease in the DNA 5hmC mark  (Control= 85.51 ± 1.14% vs  uCMS= 
75.61 ± 4.35%; t8= 2.292; P= 0.0256; Fig. 5c). Further analysis showed that these reduction occurs 
at the level of the BrdU+/SOX2+ cell population (Fig. 5 d,e), and that this is reversed by fluoxetine 
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Figure 5. Loss of 5hmC in hippocampal progenitor cells. a-c. 5hmC labelling was evaluated in 5 to 8 days 
BrdU-retaining hippocampal cells (a). Total double positive 5hmC/BrdU cell density (b) and the percentage of BrdU 
positive cells co-labelled with 5hmC (c) was determined. d-e. Similar analysis was conducted in the BrdU/Sox2 
double-positive progenitor cell population. Error bars denote S.D.. *P<0.05, **P<0.01, ***P<0.001; *denotes the 
effect of uCMS, #denotes antidepressant effect; n = 5 per group.
Ct    Sal    Flx
treatment (Fig. 5 b,c and e), indicating that the levels of 5hmC in hippocampal progenitor cells are 
significantly modulated by chronic exposure to stress and AD treatment. 
Stress promotes a decrease in genome-wide levels of 5hmC specifically in the dDG 
With DNA extracted from both the dDG and vDG of all animal groups, we conducted a first run of 
oxidative reduced representation bisulfite sequencing (oxRRBS) analysis. This recently-developed 
technique allows for the precise discrimination between 5hmC and 5mC. The obtained data appears to 
validate the previous data from our immunofluorescence analysis, showing that uCMS exposed animals 
present a reduction in global levels of 5hmC specifically in the dDG (Fig. 6 a,b). Also corroborating our 
previous analysis, such reduction is not present in the vDG (Fig. 6 a,b). Moreover, data supports the 
ability of fluoxetine to revert these changes, specifically in the dDG (Fig. 6 a,b), although by promoting 
hydroxymethylation in different genetic loci than those affected by stress (Fig. 6 b). Interestingly, our 
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Figure 6. Genomic DNA 5hmC distribution in the dDG and vDG. a. Global levels of DNA 5mC and 5hmC were 
determined by oxRRBS. a. Number of CpG islands differentially hydroxymethylated in each experimental group; total 
common (grey) and unique (yellow) gene loci are displayed. c,d. Identified hydroxymethylated genes in the dDG (c) and 
vDG (d). Examples of cytogenesis regulation genes are showed (right panels). Error bars denote S.D.; n= 2-3 per group.
dDG vDG
dDG vDG
c
c
first screening of genes differentially hydroxymethylated between experimental groups identified 
transcription factors and cell cycle regulators known to promote hippocampal neurogenesis (Fig. 6 
c,d). Curiously, the recovery of hydroxymethylation within these gene regions promoted by fluoxetine 
was exclusively observed in the dDG (Fig. 6 c,d). 
DISCUSSION 
In this work we addressed the question of whether chronic exposure to stress could produce 
significant impact on brain DNA demethylation machinery. In particular, we focused our analysis 
on the hippocampal region, since it is involved in the pathophysiology of many stress-related 
disorders, such as depression 15,16.  
We were able to detect significant changes in the mRNA levels of TET3 enzyme in animals 
exposed to stress, that we were subsequently able to correlated with stress hallmarks, such as 
corticosterone levels and behavior impairments. Interestingly, stress produced alterations 
specifically in TET3 (and not in TET1or 2), whose expression in the brain has been shown to be 
the highest among TETs11. Moreover, it is important to note that TET3 expression was only altered 
in the  dorsal DG. Accordingly, our first immunofluorescence analysis revealed that DNA 5hmC 
mark levels were globally deceased in the dorsal DG. Since we did not observe, again, the same 
alterations in the vDG it is likely that the reduction on 5hmC levels in the dorsal region was 
produced by the dowregulation of Tet3 produced by stress exposure. However, although this data 
suggests a rational link between the low levels of TET3 and the reduced levels of 5hmC in the 
dorsal hippocampus, a causative association is still to be established using alternative 
approaches. Hence, in the future, we will use TET3 conditional knockout mice to better dissect the 
putative link between stress, TET3 and hippocampal DNA 5hmC levels. It is important to note that 
oxRRBS technique quantitatively supported our immunohistochemical analysis by showing the 
reduction of 5hmC in the dDG, with no alterations in the vDG. 
Moreover, it is well described that several behavioral dimensions are affected after chronic 
exposure to stress17,18. Some emotional and cognitive deficits emerge due to several pathological 
mechanisms, one of which corresponds to the deterioration of the neuroplastic capacity of the 
adult brain upon stress exposure. The ability to constantly generate new cells in the hippocampus, 
a process therefore known as hippocampal cytogenesis, is one of the neuroplastic processes that 
becomes compromised after stress exposure, which is believed to account for the development of 
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several behavioral disabilities. For such reason we investigated whether the loss of 5hmC mark in 
the dDG was affecting proliferating cells, or alternatively, whether it was restricted to post-mitotic 
cell populations. Our analysis have indeed showed that, along with post-mitotic neurons, 
proliferating cells were impoverished in DNA 5hmC levels. In fact, our analysis demonstrate that 
these proliferative cells are in fact SOX2+ cells, again pointing for the effect of chronic stress 
exposure on the reduction of 5hmC levels of hippocampal neural progenitors. Importantly, data 
obtained from the oxRRBS analysis showed 5hmC alterations in cytogenesis regulation genes, that 
were only reverted by fluoxetine in the dDG. Although, this observation may correlate with the 
stronger pro-cytogenic action of monoaminergic ADs observed in dDG, comparatively to the vDG, 
additional studies are required to further dissect this link.  
Finally, a brief note in respect to the functional dichotomy between the dorsal and the ventral 
hippocampal regions. Although it is still a matter of much controversial and debate, several 
authors claim that the hippocampus is not  an homogeneous brain area, and a converging body of 
evidence indicates a functional dissociation along its septo-temporal axis, in which the dorsal part 
is more directly involved in learning/memory, while the ventral sub-region is linked to emotional 
behavior. In our uCMS model, animals acquire different deficits, both in cognitive and emotional 
dimensions. In a linear interpretation of our results, it is fair to hypothesize that TET3-mediated 
reduction of 5hmC in the dorsal hippocampus could be responsible for the emergence of cognitive 
disabilities; however, the lack of alterations in the ventral hippocampus are difficult to conciliate 
with the observed emotional deficits, such as anxiety-like behavior. Two hypothesis can be put 
forward: either hippocampal regional functional regionalization between the dorsal and the ventral 
areas is not that strict, and these two areas are quite interdependent, as many authors have also 
claimed; or, alternatively, DNA hydroxymethylation is primarily involved in the modulation of 
cognitive function, in disregard of other behavioral modalities. Considering the fact that TET3 is 
highly expressed in different areas of the brain and that DNA hydroxymethylation occurs in a wide 
range of brain regions, the last hypothesis seems quite unlikely. In the future, studying the effects 
of pharmacological treatments known to revert cognitive deficits caused by stress exposure, such 
as some anti-demential drugs (e.g. memantine), may also provide important clues in this matter. 
In conclusion, this data provides important insight on the ability of chronic stress to interfere with 
DNA demethylation pathways in the dorsal hippocampus, resulting in significant reduction of the 
DNA 5hmC mark. Whether these alterations are causally linked to neuroplastic defects and to the 
emergence of abnormal behavior is still to be demonstrated. 
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SUPPLEMENTARY FIGURE 
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Supplementary Figure 1. No alterations in 5hmC immunofluorescence labelling intensity in the vDG, 
promoted by stress. a,b. Representative confocal microscopy z-stacks of vDG showing 5hmC immunofluorescence 
labelling in control (a) and uCMS+sal (b) (top panels). Lower panels depict labelling intensity plots of the images above.
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Chapter VI 
THE SWEET DRIVE TEST: REFINING PHENOTYPIC 
CHARACTERIZATION OF ANHEDONIC BEHAVIOR IN 
RODENTS 
The Sweet Drive Test: refining phenotypic characterization of anhedonic behavior in 
rodents 
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Measuring anhedonic behavior in rodents is a challenging task as current methods display
only moderate sensitivity to detect anhedonic phenotype and, consequently, results from
different labs are frequently incongruent. Herein we present a newly-developed test, the
Sweet Drive Test (SDT), which integrates food preference measurement in a non-aversive
environment, with ultrasonic vocalizations (USVs) recording. Animals were placed in a
soundproofed black arena, under red light illumination, and allowed to choose between
regular and sweet food pellets. During the test trials, 50 KHz USVs, previously described to
be associated with positive experiences, were recorded. In a first experimental approach,
we demonstrate the ability of SDT to accurately characterize anhedonic behavior in animals
chronically exposed to stress. In a subsequent set of experiments, we show that this
paradigm has high sensitivity to detect mood-improving effects of antidepressants. The
combined analysis of both food preference and the number of 50KHz vocalizations in the
SDT provides also a valuable tool to discriminate animals that responded to treatment
from non-responder animals.
Keywords: depression, anhedonia, Sweet Drive Test, ultrasonic vocalizations, antidepressants, sucrose
consumption test
INTRODUCTION
Animal models of depression are valuable tools to better elucidate
the neuropathological basis of depressive spectrum disorders, and
to provide insights into antidepressants mechanisms of action, as
well as into the identification of new putative therapeutic targets
(Cryan et al., 2002; Berton et al., 2012). However, it is important
to consider that the translational potential of rodent models of
depression relies not only on the capacity to reproduce the etiol-
ogy and core pathological marks of the disease in the animals, but
also in the ability to properly measure and characterize key behav-
ioral hallmarks of depression. Anhedonia (i.e., a relative lack of
pleasure in response to a formerly rewarding stimuli) is a cardi-
nal hallmark of several forms of depression (typical and atypical
major depression, dysthymic disorder or melancholic depres-
sion) (American Psychiatric Association, 2013) and it is therefore
highly relevant to accurately characterize anhedonic behavior in
rodent models of psychiatric disorders, such as depression. The
gold-standard methods to characterize hedonic behavior involve
the preference for highly palatable substances, in the usually
called “sucrose (or saccharine) consumption test” (SCT); in these
tests, preference for a sweetened solution, in relation to water,
is assessed (Papp et al., 1991; Tye et al., 2013). However, several
authors raised concerns regarding the interpretation of reduced
sucrose consumption as a manifestation of anhedonia, due to
confounding factors such as the long-lasting simultaneous food-
and water-deprivation periods preceding the test (usually from
18 to 24 h), its moderate sensitivity do discriminate anhedonic
behavior, its variability between different strains and due to the
unreliability of the procedure among laboratories (Konkle et al.,
2003; Anisman and Matheson, 2005; Der-Avakian and Markou,
2012; Stuart et al., 2013). Different labs have put forward alterna-
tive methods to measure anhedonic behavior in rodents (Surget
et al., 2011; Stuart et al., 2013), ranging from the characteriza-
tion of behavioral traits that have been arguably correlatable with
the manifestation of anhedonia for instance, submissive behavior
(Strekalova et al., 2004) or reduced sexual activity (Gronli et al.,
2005) tomore elaborate protocols involving intracranial self stim-
ulation (ICSS) in goal-directed test paradigms (Harrison et al.,
2001; Stoker and Markou, 2011).
In the attempt to refine and complement current approaches,
we developed a test to characterize anhedonic behavior in rats
based on the simultaneous assessment of food preference and
ultrasonic vocalizations (USVs) recording- the Sweet Drive Test
(SDT). Previous studies have shown that rodents USVs patterns
provide important information regarding context perception and
the emotional status of the animals. In particular, while USVs in
the 20–22KHz frequencies band have been associated to negative
and aversive experiences, such as anxiety, fear or even pain per-
ception, 50 KHz vocalizations have been associated to positive and
pleasurable experiences. In light of these observations, we incor-
porated ultrasound microphones in the SDT apparatus to record
USVs during test trials and to assess whether it could reinforce the
assessment of hedonic behavior in rodents.
In a first set of experiments, we sought to validate SDT
in an animal model of depression based in the exposure to
unpredictable chronic mild stress (uCMS). In a subsequent
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experimental set, we assessed SDT sensitivity to characterize the
mood-improving effects of two antidepressants (fluoxetine and
imipramine) and compared it to the gold-standard method, SCT.
MATERIALS AND METHODS
ANIMALS AND TREATMENTS
Two month-old male Wistar rats, weighing 200–250 g (Charles-
River Laboratories) were maintained under standard laboratory
conditions (12 h light: 12 h dark cycles with the dark phase begin-
ning at 8 pm, 22◦C, relative humidity of 55%, ad libitum access
to food and water). Groups of rats (n = 10–18 per group) were
randomly assigned to the following four experimental groups:
non-stress control + saline; stress (uCMS) + saline; uCMS +
fluoxetine and uCMS + imipramine. Additionally, 2 month-old
Sprague Dawley male and female rats (Control + saline and
uCMS + saline) were also used to assess the reproducibility and
usefulness of the test in other strains and in female rodents.
In the first set of experiments, an uCMS protocol was applied
for 4 weeks, accordingly to what was previously validated and
described (Bessa et al., 2009). In the second experimental set,
animals were exposed to uCMS during 6 weeks and antidepres-
sants (ADs) fluoxetine (10mg.kg−1; Kemprotec) and imipramine
(10mg.kg−1; Sigma-Aldrich) were administered intraperitoneally
(1ml.kg−1) everyday, during the 2 last weeks of the uCMS proto-
col.Weight gain and food intake weremeasured weekly during the
entire protocol to monitor eventual changes induced by uCMS.
All behavioral tests were conducted during the animals’ noctur-
nal activity period. All procedures were carried out in accordance
with EUDirective 2010/63/EU andNIH guidelines on animal care
and experimentation.
SWEET DRIVE TEST (SDT)
SDT arena
The SDT apparatus consists in a black acrylic enclosed arena
(L 82 cm × W 44 cm × H 30 cm), divided by transparent and
perforated walls that defined 4 separated chambers (Figures 1A,B
and Movie 1): a pre-chamber (PC; L 82 cm × W 12 cm × H
30 cm) in which the animal is initially placed, which is connected
by an automatic trap-door to a middle chamber (MC; L 20 cm ×
W 30 cm × H 30 cm); once the animal enters the MC, the trap-
door closes, and the animal is allowed to move freely between
the right- (RC) and left-chambers (LC) (86× 50× 30 cm). The
arena has a transparent acrylic lid used in every trial to provide
noise-reduction.
Ultrasonic Vocalizations (USVs)
The RC and LC are equipped with ultrasound microphones
(Figure 1C), so that animals’ USVs can be recorded during trials.
Ultrasound Microphones (CM16/CMPA, Avisoft Bioacoustics)
sensitive to frequencies of 10–200 KHz were used, 20 cm above
the floor, in all experiences. These were connected via an
Avisoft UltrasoundGate 416H (Avisoft Biocoustics) to a per-
sonal computer. Vocalizations were recorded using the Avisoft-
Recorder (version 5.1.04) with the following settings: sampling
rate: 250,000; format: 16 bit. All 50 KHz vocalizations, identi-
fied by automatic data processing, were individually analyzed
and validated by the experimenters. The total number of 50 KHz
vocalizations emitted was assessed.
Experimental protocol
Animals were pre-habituated to sweet pellets (Cheerios®, Nestlé)
in two different days, 4 and 2 weeks before the test, during the
animals’ activity period (60 Cheerios per cage evenly distributed
among the corners of the cage); during periods of habituation
to the sweet pellets, exposure to mild stressors was suspended.
Furthermore, animals were firstly habituated to the SDT appara-
tus in the day preceding the first trial, for 6min. In each testing
day, food was removed specifically during the animals’ inactive
period, only 10 h before the test trial (to avoid test execution
in an eventually confounding starvation state, but also to pre-
clude odor and/or taste pre-conditioning to the usual regular
food). Three SDT trials were conducted (1 trial every 48 h). Trials
started at 8:30 pm (30min after the beginning of the animals’
nocturnal activity period) and were performed under red light.
FIGURE 1 | Characterization of anhedonic behavior in rats exposed to
uCMS, in the Sweet-Drive Test (SDT) paradigm. (A) Preference for sweet
pellets was measured in a compartmentalized SDT apparatus (B), in which
ultrasonic vocalizationswere recorded using ultrasoundmicrophones (C). (D,E)
Preference values, along 3 trials, in a sweet pellet vs. regular pellet paradigm
(D) and in a regular pellet vs. regular pellet paradigm (E). (F–I) The total number
of 50 KHz vocalizations was measured (F,H) and correlated with preference
values (I). ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001. Error bars, s.e.m., n = 8–10.
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Before initiating a new trial, the SDT arena was carefully cleaned
with ethanol 10%. Twenty pre-weighted regular food pellets
(Mucedola 4RF21-GLP; 53.3% Carbohydrates, 3700Kcal.Kg−1)
were placed in the LC, and 20 pre-weighted Cheerios® (68%
Carbohydrates, 3800Kcal.Kg−1) pellets were placed in the RC.
After placing the animals in the PC, the transparent acrylic lid was
placed. At this moment video and USVs recording were started.
Once the animal crossed the trap-door and entered the MC,
this door closed and the animal was allowed to freely explore
the LC and the RC, for 10min. At the end of the trial, pellets
consumption was determined and preference for sweet pellets
(Cheerios® pellets) was determined as follows: preference for
sweet pellets (%)= Consumption of Sweet Pellets (g)/Total Food
Consumption (g)× 100.
Video recording allowed to assess exploratory parameters,
namely the “first choice” (first chamber in which the animal
entered), “time in the pre-chamber” (latency to enter to the MC),
“number of incursions” (number of entrances in each chamber)
and evaluate whether thesemeasures could differentially affect the
test performance in different experimental groups. USVs analysis
allowed to assess the total number of “positive” 50KHz vocaliza-
tions during trials, and to correlate these values with the evaluated
preference values.
SUCROSE CONSUMPTION TEST (SCT)
Anhedonia was assessed on weeks 4 and 6 of the uCMS proto-
col using the gold standard sucrose consumption test. Baseline
sucrose preference values were established during a 1-week habit-
uation period. The test consists in the presentation of two pre-
weighed drinking bottles, containing water or 2% (m/v) sucrose
solution for 1 h. Before each test, rats were food and water-
deprived for 12 h. Sucrose preference was calculated according
to the formula: sucrose preference = (sucrose intake)/(sucrose
intake+water intake)× 100, as previously described (Bessa et al.,
2009). SCT was performed during the nocturnal activity period
of animals (starting at 8.30 p.m), 24 h after the third trial of SDT;
after the SDT trial, animals were allowed to feed freely until 12 h
preceding SCT.
NOVELTY SUPPRESSED FEEDING TEST (NSF)
Anxious-like behavior was assessed through the NSF test at the
end of the uCMS protocol. After an 18 h food-deprivation period,
animals were placed in an open-field arena, where a single food
pellet was positioned in the center, as previously described (Bessa
et al., 2009). After reaching the pellet, animals were individu-
ally returned to their home cage, where pre-weighed food was
available, and were allowed to feed for 10min. The latency to
feed in the open-field arena was used as an anxiety-like behavior
index, whereas the food consumption in the home cage provided
a measure of appetite drive.
OPEN-FIELD TEST (OF)
The open field (OF) test was used as an additional measure of
anxious-like behavior, as well as to evaluate locomotor perfor-
mance and exploratory activity. The open field apparatus con-
sisted of a brightly illuminated square arena of 43.2× 43.2 cm
closed by a wall of 30.5 cm high. Rats were placed individually in
the center of the open field arena and their movement was traced,
for 5min, using a two 16-beam infrared system. The result-
ing data was analyzed using the Activity Monitor software (Med
Associates, Inc.), considering two previously defined areas: a cen-
tral and an outer area. Distance traveled in each of the zones was
recorded and analyzed. The ratio between the distance traveled in
the center and in the periphery of arena was used as indicative of
anxiety-like traits.
NOVEL OBJECT RECOGNITION TEST (NOR)
Cognitive function was assessed in the NOR test. Briefly, rats were
first habituated to the testing arena for 10min. On the next day,
each animal was allowed to explore two identical objects placed
in the arena for 10min. One hour later, rats explored the same
arena for 5min, with one of the familiar objects replaced by a
novel object. Recognition memory was expressed by the discrim-
ination index (D), which was defined as D= (time of exploration
novel object − time of exploration familiar object)/total time of
exploration.
FORCED SWIMMING TEST (FST)
Learned-helplessness was assessed using the forced swimming
test. Assays were conducted 24 h after a 5-min pretest session,
by placing the rats in transparent cylinders filled with water
(25◦C; 50 cm depth) for 5min. Trials were video-recorded and
the immobility time as well as the latency to immobility were
measured using an automated video tracking system (Viewpoint).
Learned-helplessness was considered as an increase in the immo-
bility time and a decrease in the latency to immobility.
BrdU IMMUNOSTAINING
In the last day of behavioral testing, animals were given single
intraperitoneal injection of Bromo-deoxyuridine (BrdU, Sigma-
Aldrich, 100mg.kg−1; thymidine analog that incorporates into
DNA during the S-phase of the mitotic process). Twenty-four
hours after the injection, animals were deeply anaesthetized with
sodium pentobarbital (20%; Eutasil, Sanofi) and were transcar-
dially perfused with cold 4% paraformaldehyde (PFA). Brains
were removed and post-fixed in 4% PFA. Serial coronal cryosec-
tions (20µm) were cut and stained for BrdU (1:50; Dako).
Secondary antibody Alexa Fluor® 488 (Molecular Probes) was
used for detection. Nuclei were counterstained using DAPI.
Proliferation densities were estimated in the subgranular zone
(SGZ; defined as a two-cell layer-thick zone on the inner side
of the granule cell layer of the dentate gyrus), using a confocal
microscope (Olympus FV1000).
MORPHOLOGICAL ANALYSIS
For the three-dimensional morphometric analysis, four animals
from each group were deeply anaesthetized with sodium pento-
barbital (20%; Eutasil, Sanofi), transcardially perfused with 0.9%
saline and processed. Briefly, brains were immersed in Golgi-Cox
solution for 21 days; transferred to a 30% sucrose solution and
cut on a vibratome. Coronal sections (200µm) were collected
in 6% sucrose and blotted dry onto gelatin-coated microscope
slides. They were subsequently alkalinized in 18.7% ammo-
nia, developed in Dektol (Kodak), fixed in Kodak Rapid Fix,
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dehydrated and xylene cleared before coverslipping. Dendritic
arborization was analyzed in the dentate gyrus. For each selected
neuron, all branches of the dendritic tree were reconstructed at
1000x (oil) magnification using a motorized microscope (BX51,
Olympus) and Neurolucida software (Microbrightfield). A three-
dimensional analysis of the reconstructed neurons was performed
using NeuroExplorer software (Microbrightfield). For each ani-
mal, 10 neurons were studied and total dendritic length was
determined.
CORTICOSTERONE LEVELS MEASUREMENTS
Corticosterone levels were measured in blood serum, collected
by tail venopuncture, using a commercially available ELISA kit
(R&D Systems). Sampling was performed between 8 and 9 am
(nadir) and between 8 and 9 pm (zenith; peak) at the end of the
uCMS protocol. Samples were run in duplicate.
RT-PCR MEASUREMENTS
mRNA expression levels of the genes involved in the media-
tion of anhedonia were determined by qRT-PCR in the nucleus
accumbens (NAc) and pre-frontal cortex (PFC) from six ani-
mals of each group (CT and CMS + Sal). Total RNA (500 ng)
was reverse transcribed using qScript™ cDNA SuperMix (Quanta
Biosciences™). Oligonucleotide primers for dopamine receptor
1 (Drd1), 2 (Drd2) and 3 (Drd3), prodynorphin (Pdyn), opioid
receptor µ1 (Oprm1) and cannabinoid receptor 1 (Cnr1) were
designed using Primer-BLAST software (NCBI). Sense and anti-
sense sequences can be found in Table 1. Real time reactions were
performed in an Applied Biosystems 7500 Fast Real-Time PCR
System (Applied Biosystems) using 5x HOT FIREPol® EvaGreen®
qPCR Mix Plus (ROX) (Solis Biodyne). The housekeeping gene
Beta-2-Microglobulin (B2M)was used as internal control for nor-
malization of the target gene’s expression. The relative expression
was calculated using the !!Ct method. Results are presented as
relative expression of the target gene.
STATISTICAL ANALYSIS
Statistical analyses were done using SPSS software (SPSS, Chicago,
IL, USA). t-test was used to evaluate differences between two
groups where appropriate. ADs effects on different behav-
ioral dimensions were evaluated using One-Way analysis of
variance (ANOVA). F-values and P-values derived from the
between groups analysis of variance are properly indicated
in the figures. Differences between groups were determined
by Bonferroni’s post-hoc multiple comparison test, and the
corresponding P-values are depicted in the figures. Statistical
significance was accepted for P < 0.05.
RESULTS
To assess the efficacy of the new behavioral paradigm described
herein, we used an uCMS exposure model (Bessa et al., 2009)
in Wistar-Han male rats. This protocol is known to induce
core symptoms of depression in rodents, including anhedonia
(Bessa et al., 2009). In a first approach, we aimed to evaluate
whether SDT could discriminate the impacts of uCMS expo-
sure in hedonic behavior of animals chronically exposed to stress
during 4 weeks (Figure 1). In the tested paradigm, control (non-
stressed) animals developed high preference for sweet pellets
over the three trials, reaching over 95% of preference in trial 3;
conversely, uCMS-exposed animals evidenced no significant pref-
erence for sweet food pellets over regular food pellets (preference
values ≈50%) (Figure 1D). This group discrimination based on
SDT performance was absent when using a neutral regular food
vs. regular food test paradigm (Figure 1E).
In order to have a multi-parametric measurement of anhe-
donic behavior we complement the food preference analysis
with simultaneous recording of 50KHz USVs (Figures 1F,G).
Remarkably, results showed that animals with reduced preference
for sweet pellets, also presented a reduction in the number of
50KHz “positive” vocalizations during the test (Figure 1H). In
fact, the frequency of vocalizations correlated positively with the
preference for sweet pellets (Figure 1I), and allowed to effectively
discriminate between control and uCMS animals.
Evaluation of anhedonia with SDT was subsequently
complemented with additional phenotypic characterization
of animals that revealed multi-dimensional physiological and
behavioral deficits normally encompassed in the symptomatic
profile of depressive disorders (Bessa et al., 2009;Mateus-Pinheiro
et al., 2013) (Figure 2A). As previously reported, uCMS exposure
induced a significant reduction in total body weight gain, but
no significant alterations were found in the total daily food
consumption between control and uCMS-exposed animals either
before, or after 4 weeks of stress exposure (Figure 2B). Moreover,
uCMS exposure promoted the emergence of behavioral despair
signs (Figure 2C), heightened anxiety-like behavior (Figure 2D)
and cognitive disabilities (Figure 2E). These behavioral changes
were accompanied with the disruption of normal corticosterone
serum levels (Figure 2F), a decrease in overall hippocampal
cell proliferation (Figure 2G) and dendritic atrophy of dorsal
hippocampal granular neurons (Figure 2H).
Table 1 | Sense and antisense sequences of oligonucleotide primers used in the qRT-PCR.
Gene Sense Antisense Product size (bp)
B2M GTGCTTGCCATTCAGAAAACTCC AGGTGGGTGGAACTGAGACA 136
Drd1 TCCTTCAAGAGGGAGACGAA CCACAAACACATCGAAGG 168
Drd2 ATGTGCTGGTGTGCATGGCT CACCCACCACCTCCAGGTAGAC 142
Drd3 GGGGTGACTGTCCTGGTCTA TGGCCCTTATTGAAAACTGC 169
Pdyn CCTGTCCTTGTGTTCCCTGT AGAGGCAGTCAGGGTGAGAA 157
Oprm1 CAACTTGTCCCACGTTGATG TAATGGCTGTGACCATGGAA 119
Cnr1 AGGAGCAAGGACCTGAGACA TAACGGTGCTCTTGATGCAG 166
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FIGURE 2 | Effects of uCMS exposure in different physiological and
behavioral dimensions. (A) After 4 weeks of uCMS exposure,
multi-dimensional depressive-like behavior was assessed. (B)Weight gain and
food intake, before and after 4 weeks of uCMS. Animals exposed to uCMS
presented a decreased total body weight gain during stress exposure [Week1
(!1): t(15) = 7.969, P < 0.0001; Week2 (!2): t(15) = 4.948, P < 0.0001;
Week3 (!3): t(15) = 6.877, P < 0.0001; Week4 (!4): t(15) = 5.782,
P < 0.0001]. Daily food consumption of uCMS animals remained unaltered
after stress exposure. Animals were tested in the Forced Swimming Test (C),
Novelty Suppressed Feeding (D) and Novel Object Recognition (E) test
paradigms. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001. Error bars, s.e.m., n = 8–10.
(F–H) Corticosterone serum levels (F), hippocampal proliferation (G) and
dendritic morphology of hippocampal granular neurons (H) were assessed.
∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001. Error bars, s.e.m., n = 5–10.
Importantly, we detected no significant differences between
control and uCMS-exposed animals when analyzing different
exploratory parameters, namely the total number of incursions
to each food chamber (Figures 3A,B), as well as the average
time animals took to leave the PC and start exploring the food
chambers, and the choice of the first food chamber to explore
(Figure 3C). Analysis of the percentage of distance spent in the
center of the arena in the OF test endorsed the hyperanxious-like
phenotype of uCMS-exposed animals, that was also found in NSF
(Figures 3D–F). Together with the exploratory parameters, this
data suggested an effective subtraction of any eventual anxiogenic
and neophobic components of the SDT environment.
Furthermore, we analyzed the expression of molecules
described to participate in the mediation of hedonic behavior in
the prefrontal cortex (PFC) and in the nucleus accumbens (Nac)
(Der-Avakian and Markou, 2012). From the different genes ana-
lyzed, we found that the expression of dopamine receptor D2
(Drd2) and prodynorphin (Pdyn) is decreased in the Nucleus
Accumbens (Nac) of animals exposed to uCMS (Figure 4A).
In the PFC, however, we found Drd2 mRNA levels to be
increased in stressed animals, whereas uCMS exposure induced
a decrease in dopamine receptor D3 (Drd3) levels in the same
region (Figure 4B).
To further evaluate the capacity of SDT to assess anhedo-
nic behavior, in a second approach we tested its sensitivity to
detect the reestablishment of normal hedonic behavior, pro-
moted by chronic treatment with ADs from two different classes,
fluoxetine (a selective serotonin reuptake inhibitor—SSRI) and
imipramine (a tricyclic agent). Moreover, we compared perfor-
mance in the SDT with the performance of the same animals
in the gold-standard test, SCT (Figure 5A). We found that both
ADs were able to revert anhedonic behavior measured in the
SCT and in the SDT (Figures 5B,C). Although group statis-
tics allowed to discriminate the anhedonic phenotype of the
stressed-untreated animal group in both tests, individual score
analysis demonstrates that SDT presents a high individual dis-
crimination accuracy (Figure 5D); in fact, most uCMS exposed
animals were effectively discriminated based on its preference
scores in SDT, with preference values outside the control group
score-range (Figure 5E). Furthermore, simultaneous recording of
50KHz vocalizations allowed to discriminate between uCMS ani-
mals that responded to ADs treatment (ADs R) and animals that
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FIGURE 3 | Exploratory parameters in the SDT. (A,B) The average number
of incursions into the left-chamber (LC; containing sweet pellets) and into the
right-chamber (RC; containing regular pellets), during SDT was assessed and
no significant differences were found. (C) Additional exploratory parameters
were assessed in order to exclude a possible bias introduced by
hyperanxious behavior of uCMS-exposed animals; the similar exploratory
behavior of control and uCMS animals supports the SDT arena as a
non-aversive test environment. (D–F) Evaluation in the open-field test, further
indicates that anxious-like behavior (D) did not affect total exploratory activity
(E,F). ∗P < 0.05 Error bars, s.e.m., n = 7–9.
FIGURE 4 | Expression of molecular mediators of hedonia in the (A)
nucleus accumbens (NAc) and (B) prefontal cortex (PFC) by RT-PCR:
Dopamine Receptors D1, D2, and D3 (Drd1, Drd2, and Drd3), prodynorphin
(Pdyn), Cannabinoid Receptor 1 (Cnr1) and Opioid Receptor µ1 (Oprm1).
∗P < 0.05, ∗∗P < 0.01. Error bars, s.e.m. t-test statistical measures for the
analysis of uCMS vs. Control is shown on the top of the figures.
maintained the anhedonic profile and did not respond to treat-
ment (ADs NR) (Figure 5F). Values of total number of 50KHz
vocalizations correlated positively with performance on SDT
(Figure 5G). In complementary behavioral analysis, data shows
that treatment with imipramine has a fast action in reverting the
pro-anhedonic effects induced by stress exposure, whereas flu-
oxetine effects are only significant later on, namely on the third
trial (Figure 6A). Similarly to what was found in the previous
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FIGURE 5 | Measuring the effects of uCMS and antidepressant treatment
on anhedonic behavior with the Sweet Drive Test (SDT) and the Sucrose
Consumption Test (SCT). (A–C) Anhedonic behavior was measured before
(B) and after (C) 2 weeks of antidepressant treatment, in the SDT (data from
the 3rd trial presented) and in the SCT (n = 10–18). (D,E) Performances in
both tests were correlated (n = 68) and the ability of the tests to discriminate
anhedonic behavior in untreated uCMS animals is showed as the density of
red dots outside the performance range of control animals in each test
(depicted as a shaded gray area). (F) Total number of 50 KHz vocalizations in
control animals (Cont.), uCMS untreated (uCMS) animals and in
antidepressant treatment responders (ADs R) and non-responders (ADs NR)
(n = 6). (G) Correlation between the total number of 50 KHz vocalizations and
preference values in the 3rd SDT trial (n = 24). ∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001. Error bars, s.e.m. ANOVA statistical measures for the analysis
of ADs effect is shown on the top of the figures. ∗Denotes the effect of
uCMS exposure. #Denotes antidepressant effect.
experimental set, no differences were found in the total number
of incursions that could potentially undermine SDT interpre-
tation (Figure 6B). Moreover, both ADs effectively reverted the
behavioral deficits induced by stress (Figures 6C–G).
Finally, we tested whether SDT could effectively evaluate anhe-
donic behavior in a different rat strain—Sprague-Dawley—both
in female and male animals (Figure 7A). Using the same proto-
col of previous experiments, both female and male rats exposed
to stress revealed decreased preference values in the SCT and in
the SDT (Figures 7B,C), while the exploratory parameters in SDT
were similar for all groups (Figure 7D).
DISCUSSION
Understanding the pathophysiology of anhedonic behavior is cur-
rently particularly relevant in different areas of neurosciences
research, as it encompasses the symptomatology of different dis-
eases with growing prevalence in modern societies. Studies aim-
ing to characterize this pathological trait in animal models require
methods with at least three fundamental characteristics, namely
(i) the capacity to provide a solid measure of anhedonic behavior,
with high sensitivity to both anhedonic and pro-hedonic stim-
uli and/or treatments, (ii) the ability to reduce or eliminate the
interference of confounding factors that can undermine the inter-
pretation of the obtained results, and (iii) the reliability of the
method in different experimental contexts.
A primary concern when designing SDT was to eliminate the
interference of common potential confounding factors found in
animal testing. Since test performance and exploratory behav-
ior of animals can be largely conditioned by heightened anxiety
or neophobia-based test paradigms, it was our aim to subtract
these factors as much as possible in the SDT. The use of per-
forated and transparent chamber dividers was aimed to allow
the animals to acquire complete spatial and odor maps of the
explorable area in any position, and to reduce neophobic behav-
ior. This apparatus configuration, combined with the absence
of white-light illumination and the sound-isolation provided by
the transparent lid enclosure was intended to subtract any aver-
sive nature of the testing context, during animal testing. Indeed,
despite presenting heightened anxious-like behavior, evidenced in
the NSF and OF tests, chronically stressed animals presented an
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FIGURE 6 | Additional behavioral parameters determined after 6
weeks of uCMS exposure and ADs treatment. (A) uCMS exposure
induced a significant decrease in preference for sweet pellets along the
trials [Trial 1: t(18) = 3.011, P = 0.0038; Trial 2: t(18) = 4.795, P < 0.0001;
Trial 3: t(18) = 4.007, P = 0.0004]. This anhedonic profile was effectively
reversed by imipramine in the three trials, while the improving effects
of fluoxetine were mainly observed in trial 3 [Trial 1: F(2, 27) = 3.784,
P = 0.0356, Post-hoc: PuCMS vs. uCMS+ Flx > 0.05,
PuCMS vs. uCMS+ Imip < 0.05; Trial 2: F(2, 27) = 7.176, P = 0.0032,
Post-hoc: PuCMS vs. uCMS+Flx > 0.05, PuCMS vs. uCMS+ Imip < 0.01; Trial 3:
F(2, 27) = 5.427, P = 0.0104, Post-hoc: PuCMS vs. uCMS+ Flx < 0.01,
PuCMS vs. uCMS+ Imip < 0.05]. (B) The average number of incursions into
the left-chamber (LC; containing sweet pellets) and into the
right-chamber (RC; containing regular pellets), during SDT was assessed
and no significant differences were found. (C–G) Emotional and
cognitive domains normally affected in depression were assessed in the
Forced Swimming Test (C,D) [ANOVAADs effect on Time of Immobility:
F(2, 27) = 4.490, P = 0.0050, Post-hoc: PuCMS vs. uCMS+Flx < 0.01,
PuCMS vs. uCMS+ Imip < 0.01; ANOVAADs effect on Latency to Immobility:
F(2, 27) = 3.710, P = 0.0377, Post-hoc: PuCMS vs. uCMS+ Flx > 0.05,
PuCMS vs. uCMS+ Imip < 0.05], Novelty Suppressed Feeding (E,F)
[ANOVAADs effect on Latency to Feed: F(2, 27) = 7.648, P = 0.0023,
Post-hoc: PuCMS vs. uCMS+ Flx < 0.01, PuCMS vs. uCMS+ Imip < 0.01;
ANOVAADs effect on Appetite Drive: F(2, 27) = 0.5522, P = 0.5823, Post-hoc:
PuCMS vs. uCMS+Flx > 0.05, PuCMS vs. uCMS+ Imip > 0.05] and Novel
Object Recognition (G) ANOVAADs effect on Exploratory Index:
F(2, 26) = 12.45, P = 0.0002, Post-hoc: PuCMS vs. uCMS+Flx < 0.001,
PuCMS vs. uCMS+ Imip < 0.01 test paradigms. ∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001. Error bars, s.e.m. ∗Denotes the effect of uCMS exposure.
#Denotes antidepressant effect. Error bars, s.e.m., n = 9–10.
exploratory activity in the SDT that was indistinguishable from
control animals, suggesting this test to be uninfluenced by this
behavioral dimension. In addition, tests such as the SCT are usu-
ally conducted after long periods of simultaneous water and food
deprivation (ranging from 18 to 24 h). Starvation may signifi-
cantly interfere with the test outcome as animals’ consumption
may not reflect a “hedonistic” choice based on palatability, but
rather the necessity of satiety, irrespectively of food palatability or
taste. In this study, water was never removed prior testing and ani-
mals were allowed to feed freely in their active-nocturnal period
(and during the first 2 h of the inactive-diurnal period). In light
of the fact that in SDT trials animals had to choose between a
sugared-pellet and a pellet made of the same regular food that
animals were given in a daily basis, we opted to remove food
from animals’ cages during the remaining 10 h of the inactive
period to preclude pre-conditioning to food odor or taste prior
testing.
To validate the SDT, we used an uCMS-based animal model of
depression which has been already pre-validated by our lab (Bessa
et al., 2009; Mateus-Pinheiro et al., 2013). Animals submitted
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FIGURE 7 | Measuring anhedonic behavior with the Sweet Drive Test
(SDT) and the Sucrose Consumption Test (SCT) in Sprague-Dawley (SD)
Rats. (A) Using the same experimental approach previously used with
Wistar-Han rats, male and female SD rats were tested in the SCT and the
SDT. (B) uCMS exposure induced anhedonic behavior in both male and
female animals in the SCT. (C) The effects of uCMS on anhedonic behavior
were also detected using the SDT, evidencing a marked reduction on
preference in both male and female rats. (D) No differences on exploratory
behavior were observed between groups, during the SDT. ∗P < 0.05,
∗∗P < 0.01. Error bars, s.e.m., n = 6–9.
to uCMS presented several physiological and behavioral deficits
encompassed in the spectrum of depressive disorders. Moreover,
analysis of the expression of molecules described to participate in
the mediation of hedonic behavior revealed a decrease expression
of Drd2 and Pdyn in the Nac. Both alterations have already been
described in animals presenting increased anhedonic behavior
(Blednov et al., 2006; Kruzich et al., 2006) and reinforce the
idea that uCMS animals present alterations in the brain systems
involved in the regulation of hedonia. Although, to the best of
our knowledge, Drd3 has not been associated with the emergence
of anhedonic behavior in pre-clinical studies, we have detected a
decrease of Drd3 in the PFC; whether this finding has a causal
relation with the anhedonic phenotype of stressed animals or
whether it rather represents an epiphenomenon remains to be
elucidated.
Using this animal model of depression, we show that SDT
can effectively discriminate anhedonic behavior in stressed ani-
mals, based on preference values for sugared-pellets. In addition,
we complemented food preference analysis with USVs record-
ing. In fact, USVs have been proved to be a powerful tool
to characterize rodents’ behavior (Burgdorf et al., 2000, 2007).
In particular, recording of 50KHz frequency vocalizations has
been shown to be associated with pleasurable and/or reward-
ing activities (Borges et al., 2013). Interestingly, we found that
the total number of 50KHz vocalizations emitted by uCMS
exposed animals during the test is significantly lower compara-
tively with control animals. Moreover, the fact that the number
of 50KHz vocalizations correlated positively with preference for
sugared pellets indicates that this parameter has a strong poten-
tial to complement methods currently available to characterize
anhedonic behavior. The combination of these two parameters
in the SDT, namely food preference and USVs quantification,
offers this test the ability to provide a robust multi-parametric
measure of hedonic behavior. Moreover, SDT presented high
sensitivity to detect the pro-hedonic effects promoted by two
different antidepressants, fluoxetine and imipramine. In fact,
when comparing SDT with the gold-standard SCT using group
statistics, results show that both tests can effectively discrim-
inate the anhedonic behavior induced by stress exposure and
the improving effects promoted by ADs. However, an individ-
ual analysis of animals’ performance shows that SDT has a higher
ability to discriminate uCMS-exposed animals, which presented
lower preference values, prevalently outside the control group
score-range. In addition, data from the second experimental
set shows that USVs quantification can also be a valuable tool
for the discrimination of animals that responded to treatment
from non-responder animals. Once more, the quantification of
50KHz USVs presented a positive correlation with food prefer-
ence values. It is also important to mention that the longitudinal
analysis of the three SDT trials, revealed that in this particu-
lar context of an uCMS-based protocol, anhedonic behavior can
be detected as early as in the first trial. Although this obser-
vation validates the use of a single-trial protocol of the SDT,
the longitudinal analysis of the three trials along the admin-
istration of ADs shows that different drugs differ in the time
needed to elicit their improving effects, thus justifying the use
of a multi-trial approach to accurately report their therapeutic
effects. Therefore, a careful decision must be made regarding the
use of single- or multi-trial protocol, which must be based on
the main purpose and the experimental design of the study to be
performed.
Finally, our results showed that SDT could effectively discrim-
inate anhedonic behavior in two rat strains (Wistar-Han and
Sprague-Dawley), as well as inmale and female genders. Although
these results are first indication that this test can be successfully
used in different rat strains, it will be also imperative to assess
its efficacy in mice models, which are currently widely used to
address questions on this topic.
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Overall, the present work indicates that the multi-parametric
approach of SDT represents a valuable refinement of current
methods to assess hedonic behavior in rodents, and can be
a robust complement to the characterization of this behav-
ioral dimension, with the potential to be implemented across
labs. Improvements such as this, demonstrate that conventional
paradigms are flexible to further modification, and may con-
tribute to enhance the utility of animal models of complex neu-
ropsychiatric disorders and to expand current knowledge on the
neurobiology of mental disease.
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General Discussion
Along with growing evidence unveiling the many expressions of plasticity that the mature central 
nervous system harbors, the relationship between this neuro-glioplasticity and the way we adapt and 
face an ever-changing environment is becoming increasingly comprehended. Indeed, the necessity to 
explore how adult neural plasticity participates in different brain functions is fundamental, not only to 
gain insight into the neurobiological basis of enviromentally-induced adaptations and behavioral 
patterns, but also to understand how our most essential neuroadaptive responses may degenerate 
into maladaptive pathological outcomes.  
Within the work of this thesis we have focused on hippocampal adult neural plasticity, that has 
long been implicated in the control of different behavioral dimensions and described to be 
particularly vulnerable to environmental pressures. Of interest to the work here presented, the 
hippocampus has been purposed has the gateway of the stress response in the brain (McEwen et 
al., 2016). This is particular relevant since, in a likely convergence of mechanisms, chronic stress 
exposure has been shown to affect neural plasticity in different cortical and limbic areas, among 
which the hippocampus is included. The effects in brain plasticity have in turn been associated with 
the precipitation of multi-dimensional deficits encompassing the core symptoms and some frequent 
comorbid behavioral traits that relate to the clinical presentation of major depression (Bessa et al., 
2009; Snyder et al., 2011; Mateus-Pinheiro et al., 2013a). Besides determining dendritic atrophy 
within the hippocampus, stress exposure and stress hormones were among the first known 
regulators of hippocampal cytogenesis (Gould et al., 1992). A pivotal question in the field lies in 
whether impairments in hippocampal cytogenesis are mechanistically linked to the precipitation of 
depressive-like behavior (Petrik et al., 2012; Tanti and Belzung, 2013), or may simply represent two 
coexisting epiphenomena. The second question of paramount importance is to unveil whether the 
capacity to generate new cells in the hippocampus is necessary to the therapeutical efficacy of 
antidepressant drugs (ADs).  
In the first part of this thesis work we have addressed the role of hippocampal cytogenesis in the 
onset and recovery from depressive-like behavior, using two different cytogenesis ablation models. In 
a first study we have administered the anti-mitotic drug, methylazoxymethanol (MAM), to block 
cytogenesis in young-adult rats. Complementary, in a second study, we further dissected the effects 
of adult cytogenesis supression in naïve animals, using a transgenic rat model of cytogenesis 
ablation, the Glial Fibrillary Acidic Protein (GFAP)-Thymidine kinase (Tk) rats (GFAP-Tk rats). 
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 7.1  
Hippocampal cytogenesis as a 
pathophysiological trigger of depression 
  
Decreased hippocampal cytogenesis has been consistently reported to be decreased following 
stress exposure (Sairanen et al., 2005; Magarinos et al., 2011) and in different animal models of 
depression. However, the field still struggles to conciliate into a single unifying view the apparently 
contradictory data regarding the putative causative role of cytogenesis in the precipitation of a 
multi-dimensional depressive-like phenotype.  
During the last 15 years, cytogenesis ablation studies have been fundamental to study the 
functional correlates of adult hippocampal cytogenesis in physiological conditions, but also to 
explore its participation in psychopathological contexts. Three types of strategies have been 
adopted to abrogate post-natal cytogenesis and study its impact on brain homeostasis: i) the use 
of x-ray irradiation (Santarelli et al., 2003; Surget et al., 2011), which is a regionally restricted 
procedure, but that lacks cell-specificity as it affects also mature cells and elicits a moderate 
inflammatory response; ii) the use of cytostatic drugs (Bessa et al., 2009; Jayatissa et al., 2009), 
which are able to abrogate cytogenesis in all cytogenic niches of the brain, but that again do not 
spare other mitotic cell populations; iii) the use of transgenic mice lines (Saxe et al., 2006; 
Kirshenbaum et al., 2014), that allow for the specific (promoter-directed) ablation of neural stem 
cells, without interfering with other cell types. In a previous work from our lab, we administered 
MAM to naïve animals and analyzed the behavioral profile immediately after the cessation of 
MAM-induced cytogenesis suppression (Bessa ate al., 2009). Results showed that blocking 
cytogenesis did not promote the development of short-term depressive-like behavior. Indeed, the 
same dissociation between hippocampal cytogenesis abrogation and the precipitation of 
depressive-like behavior has also been documented by several authors (Holick et al., 2008; David 
et al., 2009). Contrastingly, some authors have challenged these results, and showed that 
blocking hippocampal cytogenesis produces increased immobility in the FST, as well as anhedonic 
behavior in the SPT (Snyder et al., 2011). 
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Although these results are apparently at odds with each other, we hypothesized that a likely 
source of discrepancy between studies was related to the experimental design and time-point of 
analysis. In fact, in adult rodent neurogenesis, and despite the ability of new cells to establish 
primordial synapses with CA3 pyramidal cells within a week, a newborn cell takes approximately 4 
to 5 weeks to maturate and integrate the pre-existing circuitry (Ming and Song, 2005). Taking this 
temporal dynamic of the hippocampal cytogenic process, it comes to light the fact that studies 
analyzing the behavioral correlates of neurogenesis immediately after its abrogation are largely 
targeting a population of immature neurons and assessing the functional impact of these subset 
of cells. As a result, the full extension of the hippocampal cytogenic process has been neglected 
and the long-term consequences of the loss hippocampal cell turnover remain obscure. 
To address this question, we have followed a similar approach as before, administering MAM to 
adult naïve rats, but instead of immediately analyzing the behavioral consequences of cytogenesis 
ablation, we only conducted behavioral tests 4 weeks post-ablation (Mateus-Pinheiro, 2013a; 
Chapter 3). Our results show that MAM administration effectively reduced the number of new 
neuronal (NeuN+) and astroglial (GFAP) cells that succeed to differentiate and integrate into the 
pre-existing circuit. Regarding these ablation methods, it is important to highlight that at the time-
point of our analysis, 4 week post-ablation, hippocampal proliferation was not restored to basal 
levels, as reflected by the reduced levels of Ki-67+ cells present in MAM-treated. This aspect is 
critical, since it allows us to conclude that with this approach we are able to study the long-term 
consequences of devoiding the hippocampus of both new mature and immature cells.  
Taking this into consideration, our results showed that hippocampal suppression by MAM was 
sufficient to induce increased time of immobility in the FST, typically interpreted as measure of 
depressive-like behavior in rodents (Cryan and Holmes, 2005). Moreover, the ablation of new 
mature cells in the adult hippocampus also induced the long-term manifestation of anhedonic 
behavior in the SCT. As depression has a complex and heterogeneous clinical manifestation, 
consisting not only in mood deficits, but also in the development of anxiety and  cognitive 
disabilities, we explored wether hippocampal cytogenesis ablation would precipitate long-term 
behavioral impairments in these dimensions. Indeed, MAM-treated animals displayed heightened 
anxiety-like behavior manifested in two independent test paradigms use to measure this 
dimension (the EPM and the NSF). Moreover, and although we did not detect deficits in spatial 
reference memory, when measuring the escape latency, we did observe long-term deficits in 
working memory and behavioral flexibility, 4 weeks following ablation. Hence, our data shows that 
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MAM-induced hippocampal cytogenesis suppression is sufficient to elicit long-term multi-
dimensional behavioral deficits commonly observed in depressed patients.  
 Placing this results side by side with those of Bessa et al. (2009), in which the analysis was 
conducted immediately after the cessation of MAM treatment, some differences are apparent. 
While we were able to detect long-term mood-related deficits, these were absent when the analysis 
was performed shortly after cytogenesis ablation (Bessa et al., 2009). However, regarding anxiety-
like behavior the picture seems quite different. In fact, and similarly to our long-term analysis, 
Bessa et al. reported that the MAM-treatment was able to induce short-term deficits in anxiety 
behavior. Altogether these observations reinforce that the timeframe of the experimental design 
has critical influence in the results outcome. These results suggest that while mature and 
integrated neuronal and glial cells are likely to participate in the control of mood and hedonic 
behavior, immature newborn hippocampal cells seem to exert an early impact on anxiety-like 
behavior, which is extended to the late maturation phase. Unfortunately, a comparison with the 
short-term effects of cytogenesis ablation in cognitive performance is not possible, as these have 
not been assessed in the same study. 
Although it has been shown by us and others that using MAM at a dosage bellow 10 mg.Kg-1, 
does not seem to have a deleterious impact in general measures of animal well-being and 
inflamatory profile, as compared to untreated animals (Bessa et al., 2009; Jayatissa et al, 2009), 
it is difficult to control at what extent are the obtained results influenced by the cytostatic systemic 
effects of MAM in other mitotic cell populations. For this reason, we conducted a second study 
using a more directed cytogenesis ablation approach, using the GFAP-Tk rat model. With this 
model, we were able to selectively ablate GFAP+ neural stem cells (NSCs). As the cell death 
mechanism underlying this approach requires the metabolization of ganciclovir (GCV) by the viral 
thymidine kinase, leading to the production of a cytotoxic product, it only affect dividing cells and 
spares GFAP+ mature glial cells (Groves et al., 2013).  
Using this model we conducted a subsequent study, whose design took in consideration the 
temporal dimension of adult cytogenesis (Chapter 4). For that we defined two time-points of 
analysis, to explore the functional consequences of ablating either immature newborn cells or fully 
differentiated new neuronal and glial cells. Our results show that GCV administration was able to 
markedly decrease the number of short-term proliferating cells (BrdU+ cells) and neuroblasts (DCX
+ cells). Consequently, the same treatment also affected cell survival, showed by a significant 
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decrease in BrdU/NeuN and BrdU/GFAP double-positive cells, analyzed 4 weeks post-ganciclovir 
treatment. Making a parallelism with previous studies in which MAM was used, we started to 
analyze the same behavioral dimensions, immediately after ganciclovir treatment and in a second 
set of experiments 4-weeks post-ablation. 
In our short-term analysis, we were not able to detect any effects of cytogenesis ablation in FST 
immobility time, or any short-term alteration of hedonic behavior in both SCT or the SDT. However, 
and as previously reported using MAM, GCV administration to GFAP-Tk rats elicited the short-term 
manifestation of anxiety-like behavior, manifested as an increased latency to feed in the NSF. 
Notably, these results are in line with those reported by Bessa et al., and reinforce how immature 
cells differentially affect mood- and anxiety-related behaviors. Furthermore, we also conducted a 
short-term analysis of different cognitive categories, using paradigm variation of the water maze 
test. Our results indicate that cytogenesis ablation did not produce short-term impairments in 
spatial reference memory, working memory or behavioral flexibility. 
The behavioral profile of animals with cytogenesis ablation 4 weeks after GCV treatment was 
remarkably different. Here, the lack of new mature neuronal and glial cells produced long-term 
anhedonic behavior, manifested in both SCT and the SDT. However, we did not detect a significant 
increase in immobility in the FST. GFAP-Tk animals treated with GCV also displayed long-term 
anxiety-like behavior, measured in the NSF. Concerning cognitive behavioral dimensions, while we 
did not find any interference of cytogenesis ablation with the escape latency in a spatial reference 
memory task, the lack of new mature cells proved to have long-term deleterious effects in working 
memory and behavioral flexibility. Altogether, the results obtained using this genetic cytogenesis 
ablation approach largely replicate the results obtained in our previous studies with MAM (Bessa 
et al., 2009; Mateus-Pinheiro et al., 2013a). An exception was observed concerning the FST, 
where no short-term or long-term effects were observed upon genetic hippocampal cytogenesis 
ablation. Since this test relies in the animal motor function, it could be hypothesized that MAM 
could have collateral systemic effects affecting locomotion. This possibility is unlikely, since we 
have shown no alteration in exploratory behavior or swim velocity in our studies. A second 
possibility could be related with differences in the temporal persistence of the anti-cytogenic 
action between the two ablation methods: while in GFAP-Tk animals, normal hippocampal 
proliferation has been shown as early as after 8 days post-GCV treatment (Denny et al., 2012), we 
have shown sustained decreased of hippocampal proliferation 4 weeks post-MAM treatment. This 
implies that contrarily to the GFAP-Tk model, in which we are able to specifically study the 
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importance of new hippocampal cells at a time when they were expected to be mature cells 
without compromising the subsequent generation of new immature cells, with MAM , we promote 
a sustained abrogation of both immature and mature cells. This more severe ablation may 
account for the emergence of deficits in the FST. A third hypothesis, could lie on the very nature of 
the test itself. Although the validity of the test to measure antidepressant response is beyond 
contestation, the question of whether this test is actually modeling/ measuring depressive-like 
behavior in rodents is difficult to answer. This reinforces the need to develop more robust test 
paradigms to quantify expressions of emotional behavior in rodents. This is where the relevance of 
multi-parametric tests, such as the newly developed sweet drive test (SDT) come to light. Indeed, 
we have shown that the combination of quantifying preference for a sugared isocaloric food with 
the quantification of 50 Khz ultrasonic vocalizations presented increased sensibility to detect not 
only anhedonic behavior but also to distinguish antidepressant-responders, from non-responders 
(Mateus-Pinheiro et al., 2014; Chapter 6). 
 Fundamentally, both studies presented in this thesis support two important conclusions: first, 
that hippocampal cytogenesis ablation is sufficient to elicit long-term behavioral deficits in 
emotional and cognitive domains, known to be compromised following chronic stress exposure 
and in major depression; second, both studies corroborate the hypothesis that we had previously 
put forward concerning the importance of taking into account the full temporal extension of adult 
cytogenesis, as reflected by the contrasting behavioral phenotypes that emerge form the ablation 
of either immature or fully differentiated cells (Figure 1).  
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Figure 1. Results comparison between two cytogenesis ablation experiments. Both short-term and long-
term behavioral profiles are shown. Green boxes depict behavioral tents in which normal performance is preserved. 
Red boxes depict behavioral tests, in which animals performance became affected. SCT- sucrose consumption test; 
SDT- sweet drive test; FST- forced swimming test; NSF- novelty suppressed feeding; RM- spatial reference memory task; 
WM- working memory task; BF- behavioral flexibility task; CS- cognitive strategies analysis; CFM - contextual fear 
memory task; PS- pattern separation task. n.a. - not assessed. A-anhedonic behavior; D-depressive-like behavior; Ax-
Anxious behavior; C-Cognitive Performance
Since we observed that the ablation of newborn cells produced significant long-term cognitive 
deficits, we used the GFAP-Tk model to further characterize the participation of neuro- and 
gliogenesis in cognitive dimensions that have been previously considered as functional correlates 
of adult cytogenesis (Chapter 4). Therefore, we submitted animals to additional cognitive tasks, 
4 weeks post-ablation. Curiously, although we were not able to detect effects of cytogenesis 
ablation on the escape latency in a spatial reference memory tasks, we report alterations at the 
level of cognitive strategies employed to reach the escape platform. Indeed, GFAP-Tk animals 
treated with GVC showed delayed transition from non-hippocampal dependent to hippocampal 
dependent strategies in the same test paradigm. Corroborating these results, we have reported a 
similar finding in animals lacking the transcription factor AP2y, that is fundamental to preserve 
normal levels of adult glutamatergic hippocampal neurogenesis (Appendix 1). The participation 
of adult neurogenesis in this form of cognitive flexibility had previously been demonstrated (Gu et 
al., 2012; Garthe and Kempermann, 2013), and highlights how analysis refinement of test 
paradigms that have long been used may be fundamental to finely dissect how hippocampal 
cytogenesis impact on different forms of behavior. In addition, cytogenesis ablation also promoted 
the long-term manifestation of deficits in contextual fear memory, as well as in pattern separation, 
measured in an adapted version of the NOR test.  
Interestingly, we also found that cytogenesis ablation promoted the development of long-term 
impairments in the inter-regional communication between the ventral hippocampus and the 
medial PFC. As both regions have been implicated in some of the studied behavioral dimensions, 
it is likely that the lack of new mature cells may promote profound alterations in the cortico-limbic 
neuro-glial networks, contributing to the observed cognitive deficits.  
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  7.2 
Hippocampal cytogenesis as a neural substrate in 
the spontaneous and antidepressant-mediated 
remission from depressive behavior 
The pro-cytogenic actions of different antidepressant drugs (ADs) has been consistently 
reported in several works (Surget et al., 2008; Perera et al., 2011). Similarly to the conflicting 
reports regarding the involvement of cytogenesis in the precipitation of depressive behavior, 
studies addressing whether hippocampal cell turnover is essential for AD’s therapeutical efficacy 
also report inconsistent results. In a previous work from our lab, we have provided evidence for 
the non-reliance of monoaminergic ADs on adult hippocampal cytogenesis; instead, short-term 
behavioral improving effects of these drugs seem to be attributable to rapid reversal of stress-
induced neuronal dendritic atrophy in the hippocampus and prefrontal cortex (PFC). Nevertheless, 
and taking again into consideration the temporal progression of hippocampal cytogenesis, studies 
such as these have focused on the contribution of new cells to behavioral-improving  actions of 
ADs, shortly after the conclusion of treatment, when these cells are still essentially immature.  
Following the assessment of the effects of MAM administration in the long-term behavioral 
profile of naïve animals, we sought to explore the long-term impact of hippocampal cytogenesis to 
both spontaneous and ADs-induced remission from a depressive phenotype (Mateus-Pinheiro et 
al., 2013a; Chapter 3). We submitted young-adult rats to 6 weeks of an unpredictable chronic 
mild stress (uCMS) protocol to induce core symptoms of depressive-like behavior and analyzed the 
behavioral impact of MAM administration in the remission from depressive-like behavior 4 weeks 
later. Similarly to MAM effects on cytogenesis, uCMS exposure induced a pronounced decrease in 
hippocampal cyotgenesis, compromising the generation and survival of both new neuronal (BrdU/
NeuN double-positive) and (BrdU/GFAP double-positive) astroglial cells. However, in spite of the 
fact that stressed animals without MAM treatment were able to revert hippocampal cytogenesis to 
basal physiological levels 4 weeks after uCMS conclusion, those receiving MAM treatment 
exhibited long-lasting impairments in hippocampal cytogenesis. When analyzing the implications 
of cytogenesis ablation to the ability of adult animals to spontaneously remit from multi-
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dimensional behavioral deficits, we have been able to conclude that hippocampal cytogenesis is 
indeed critical for this process (Figure 2). In fact, MAM administration to chronically stressed 
animals promoted persistent and long-lasting deficits in hedonic behavior, anxiety traits and 
cognitive function (working memory and behavioral flexibility). Contrastingly, stressed animals in 
which cytogenesis was not ablated were able to, either partially or completely, recover from these 
deficits. Curiously, results obtained in the FST show that stressed animals are able to 
spontaneously recover from “depressive-like behavior” measured in this test paradigm. 
Considering that in the previous set of experiments MAM administration to control rats elicited 
long-term deficits in the FST, it becomes likely that both the mechanism and abruptness of 
cytogenesis ablation may account for these different results: in light of the fact that in stressed 
animals the progressive anti-cytogenic effect resulting from uCMS exposure precedes that of MAM 
administration, it is possible that these animals are able to develop compensatory mechanisms 
that reinforce their resilience to the subsequent anti-mitotic insult induced by this drug. In fact, 
unpublished data from our group shows that animals in which a stress-induced decrease in 
hippocampal cytogenesis had already been elicited, show increased resilience to a subsequent 
period of stress exposure (Alves et al., unpublished). Alternatively, and as discussed before, this 
apparent discrepancy may relate to the natural variability or intrinsic limitations of the FST to 
measure what is believed to be a proxy of depressive behavior in rodents. 
Although MAM cytostatic action was not spontaneously restored, it has proved to be 
pharmacologically reversible by chronic administration of two monoaminergic ADs, fluoxetine and 
imipramine. This aspects correlates with the behavioral improving actions that we observed in 
treated animals. Curiously, the action of the used ADs was differentially affected by MAM co-
administration. While the efficacy of fluoxetine became significantly compromised upon 
cytogenesis ablation, that of imipramine remained virtually unaffected. This may relate with the 
type of pro-cytogenic response elicited by each antidepressant, as neurogenesis had essentially a 
pro-neurogenic action, while imipramine promoted a strong pro-gliogenic response. Although we 
are unable to be sure if this relates with the different magnitude of MAM action in the efficacy of 
both drugs, these findings add up a new perspective into the debate of whether hippocampal 
cytogenesis is needed to mediate the actions of ADs. This perspective is grounded in two 
premisses: one relates to a “when”, and the second relates to a “what”. Indeed, while we have 
seen before that hippocampal cytogenesis was not determinant for the short-term actions of ADs, 
their relevance is clear in the long-term remission mediated by these drugs, highlighting how 
deciding when to experimentally approach this question dictates different outcomes. Moreover, 
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these results support the idea that deciding what to study is equally determinant. As different 
classes of ADs elicit different types of pro-cytogenic actions and depend at different extends from 
ongoing hippocampal cell genesis, this is very likely to be an important source of discrepancy 
among studies. 
i i  173
Figure 2. Spontaneous and ADs-induced remission from a multi-dimensional depressive phenotype. 
Both short-term and long-term behavioral profiles are shown. Green boxes depict behavioral tents in which normal 
performance is restored. Red boxes depict behavioral tests, in which animals performance remained affected. Gray 
boxes correspond to behavioral dimensions in which cytogenesis ablation promoted blunted antidepressant effects. 
SCT- sucrose consumption test; SDT- sweet drive test; FST- forced swimming test; NSF- novelty suppressed feeding; 
RM- spatial reference memory task; WM- working memory task; BF- behavioral flexibility task; CS- cognitive strategies 
analysis; CFM - contextual fear memory task; PS- patter separation task. n.a. - not assessed. A-anhedonic behavior; D-
depressive-like behavior; Ax-Anxious behavior; C-Cognitive Performance.
 7.3 
The importance of neural plasticity in the adult 
hippocampus for the onset and remission from 
depression: a matter of time 
Taken together, the above discussed results support the view of a time-dependent participation of 
hippocampal neural plasticity in both the pathological manifestation of depression-like behavior and 
the remission from the installed emotional and cognitive deficits.  
Concerning the participation of hippocampal neural plasticity in the development of depressive 
traits, several works have purposed the association of hippocampal neuronal dendritic atrophy 
(Pittenger and Duman, 2008; Bessa et al., 2009), as well as astroglial structural remodeling (Czeh 
et al., 2006) with the short-term manifestation of different behavioral deficits, typically evidenced by 
depressed patients. In contrast, several cytogenesis ablation studies have failed to detect the short-
term development of behavioral deficits in most of the dimensions that we discussed above. The 
exception lies on anxiety, as abrogation of hippocampal cell genesis is sufficient to induce short-term 
heightened anxiety signs. Contrastingly, the two ablation approaches used in this thesis work have 
provided consistent evidence for the participation of adult cell genesis in the long-term development 
of anhedonic and hyper-anxious behavior, along with different cognitive impairments. Integrating our 
results with those of other authors, we have purposed a bi-phasic model for the participation of 
hippocampal neural plasticity in the pathophysiology of depression (Mateus-Pinheiro et al., 2013b). 
The suggested model, has in consideration the longitudinal course of the disease, as well as the very 
dissimilar temporal dynamics of hippocampal neuroplastic processes (Figure 3). Hence, we 
purpose that the fast neuroplastic response at the level of neuronal synaptic dendritic remodeling 
and astroglial morphological changes following chronic stress exposure serve as initiators for the 
installment of short-term behavioral impairments. Contrarily to the rapid neuro-glial morphological 
changes, hippocampal neuro- and astrogliogenesis are slower processes, that take several weeks to 
be accomplished. Accordingly, the behavioral manifestations of anti-cytogenic insult mainly come to 
light approximately 4 weeks later, when cells that had been otherwise generated within the 
hippocampus, were expected to be fully functional and integrated in the pre-existing neuro-glial 
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network. Interestingly, these results are in line with a previous study, reporting no alterations 1 week 
after cytogenesis ablation, but unveiling the development of cognitive deficits when the analysis was 
conducted 2 and 4 weeks post-ablation (Denny et al., 2012). In addition, a recent study has showed 
how optogenetically interfering with the function of 4-weeks old new neurons, but not with those of 1- 
or 8 weeks old, elicited the development of impairments in contextual fear memory and in cognitive 
strategies used in the water maze (Gu et al., 2012). Unfortunately, none of these studies addressed 
emotional dimensions of behavior. Nevertheless, our results further support the emerging idea of an 
important role of immature newly-born cells in the neurobiological mechanisms underlying anxiety 
behavior. 
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Figure 3. Hippocampal Neuroplasticity in the remission of the depressive-phenotype: the dorso-ventral 
dichotomy. Chronic stress exposure has opposing effects in dendritic plasticity of the dorsal (dDG) and (vDG). While 
promoting neuronal atrophy in granule neurons of the dDG, chronic stress promotes neuronal hypertrophy in the vDG. 
In both hippocampal poles, stress exerts an anti-cytogenic action. Antidepressants (ADs) revert neuroplastic deficits in 
both hippocampal poles and reestablish the basal phenotype in behavioral dimensions previously affected, namely 
mood, anxiety and cognitive performance (full lines). Dashed lines represent behavioral alterations following 
cytogenesis ablation, 28 days before. Cytogenesis ablation has immediate short-term detrimental effects on ADs 
efficacy to revert anxiety behavior (dashed green line). Contrastingly, ADs are able to promote short-term behavioral 
improvement on mood and cognitive performance, but fail to reveal a sustained long-term effects following cytogenesis 
ablation (red and blue dashed lines). While ADs present sustained effects on some cognitive dimensions (a.), 
cytogenesis ablation compromises remission of a subset of cognitive fundtions.  © Mateus-Pinheiro 2016.
In a similar fashion, we suggest the therapeutical action of ADs to rely in a bipartite neural-plastic 
basis: while having a pro-cytogenic effect, the short-term action of ADs rely on their modulatory 
effects upon genes responsible for the observed rapid recovery from neuromorphological alterations 
that ensued chronic stress exposure (Pittenger and Duman, 2008; Bessa et al., 2009). The 
potentiation of hippocampal neuro- and gliogenesis will be fundamental latter on, once new cells 
attain full development and become essential to the sustained remission from depression. Moreover, 
differences in the potential to trigger a pro-cytogenic response by different antidepressant agents 
may explain, at least partially, why some antidepressant classes are more associated to relapse after 
initially signs of remission.   
In conclusion, our results substantiate the need to consider the longitudinal course of neuro-
glioplastic processes in both the development and remission from depressive behavior, in order to 
achieve a more comprehensive view on the participation of adult hippocampal plasticity in both 
contexts. Among many other influencing factors, it becomes increasingly evident that the apparent 
data incongruence that has marked this topic during the last years may actually relate to a matter of 
time.  
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 7.4  
Epigenetics and the stressed brain: is there a role 
for DNA 5hmC? 
Along with the importance to study the participation of neural plasticity in physiologic and 
pychopathological contexts, runs the need to unveil the regulatory mechanisms behind these 
phenomena. Among many other forms of molecular regulation already identified to orchestrate 
hippocampal neural plasticity, mounting evidence support the importance of epigenetic regulation 
as transducer of environmental stimuli into functional and structural remodeling of the post-natal 
hippocampus (Sun et al., 2011). 
We have conducted a longitudinal experiment, using a similar uCMS protocol as before, in 
which we defined three time-points of analysis, to achieve a full perspective on both short- and 
long-term aspects of hippocampal neural plasticity (Chapter 6). In brief, our longitudinal 
behavioral characterization allowed us to characterize how different emotional and cognitive 
modalities are affected across time. In our uCMS-based animal model of depression, mood 
related deficits seem to be transversally installed along all time-points, exhibiting signs of partial 
remission 4 weeks after subsiding stress exposure. In the case of anxiety behavior, deficits in this 
dimension are precipitated shortly following the initial weeks of stress exposure, but are readily 
reversed at long-term. The immediate precipitation of stress-induced anxiety signs, along with its 
complete reversion on latter time-points, are in agreement with the previously discussed idea of 
the association between this behavioral dimension and short-term neuroplastic alterations, such 
as rapid dendritic remodeling and the modulatory action of immature newborn hippocampal cells. 
Contrastingly, cognitive memory deficits are absent in earlier stages of the uCMS protocol. 
Instead, this deficit emerge only after 6 weeks of stress exposure and, interestingly, persists in 
untreated animals long after subsiding stress exposure. The late manifestation of these deficits 
again suggests an important association with the functional importance of new mature 
hippocampal cell population, that is impoverished at latter time points, following the precedent 
stress-induced anti-cytogenic insult.  
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Taking into account the neuro-anatomical and functional dichotomy existing between the dorsal 
and ventral hippocampus, we analyzed neural plasticity occurring in both regions independently. 
While we found a significant dendritic atrophy of granule cells in the dorsal DG (dDG) following 
stress exposure, we described a contrasting hypertrophic effect in granule cells of the ventral DG 
(vDG). Curiously, the vDG is anatomically and functional linked to the extended amygdala, in which 
neuronal hypertrophy have also been described (Vyas et al., 2004). Moreover, a similar effect was 
described specifically within the ventral hippocampus, in CA3 pyramidal neurons (Pinto et al., 
2015). Regarding hippocampal cytogenesis, stress promoted a significant decrease in cell 
proliferation and long-term survival in both regions. However, as discussed in Chapter 6 
monoaminergic ADs seem to have pro-cytogenic effects that are manifested at different extents 
along the DG septo-temporal axis, and even differentially manifested along the transversal axis 
within the dDG.  
When exploring wether epigenetic alterations related with DNA demethylation pathways were 
affected by stress and ADs treatment, the dorso-ventral dichotomy was also evident. A global 
decrease in DNA 5hmC levels was only detectable within the dDG, along with decreased 
expression specifically of TET3, suggesting perhaps a greater vulnerability of this region to 
environmentally-induced epigenetic alterations. Importantly, these alterations are not specific of 
post-mitotic cell populations, as newborn cells were also shown to be affected, supporting the 
possibility that DNA demethylation pathways may influence hippocampal cell genesis in stress 
exposure conditions. Moreover, our oxRRBS analysis revealed that, although global 5hmC 
variations were only detected in the dDG, both regions are differentially affected by uCMS and ADs 
treatment. Within the dDG, we have found decreased hydroxymethylation in genes involved in the 
positive regulation of hippocampal cytogenesis promoted by stress, which were reversed by 
fluoxetine treatment. Contrastingly, in the vDG we identified a stress-induced hydroxymethylation 
of GR and MR coding genes, absent in control or fluoxetine-treated animals. These results are still 
to be confirmed by glucMS-qPCR and to be correlated to transcriptomic data that we have recently 
generated using the same experimental paradigm (Patricio et al., 2015). Theoretically, if these 
alterations in hydroxymethylation levels  are confirmed to be positively correlated with gene 
expression, our results may support an important role of DNA demethylation pathways in the 
modulation of hippocampal cytogenesis within the dDG. Interestingly, the dDG corresponds to the 
DG domain were we have observed a greater AD-induced cytogenesis promotion. In the same line 
of thought, the hyper-hydroxymethylation of genes coding corticosteroid receptors, may highlight 
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the already purposed pivotal importance of the ventral hippocampus in the mediation of the stress 
response. If confirmed, these results may pinpoint DNA demethylation mechanisms as 
determinant for the role of the hippocampus as a gateway of the systemic stress response into the 
CNS. Interestingly, we have recently identified the presence of glucocorticoid response elements 
(GRE) within the promoter region of tet3 (unpublished data), further suggesting a functional 
crosstalk between stress response and the DNA demethylation pathways. 
Besides the already mentioned confirmatory analysis, this study would benefit from the 
following subsequent steps:  
• To assess wether chronic administration of corticosterone to naïve animals can reproduce 
our findings, further endorsing the relation between stress hormones and the observed 
alterations;  
• To study alterations in 5hmC levels and tet genes expression in both undifferentiated and 
differentiated neurosphere cultures, supplemented with corticosterone and monoaminergic 
neurotrasnmitters, to pinpoint the epigenetic alterations that are specifically promoted in either 
pos-mitotic or progenitor cell populations. 
• To characterize hippocampal neuroplastic and behavioral alterations found in a conditional 
forebrain tet3 knockout model, to further dissect the link between tet enzymes and the observed 
neuro-behavioral phenotype. 
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 7.5  
Concluding Remarks & Future Perspectives 
In conclusion, through complementary experimental approaches, we have provided evidence 
for the participation of different forms of hippocampal neural plasticity in several cognitive 
dimensions and emotion-related behaviors, both in the healthy and stressed/depressed brain. 
Moreover, the results of this thesis contribute to a better comprehension on how adult 
hippocampal cytogenesis modulate different modalities in a time-dependent manner, emphasizing 
the importance of considering the longitudinal course of neural plasticity processes in the 
evaluation of their impact in both basal and psychopathological conditions. 
Further insight on this field will come with the development of strategies to selectively ablate 
either neuro- or gliogenesis independently. Such approach will allow to precisely underpin the 
individual participation of new neuronal and glial cells to different brain functions, as well as their 
role in the onset and remission from stress-related disorders, such as depression. Moreover, viral 
tracing techniques may be used to better elucidate how new cells promote the reconfiguration of 
cortico-limbic circuits. In the context of depression, this would allow to characterize a possible 
underlying “deconectome” or “reconectome”, and how inter-regional connections are modulated 
by different antidepressant pharmacological classes. Although we normally associate typical 
antidepressant treatment with the potentiation of the endogenous brain plasticity, additional 
therapeutical advances may stem from exploring the potential of alternative approaches seeking to 
extend the cytogenic potential to other fundamental brain regions, such as the prefrontal cortex 
(PFC). These approaches, although challenging in many aspects, may contribute to reinforce 
cortico-limbic connections, known to become impoverished in depression, such as the ventral 
hippocampal-PFC projections. Finally, progress may come from the effort to develop non-invansive 
neuroimaging techniques to monitor forms of neuroplasticity in the human brain. Even if presently 
this may configure an utopian idea, to embrace this challenge is also to bravely acknowledge that 
this field is arriving to a developmental plateau from which progression is strikingly limited due to 
the lack of translational validation, that would ideally come from human data.  
i i  180
What remains indisputable, in virtue of its participation in a broad range of physiological and 
functional brain processes, is the need to continue to unveil the many facets of adult neural 
plasticity. Indeed, in a broader perspective, understanding how neural plasticity remodels our 
brain is to seek comprehension on how it reshapes the way we behave and, ultimately, how it 
defines the very essence of what we are. 
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Abstract 
Adult neurogenesis represents one form of non-synaptic neuroplasticity that is critical both for brain 
homeostasis and for adaptations to the ever-changing environments; however, there is still much to 
disclose regarding the functional role of transcription factors that regulate adult neurogenesis. Here, 
we identified AP2γ as transcription factor regulating the generation and maturation of new 
glutamatergic neurons in the adult brain. In addition, we demonstrate the relevance of AP2γ in 
hippocampal and prefrontal cortex activity and its implications to distinct emotional and cognitive 
functions.  
Introduction 
Although this notion is very likely to be revisited in the near future, there are two brain regions 
consensually accepted as neurogenic niches in the adult brain, where new cells are persistently 
generated throughout life: while cells born in the subgranular zone (SGZ) become mostly 
glutamatergic neurons of the hippocampal dentate gyrus, those originated in the subependymal zone 
(SEZ) become largely GABAergic interneurons of the olfactory bulb(). Research in recent years has 
provided insights on the transcriptional network involved in the regulation of neurogenesis, both in 
early developmental stages and during adulthood3,6-11. During cortical development the regulation of 
glutamatergic neurogenesis is controlled by a set of transcription factors including Pax6, Tbr2, 
NeuroD and Tbr1, with implications on proliferation, cell cycle kinetics, lineage and fate specification, 
regional identity, axonal growth and cell adhesion processes(). Interestingly, the transcriptional 
sequence (Pax6→Tbr2→NeuroD→Tbr1) regulating cortical glutamatergic neurogenesis during 
development is recapitulated in the adult hippocampus and, with some variations, also participates 
in cell commitment to glutamatergic lineages in the SEZ(). Activating Protein 2 gamma (AP2γ, also 
known as Tcfap2c or Tfap2c) is a transcription factor that integrates the transcriptional network of 
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glutamatergic neurogenesis during early developmental stages(), as it directly regulates the basal 
progenitor fate determinants Math3 and Tbr2(). Deletion of AP2γ in the developing cortex results in a 
specific reduction of upper layer neurons in the occipital cerebral cortex, while its overexpression 
potentiates region- and time-specific generation of cortical layers II/III. Yet, the function of AP2γ in 
the adult neurogenic niches remains to be disclosed. Herein, we addressed the question of whether 
AP2γ is an active determinant of adult glutamatergic neurogenesis and whether its function is 
relevant for the homeostasis of different emotional dimensions, as well as for the integrity of 
cognitive function. Indeed, we report here an important role of AP2γ in the regulation of adult 
glutamatergic neurogenesis, both in the adult hippocampal dentate gyrus (DG) and in the SEZ, as 
well as in the preservation of emotional and cognitive behaviors. 
Results 
AP2γ expression in the adult brain 
As a first step to characterize AP2γ function in the adult CNS, we used an in situ hybridization 
approach to identify the regional expression patterns of the gene. AP2γ mRNA expression was 
exclusively observed in two adult neurogenic niches, the subependymal zone (SEZ) and the 
subgranular zone (SGZ) of the hippocampal dentate gyrus (DG) (Fig. 1a). Specifically, in the DG 
AP2γ-mRNA positive cells were predominantly localized in the SGZ, although positive cells were also 
found more distally in the granular region (Fig. 1a). In addition, AP2γ-mRNA positive cells were 
present along the SEZ, including the dorsal wall (Fig. 1a), as well as in the rostral migratory stream 
(RMS) and the molecular cell layer (MCL) and glomerular layer (GL) of the olfactory bulbs (OB) 
(Supplementary Fig. 1a). Both in the dorsal wall of the SEZ and SGZ of the DG, AP2γ-mRNA 
positive cells were co-labeled with BrdU-label retaining progenitor cells (neural stem cells labeled 
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after an 8-week chase period), and with Tbr2 positive cells (Fig.1b). Furthermore, in the OB, AP2γ-
mRNA positive cells were also co-labeled with BrdU-positive newly generated neurons and with Tbr2-
positive cells both in the MCL and GL (Supplementary Fig. 1b-d). Immunohistochemistry analysis 
revealed that most AP2γ positive cells in the SEZ and in the SGZ were also positive for doublecortin 
(DCX) (61.5% ±2.7 and 53.6% ±3.6 in the DG and SEZ, respectively; Fig. 1c-e), while a smaller 
subset of these cells expressed Tbr2 (21.3% ±4.1 and 10.9% ±7.9 in the DG and SEZ, respectively; 
Fig. 1c, d), indicating a predominant commitment of AP2γ positive cells to the glutamatergic 
neuronal lineage. AP2γ positive cells were also positive for BrdU-label retaining progenitor cells (after 
an 8-week chase period), both in the SEZ and DG (13.9% ±3.5 and 7.7% ± 2.4 in the DG and SEZ, 
respectively; Fig. 1c, d), showing that a small portion of AP2γ positive cells are slow dividing 
progenitor cells. Importantly, we did not find any co-localization between AP2γ positive cells and 
astroglial cells (GFAP+ cells) or mature neurons (NeuN+ cells) in both neurogenic niches, while most 
were co-localizing with Ki67+ proliferating cells (Supplementary Fig. 2). Thus, this data reveals 
that AP2γ (both mRNA and protein) expression persists in the adult brain, being present in the 
neurogenic niches and most predominantly expressed in cells of the glutamatergic lineage. 
AP2γ regulates adult neurogenesis  
After identifying the presence of AP2γ in progenitors and neuroblasts of the adult neurogenic niches, 
we sought to understand its role in the neuronal fate specification of Neural Stem Cells (NSCs) 
primary cultures, derived from both the adult SEZ and DG21. For that we used Moloney murine 
leukemia virus–based retroviral vectors containing Cre-IRES-GFP to infect cultured NSCs from 
controls and mice containing AP2γ flanked by loxP sites (henceforth referred to as AP2γfl/fl) to 
delete AP2γ (Fig. 2). In the SEZ, viral-mediated deletion of AP2γ reduced the percentage of mixed 
clones (clones containing both neuronal (Tuj1-positive) and non-neuronal cells; IRES-GFP: 59% ± 3.7, 
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Cre-IRES-GFP: 27.3% ± 3.1, t18 =6.567, P <0.0001) at the expense of a significant increase in the 
generation of non-neuronal clones (exclusively formed by non-neuronal (TuJ1-negative) cells; IRES-
GFP: 27.4% ± 7.1, Cre-IRES-GFP: 60.6.3% ± 6.2, t18 =3.522, P =0.0012) (Fig. 2a-b). Similarly, AP2γ 
deletion in the NSCs from the DG also produced a decrease in the generation of mixed clones (IRES-
GFP: 49% ± 2.0, Cre-IRES-GFP: 14% ± 5.8, t18 =5.705, P <0.0001), counterbalanced by a marked 
increase in the formation of non-neuronal clones (IRES-GFP: 51% ± 3.4, Cre-IRES-GFP: 86% ± 3.5, t18 
=7.173, P <0.0001), supporting the role of AP2γ in commitment and differentiation into the 
neuronal lineage (Fig. 2d). We did not observe a significant difference in the clone size of control 
and AP2γfl/fl infected cells from the SEZ and DG (Fig. 2c,e). 
To verify if the effects observed in vitro upon deletion of AP2γ were present in the adult mouse brain, 
we used tamoxifen-inducible GLAST:CreErt2/Z/EG mice and crossed with AP2γfl/fl mice 
(henceforth referred to as AP2γ-/-, Fig. 2f). This allowed us to promote tamoxifen inducible excision 
of AP2γ in the progeny, and assess how the lack of this transcription factor affects hippocampal 
neurogenesis 1 week after induction (cells with AP2γ deletion become detectable by 
immunohistochemistry as GFP positive cells). In the AP2γ-/- mice we observed a significant decrease 
in the percentage of GFP/DCX double-positive cells both in the SEZ and in the DG in comparison to 
wild-type (Wt) mice (in the SEZ, Wt: 58% ± 12.3, AP2γ-/-: 30% ± 1.8, t18 =2.252, P =0.0185; in the 
DG, Wt: 64% ± 2.8, AP2γ-/-: 45% ± 3.5, t18 =4.239, P =0.0002) (Fig. 2g-h). In both regions, the 
decrease of AP2γ negative neuroblasts was accompanied with a marked increase in GFP/GFAP 
double-positive cells (in the SEZ, Wt: 10% ± 0.7, AP2γ-/-: 36% ± 7.7, t18 =3.361, P =0.0017; in the 
hippocampal DG, Wt: 8.4% ± 0.5, AP2γ-/-: 41% ± 7.8, t18 =4.171, P =0.0003; Fig. 2g,h). This 
increase in GFAP positive cells likely represents an increase in the GFAP-expressing progenitors pool 
or in the number of newly formed glial cells, as a result of a defect at the level of lineage 
commitment and subsequent differentiation into glutamatergic neurons. To complement this data, 
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an additional experiment in which we promoted the deletion of AP2γ in the forebrain, by crossing 
Emx1-Cre with AP2γfl/fl mice (henceforth referred to as AP2γfl/fl::Emx1-Cre) was performed; In 
fact we observed a decrease in DCX-positive neuroblasts in the DG (Supplementary Fig. 3). 
Effects in the neuroblast populations of the SEZ were not pronounced in AP2γfl/fl::Emx1-Cre mice 
(Supplementary Fig. 4a,b); however, AP2γfl/fl::Emx1-Cre mice show a decrease in Tbr2 positive 
cells in the granular cell layer (GCL) of the olfactory bulbs, as well as a decrease in Tbr1 positive 
cells in the molecular cell layer (MCL) of the same region, indicating an impairment in the 
progression to the glutamatergic neuronal lineage throughout development (Supplementary Fig. 
4c,d).  
In vivo AP2γ overexpression promotes neuronal differentiation in the adult brain 
To assess whether increased levels of AP2γ in the adult neurogenic niches could modulate the 
generation of new neurons, we used retroviral vectors containing either IRES-GFP as control or AP2γ-
IRES-GFP for AP2γ overexpression, and injected both in the DG and SEZ of adult mice (from now on 
designated as AP2γOE) (Fig. 3a,b). In this way, proliferative cells were stably transduced by the viral 
vectors, resulting in the overexpression of AP2γ and in the co-expression of GFP. Analysis performed 
at 1 week post-injection showed an increase in SEZ neuroblasts, reflected by an increase in GFP/
DCX double-positive cells (Wt= 64% ± 2.9, AP2γOE= 71% ± 2.8, t18 =1.749; P =0.0487, Fig. 3c,d). 
In the hippocampal DG, the large proportion of GFP positive cells corresponded to the neuroblasts 
population (DCX+ cells). We found a reduction in the percentage of neuroblasts in AP2γOE animals in 
relation to control animals in the DG 1 week post-injection (Wt= 66% ± 0.7, AP2γOE= 55% ± 3.5; t18 
=3.082; P <0.0032) (Fig. 3c,e); moreover, this reduction in neuroblasts was accompanied by a 
significant increase detected in mature granular neurons (NeuN+ cells) in AP2γOE mice (Wt= 12% ± 
3.4 and AP2γOE= 30% ± 1.3, t18 =4.945; P <0.0001) (Fig. 3c,e), indicating the promotion of 
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neurogenesis and the acceleration of the differentiation process in AP2γOE mice. A reduction was 
also detected in the GFAP-positive proliferating cell population of AP2γOE mice (Wt= 5.8% ± 0.34 and 
AP2γOE= 2.0% ± 1.3, t18 =2.828; P =0.0056) (Fig. 3e). Furthermore, in animals sacrificed 1 month 
post-injection, most GFP+ cells were now mature neurons (NeuN+ cells), whereas the GFP+/ DCX+ cell 
population was scarce (Fig. 3f). At this time-point, the increase in the differentiation of neuronal 
cells in the DG was maintained in AP2γOE mice that presented a significant increase in the 
percentage of GFP+/ NeuN+ cells (Wt= 69% ± 1.9 and AP2γOE= 95 %± 3.5, t18 =6.529; P <0.0001) 
(Fig. 3f). Few GFP+ cells co-localized with GFAP+ cells in the DG and no significant variation was 
observed in the percentage of GFP+/ GFAP+ cells (Fig. 3f and Supplementary Figure 5). 
Together, these data support the participation of AP2γ in the regulation of adult neurogenesis.  
AP2γ integrates the transcriptional network regulating glutamatergic neurogenesis 
To better understand how AP2γ participates on the regulation of adult glutamatergic neurogenesis 
modulators, we transfected mouse embryonic carcinoma P19 cells with a pGL3 luciferase vector 
containing either NeuroD or Tbr2 promoters (which contain AP2γ binding sites) and with a control, 
Sox2, Pax6 or AP2γ cDNA expression vector. Transfection with AP2γ led to a significant activation of 
both promoters (Tbr2, P <0.001; NeuroD, P =0.031; Fig. 4a) as previously described(). We also 
observed significant activation of these promoters by Sox2 (Tbr2, P =0.001; NeuroD, P =0.001; Fig. 
4a) and Pax6 (Tbr2, P =0.026; NeuroD, P =0.022; Fig. 4a), but no cooperative effects of Pax6 with 
AP2γ. However, simultaneous transfection with Sox2 and AP2γ potentiated the activation of the 
Tbr2 promoter (Tbr2, P =0.026; NeuroD, P =0.022; Fig. 4a). To uncover the upstream regulators of 
AP2γ, we transfected P19 cells with a pGL3 luciferase vector containing the AP2γ promoter and 
with a control, Pax6, Neurogenin 1 (Ngn1), Neurogenin 2 (Ngn2), Neurogenin 3 (Ngn3), Mash1, 
Sox2 or AP2γ cDNA expression vector (Fig. 4b). We observed that Pax6 and Sox2 activate the 
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AP2γ promoter while Mash1 and Ngn1 inhibit this promoter (Fig. 4b). AP2γ was also able to 
promote its self-activation, as previously described(). 
To further clarify the transcriptional network involving AP2γ in vivo, we crossed AP2γfl/flmice with 
Glast:CreEtrt2 mice and obtained tamoxifen inducible AP2γ conditional knockout mice - AP2γfl/fl//
Glast::CreErt2 (henceforth referred as AP2γ cKO). Here, we focused our analysis on the 
hippocampal region, since we were interested in characterizing the importance of AP2γ regulation to 
behavioral dimensions depending on hippocampal function. Twenty-one days after tamoxifen 
treatment of adult mice (2 month-old), we studied the impact of AP2γ deficiency on the above-
mentioned proteins (Fig. 4c), in the hippocampus of both heterozygous (AP2γ+/- cKO) and 
homozygous conditional knockout (AP2γ-/- cKO) mice. In fact, AP2γ deficiency triggered decreased 
levels of Pax6 and Tbr2 protein, but not Sox2, in the adult dorsal and ventral DG (Fig. 4d). Together, 
both in vitro and in vivo results are consistent with the view of AP2γ as a regulator of its targets Pax6 
and Tbr2 also in the adult hippocampus (Fig. 4e).  
AP2γ cKO adult mice display hippocampal neurogenesis impairments but no 
alterations in neuronal morphology 
After using complementary approaches to manipulate AP2γ levels both in vitro and in vivo, we have 
further used the AP2γ cKO mouse model to better dissect the functional implications of AP2γ 
deficiency in the adult brain.  
We have previously confirmed by western blot, that 2 month-old AP2γ-/- cKO animals present 
significantly lower levels of this transcription factor in the ventral and dorsal DGs, as well as in other 
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brain regions, such as the prefrontal cortex (PFC) and the SEZ (Supplementary Fig. 6), 21 days 
after tamoxifen administration (Fig. 4c). Analysis of proliferation and neurogenesis in the adult 
hippocampal DG (Fig. 5a-c) showed that AP2γ-/- cKO animals present deficits in hippocampal 
proliferation (decrease in BrdU-positive cells), an effect that is more pronounced in homozygous 
mice (dorsal DG: Wt= 3.89 ± 0.62 x10-3 cells/100µm2, AP2γ-/- cKO= 1.04 ± 0.28 x10-3 cells/
100µm2, F3-37 =11.97, P <0.0001; Post-hoc: P <0.001; ventral DG: Wt= 3.13 ± 0.8 x10-3 cells/
100µm2, AP2γ-/- cKO = 0.55 ± 0.1 x10-3 cells/100µm2, F3-37 =8.596, P <0.0001; Post-hoc: P 
<0.001, Fig. 5b) as well as in hippocampal neurogenesis (detected as lower number of BrdU/DCX 
double-positive cells; dorsal DG: Wt= 2.79 ± 0.48 x10-3 cells/100µm2, AP2γ-/- cKO = 0.29 ± 0.09 
x10-3 cells/100µm2, F3-37 =19.87, P <0.0001; Post-hoc: P <0.001; ventral DG: Wt= 1.75 ± 0.66 x10-3 
cells/100µm2, AP2γ-/- cKO = 0.16 ± 0.09 x10-3 cells/100µm2, F3-37 =4.678, P = 0.0154; Post-hoc: P 
<0.01, Fig. 5c).  
To explore whether AP2γ deficiency could affect additional neuroplastic processes in the adult DG, 
such as dendrite morphogenesis, we analyzed the dendritic morphology of DG granular neurons 
using 3D morphometric reconstruction (Fig. 5d, e), and spines’s densities and morphology (Fig. 
5f). Neither of these parameters was affected in both AP2γ+/- cKO or AP2γ-/- cKO animals. 
AP2γ deficiency induces deficits in specific cognitive modalities  
Given the role of AP2γ in adult hippocampal neurogenesis we tested AP2γ cKO mice in different 
behavioral paradigms to assess its relevance in several emotional and cognitive domains (Fig. 6). 
We used two behavioral tests to detect anxious-like behavior, namely the open field (OF) test and the 
elevated plus maze (EPM). In the OF test (Fig. 6a), although not statistically significant, both  AP2γ
+/- cKO or AP2γ-/- cKO mice displayed a decrease in the total distance travelled in the center of the 
arena (Wt= 168.25 ± 55.7 cm vs AP2γ+/- cKO= 73.57 ± 45.19 cm and AP2γ-/- cKO= 88.08 ± 20.23 
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cm,   F3-27 =1.405, P =0.263), while average velocity was identical, (Supplementary Fig. 7). In 
accordance, AP2γ cKO animals displayed a decreased exploration of open arms in the EPM (Fig. 
6b), (Wt= 21.0 ± 7 % vs AP2γ+/- cKO= 12.12 ± 4.87 % and AP2γ-/- cKO= 7.86 ± 3.23 cm, F3-27 
=1.623, P =0.216). Both trends point for a possible effect of the reduced levels of AP2γ levels in 
anxiety-like behavior, although results in both tests failed to reach statistical significance. In the 
forced swimming test (FST) that assesses behavioral despair, AP2γ cKO mice displayed mobility 
levels similar to control animals, discarding the contribution of AP2γ to this behavioral domain, at 
least in basal conditions (Fig. 6c). Next, we tested the animals in a contextual fear conditioning 
(CFC) task, previously described to be sensitive to neurogenesis impairments22. In the CFC task 
(Fig. 6d), animals were submitted to a context probe (on day 2), aimed to test hippocampal-
dependent memory, and a light-cued probe (on day 3), aimed to assess the integrity of extra-
hippocampal memory circuits22. All groups presented similar average freezing percentages after the 
conditioning trials (Fig. 6e). In the context probe, AP2γ-/- cKO presented a reduction in the 
percentage of freezing, while Wt animals presented higher freezing percentages when exposed to a 
familiar context (Wt= 77.37 ± 4.67% vs AP2γ-/- cKO = 60.47 ± 7.24%, F3-15 =3.767, P =0.047; Post-
hoc: P <0.05 Fig. 6f). Switching to a new environment, promoted a decrease in freezing in both 
groups (Wt= 30.29 ± 4.65% vs AP2γ-/- cKO = 36.69 ± 3.18%, Fig. 6g). Curiously, this impairment in 
contextual memory was not observed in AP2γ+/- cKO animals. In the light probe, both animal groups 
presented high percentages of freezing after exposure to the light cue (Wt= 58.61 ± 5.74% vs AP2γ-/- 
cKO = 65.46 ± 5.53%, t14 =0.7959, P =0.219, Fig. 6h). Overall, CFC results show that AP2γ-/- cKO 
display specific deficits in contextual hippocampal-associated memory, while AP2γ deletion leaves 
associative non-hippocampal dependent memory intact. 
We proceeded with the cognitive characterization of AP2γ cKO using different test paradigms based 
on the Morris Water Maze (as previously described()) (Fig. 7). In a reference memory task, which 
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relies at great extent on hippocampal function(), Wt and AP2γ-/- cKO mice presented similar learning 
curves, without significant differences in the overall distances swum along the four trials days (Fig. 
7a). However, analysis of the strategies adopted to reach the escape platform() showed that AP2γ-/- 
cKO mice are able to maintain test performances comparable to Wt animals by delaying the switch 
from non-hippocampal dependent strategies (“Block 1”) to hippocampal dependent strategies 
(“Block 2”) (Fig. 7b-h). In fact, the majority of AP2γ-/- cKO animals initiate Block 2 strategies by test 
days 3 and 4, while presenting an increased mean duration of Block 1 in relation to Wt mice 
(Block1: Wt = 5.2 ± 1.1 vs AP2γ-/- cKO = 9.0 ± 1.58; t18 = 1.966; P = 0.0324; Block2: Wt = 10.0 ± 
1.2 vs AP2γ-/- cKO = 4.8 ± 1.5; t18 = 2.690; P = 0.0075, Fig. 7e-h).  Furthermore, in a working 
memory test paradigm, both AP2γ-/- cKO and Wt mice presented similar performances along all the 
trials (Fig. 7i), showing that post-natal deletion of AP2γ does not interfere with this cognitive domain 
in basal conditions. In terms of behavioral flexibility, AP2γ-/- cKO displayed increased time spent on 
the “older quadrant”, in relation to Wt mice (t18 =4.806, P <0.0001, Fig. 7j). Interestingly, these 
results were only found in homozygous mice, as AP2γ+/- cKO present test performances similar to 
Wt animals (Supplementary Fig. 8).  
The hippocampal-to-PFC link is impaired in AP2γ-/- cKO mice  
In order to better understand the translation of AP2γ deficiency into poor reference memory and 
behavior flexibility performances, we sought for a functional characterization of the hippocampus-
PFC network by analyzing electrophysiological features of local field potentials (LFPs) recorded in 
these areas (Fig. 8a). Interestingly, the temporal structure of the LFPs recorded from AP2γ cKO 
animals was affected. Specifically, in AP2-/- cKO coherence measurements between simultaneously 
recorded LFPs() of the medial PFC and the ventral hippocampus are significantly decreased in all 
bands when compared to similar recordings obtained from Wt animals (theta: Wt= 0.71 ± 0.06, 
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AP2γ-/- cKO= 0.44 ± 0.03, F3-12 =6.788, P =0.011, Post-hoc: P <0.01; beta: Wt= 0.79 ± 0.03, 
AP2γ-/- cKO= 0.40 ± 0.05, F3-12 =28.72, P <0.001, Post-hoc: P <0.001; low gamma: Wt= 0.48 ± 
0.03, AP2γ-/- cKO= 0.21 ± 0.04, F3-12 =19.77, P <0.001, Post-hoc: P <0.001; Fig. 8b), thus 
showing a compromised connection between these two brain regions. Power spectra densities (PSD) 
translate the amplitude of the signals recorded in a brain region across the frequency domain and 
are important read-outs of the function of that region(). AP2γ depletion did not exert an effect in PSD 
of the ventral hippocampus (Fig. 8c) but promoted a reduction in PSD of the PFC, namely in the 
beta and low gamma frequency bands (beta: Wt= 67.6 ± 0.58μV2/Hz, AP2γ-/- cKO= 62.1 ± 
0.68μV2/Hz, F3-12 =11.94, P =0.0014, Post-hoc: P <0.01; low gamma: Wt= 59.0 ± 0.71μV2/Hz, 
AP2γ-/- cKO= 54.9 ± 0.86μV2/Hz, F3-12 =11.03, P =0.0038, Post-hoc: P <0.01; Fig. 8d).  
Discussion 
This study identifies, for the first time, AP2γ as a molecular regulator that integrates the 
transcriptional network responsible for the generation of new glutamatergic neurons in the post-natal 
brain, and reveals its modulatory function in different cognitive modalities.  
The function and the underlying mechanisms of AP2γ in adult neurogenesis 
The functional importance of transcription factors in adult neurogenesis is now becoming 
increasingly comprehended. On the premise that adult hippocampal neurogenesis may recapitulate 
embryonic cortical neurogenesis in its regulatory mechanisms(), we investigated if the function of 
AP2γ in the developmental brain was preserved in the adult brain. Indeed, we found that AP2γ is 
present in the two main post-natal neurogenic niches, the SEZ and the SGZ. Previous studies have 
shown that the adult hippocampus NSCs are mainly specified towards the glutamatergic lineage(). 
Based on these observations, the presence of AP2γ, a molecular partner in the glutamatergic 
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neurogenesis is not unexpected in the SGZ, neither in the SEZ. In fact, despite the predominant 
GABAergic nature of the SEZ neurogenic niche, our results show that a proportion of AP2γ positive 
cells are also Tbr2 positive, suggesting that AP2γ may regulate the specification of a subpopulation 
of neuronal progenitors towards the glutamatergic lineage in this brain region. This finding is in line 
with the observation that SEZ progenitors also give rise to a subpopulation of adult-born 
glutamatergic juxtaglomerular neurons of the olfactory bulb(). 
After the demonstration of the presence of AP2γ in the two neurogenic niches, we explored the 
molecular mechanisms regulating its action in adult neurogenesis. Our in vitro approaches, suggest 
that AP2γ acts as an effector of Sox2 and Pax6 in the promotion of Tbr2 expression. Furthermore, 
the fact that AP2γ can bind to its own promoter, and positively regulate its expression, suggests a 
dose-dependent mechanism whose exact importance is yet to be fully elucidated. It is well 
established that Pax6 continues to be expressed in the adult SGZ; in fact Pax6-positive cells co-
express GFAP and Nestin, both markers of type I progenitors(). Pax6 expression appears to persist to 
some extent in Type-2 progenitors co-expressing DCX, but is not present in postmitotic neuroblasts(). 
It is therefore comprehensible that AP2γ, as a Pax6-downstream target, preserves its regulatory 
function on glutamatergic neurogenesis in the adult brain, as demonstrated herein. In fact, our 
results demonstrate that AP2γ is a positive regulator of adult neurogenesis in the hippocampal DG 
and in the SEZ as its overexpression increments the generation of new neurons in these two regions. 
Accordingly, our experiments of AP2γ deletion, both in vitro and in vivo, confirm that the absence of 
this transcription factor produces a marked decrease in the neuroblast populations both in the SGZ 
and SEZ.   
Importantly, the present data points out that AP2γ expression alterations produce a net effect in the 
Tbr2+ cells (either an increment in overexpression experiments, or a decrease when using retroviral-
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mediated deletion of AP2γ). Therefore, this transcription factor regulates post-natal glutamatergic 
neurogenesis by mobilizing transient amplifying progenitors (TAPs), rather than interfering with the 
NSCs pool. The presence of an alternative regulatory pathway using AP2γ as an intermediate 
transcriptional regulator, in parallel with the direct regulation of Tbr2 by Pax6, suggests that AP2γ 
function may allow a fine-tuning of the neurogenic process, by either rapidly expand or restrict the 
TAPs pool34,35.  
AP2γ modulates cognitive function 
In this work, we aimed not only to identify the molecular/cellular consequences of AP2γ function, 
but also to explore how this transcriptional modulation could impact on different behavioral 
dimensions. Since impairments in hippocampal neurogenesis have been associated with the 
emergence of depressive-like behavior(), we analyzed the performance of AP2γ cKO mice (with 
significant reduction in AP2γ protein levels in Glast positive cells) in the FST, but no significant 
impact in behavioral despair was detected in animals with reduced levels of AP2γ. Interestingly, 
AP2γ cKO mice performance in the open-field test and elevated-plus maze tests suggests an hyper-
anxious state of these animals. Such effect of AP2γ depletion would be consistent with previous 
works suggesting a link between anxiety and decreased neurogenesis23. However, since we were 
unable to find statistical significant differences in this domain, further studies are needed to clarify 
the role of AP2γ in the control of anxiety behavior. 
Furthermore, impairments in the generation of new hippocampal neurons have also been associated 
with cognitive deficits(). Indeed, spatial memory assessment revealed that AP2γ regulation of the 
population of hippocampal TAPs seems essential to the preservation of hippocampal-dependent 
cognitive tasks, such as strategies on spatial memory tasks. In addition, cognitive dimensions that 
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are based in the interaction of the hippocampal formation and prefrontal cortical areas, such as 
spatial behavioral flexibility were also found to be impaired in AP2γ-/- cKO animals. Such phenotype 
suggests that AP2γ deficiency also impacts on PFC function. Strikingly, our electrophysiological 
studies revealed that AP2γ deficiency in the adult brain led to a significant decrease of coherence 
between the ventral hippocampus and the PFC, indicating a decrease in the ability of these regions 
to functionally interact, including the theta and beta frequencies, previously shown to be critically 
related with behavior outputs dependent on the cortico-limbic networks29,(). Altogether, the data 
presented here suggest that this impairment of neuronal activity and interregional communication 
occurs as a consequence of glutamatergic network malfunction triggered by the lack of AP2γ 
regulation in adult neurogenesis. This may likely underlie the poor cognitive performance observed in 
animals with depleted levels of AP2γ in the CNS. 
In conclusion, the present study identifies for the first time AP2γ as a key regulator of adult 
neurogenesis and demonstrates its modulatory role in hippocampal and PFC activity. In light of the 
role of these brain regions in emotional and cognitive behaviors and of the behavioral and functional 
data presented here, AP2γ has a potential relevance to normal cortico-limbic functions. 
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Online Methods 
Animals 
 AP2γloxP/loxP(AP2γfl/fl) (Kindly provided by Dr. Hubert Schorle), Emx1-cre, Glast:CreErt244 and Z/
EG45 mice were maintained on a C57Bl/6J background (also used as wild type) and identified the 
genotypes by PCR of genomic DNA46. loxP sites flanked exon 5, whose deletion caused a loss of the 
helix-span-helix domain near the protein carboxy terminus. AP2γfl/fl mice were crossed with Emx1-
cre or Glast:CreEtrt2 and Z/EG mice and considered the day of vaginal plug as E0 and the day of 
birth as P0. Animals were housed in polypropylene cages. All procedures were carried out in 
accordance with EU Directive 2010/63/EU and NIH guidelines on animal care and experimentation 
and were approved by the Portuguese Government/Direção Geral de Alimentação e Veterinária 
(DGAV) with the project reference 0420/000/000/2011 (DGAV 4542). 
Tamoxifen administration  
Tamoxifen (Sigma, St. Louis, MO; T-5648) was dissolved in corn oil (Sigma; C-8267) at 20 mg/ml. 
For the deletion experiments with the AP2γfl/fl//Glast::CreErt2//Z/EG mice, 1 mg was injected 
intraperitoneally (i.p.) twice a day for 5 consecutive days44. Animals were sacrificed 1 week after the 
end of tamoxifen administration. For the deletion experiments with the AP2γfl/fl//Glast::CreErt2+/- 
mice, 2 month-old animals were i.p. injected with 1 mg twice a day for 5 consecutive days, with 7 
days break followed by injections for 5 additional consecutive days. Animals were subjected to 
behavioral testing 21 days after the end of the injections (n=6-10). 
Viral Constructs, Virus Production, and Stereotactic Injections 
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We cloned the full-length cDNA of mouse AP2γ (1,816 bp, EMBL accession number X94694, kindly 
provided by M. Moser, Max Planck Institute of Biochemistry) into the EcoRI unique restriction site of 
the retroviral vector pMXIG between the upstream long terminal repeat and the IRES sequence as 
previously described20. Retrovirus was produced in a packaging cell line (GPG-293) after transient 
transfection with the retroviral expression plasmid. Estimation of the viral titer was performed as 
described() and titered to 5x107 colony-forming units (cfu) ml-1 . For all overexpression experiments, 
8-week-old males were stereotactically injected with 1 ml of either CAG-IRES-GFP (IRES-GFP) or CAG-
IRES-AP2γ (AP2γ-IRES-GFP) retroviruses into the left and the right SEZ or DG (coordinates relative to 
the bregma were (in mm) for the SEZ: 0.75 anterior/posterior, 1.2 medial/lateral, and -1.7 dorsal/
ventral from the dura; for the DG: -2.0 anterior/posterior, 1.6 medial/lateral, and -1.9 dorsal/ventral 
from the dura). For the deletion experiments, 2-month-old AP2γfl/fl males were injected with 1 ml of 
either IRES-GFP or Cre-IRES-GFP retroviruses. Analyses were performed 1 week or 1 month post-
injection (n=5 mice per group for each experimental condition). 
BrdU labelling 
Mice used for cell type analyses with ISH and immunofluorescence co-labeling analyses were given 
BrdU in drinking water (1 mg/ml, Sigma Aldrich) for 2 weeks, and sacrificed 8 weeks after. For the 
remaining experiments, mice were injected once with BrdU (100mg/Kg, i.p.), 24 hours before 
sacrifice.  
Primary SEZ and DG cultures  
For primary subependymal and dentate gyrus cultures, six mice (AP2γfl/fl mice, 2 months-old) were 
used. Appropriate dissection was confirmed by qRT-PCR analysis using genes that are specific for 
these regions. Cells were directly plated after preparation on six coverslips coated with poly-D-lysine 
in DMEM/F12-supplemented medium (without any addition of EGF and FGF2) and were transduced 
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with a retroviral vector IRES-GFP or CRE-IRES-GFP 2h later(). After 7d in culture, cells were fixed with 
4% paraformaldehyde (PFA) in PBS for 15 min at room temperature and processed for antibody 
staining. 
Histology and Immunostaining 
Animals were deeply anaesthetized with sodium pentobarbital (20%; Eutasil, Sanofi) and were 
transcardially perfused with cold 4% paraformaldehyde. Brains were removed and post-fixed in 4% 
paraformaldehyde. Coronal vibratome sections (40 mm) were obtained and immunostainings were 
performed as previously described11. Antibodies used were: Beta3Tubulin (Tuj1, Sigma, Mouse 
IgG2b, 1:2000), Doublecortin (DCX, Chemicon, Guinea pig, 1:1000), GFAP (SIGMA, IgG1, 1:100), 
GFP (Chemicon, rabbit, 1:5000 or Aves, chicken 1:500), NeuN (Chemicon, IgG1, 1:75), Pax6 
(Chemicon, rabbit, 1:700), TH (Chemicon, chick, 1:200), BrdU (rat, 1:200, Abcam), Ki67 (DAKO, 
rat, 1:50), Tbr2 (Abcam, rabbit, 1:100), Tbr1 (Abcam, rabbit, 1:100), AP2γ (specific to an N-
terminal epitope, Santa Cruz, rabbit, 1:100; Abcam, mouse IgG1, 1:100), beta3-tubulin (Sigma, 
mouse IgG2b, 1:100), PSANCAM (Millipore, Marseille, mouse IgGM, 1:500). For AP2γ 
immunostaining, brain sections were first incubated for 20 min with citrate buffer (10mM) at the 
microwave (400 Watts) for antigen retrieval. After cooling for 15 min, sections were washed in 
phosphate-buffered saline (PBS) and incubated in hydrogen chloride (HCl) solution for 15 min at 
room temperature. Primary antibodies were incubated overnight at 4ºC. The subclass-specific 
antibodies Alexa Fluor 488 and Alexa Fluor 594 (Molecular Probes) were used for detection. Nuclei 
were counterstained using DAPI. Analyses were performed in a confocal microscope (Olympus 
FV1000). 
In Situ Hybridization 
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Digoxigenin-labeled RNA probes for AP2γ (1,816 bp, EMBL accession number X94694) (kindly 
provided by M. Moser) were used as described previously11. 
3D morphological analysis  
To assess the 3D dendritic morphology of hippocampal neurons we performed Golgi-Cox 
impregnation technique. Briefly, brains were immersed in Golgi-Cox solution for 21 days and then 
transferred to a 30% sucrose solution and cut on a vibratome. Coronal sections (200 μm thick) were 
collected in 6% sucrose and blotted dry onto gelatin-coated microscope slides. They were 
subsequently alkalinized in 18.7% ammonia, developed in Dektol (Kodak, Rochester, NY, USA), fixed 
in Kodak Rapid Fix, dehydrated and xylene cleared. Dendritic arborization and spine numbers/
density were analyzed in the dentate gyrus of control and AP2-/- cKO mice as previously described 
(10-15 neurons for each animal; n=4 per group)23,24. Dendritic trees were reconstructed at 1000x 
(oil) magnification using a motorized microscope (Axioplan 2, Carl Zeiss, Germany) and 
Neurolucida/NeuroExplorer software (Microbrightfield, U.S.A.).  
Western Blot 
Hippocampus, SEZ and PFC of AP2γ cKO mice and Wt littermates were carefully dissected out after 
decapitation. Tissue was weighted and homogenized in RIPA buffer [containing 50 mM Tris HCl, 2 
mM EDTA, 250 mM NaCl, 10 % glycerol, 1 mM PMSF protease inhibitors (Roche)] and then 
sonicated for 2 min. The samples were centrifuged for 25 min at 10.000 rpm at 4°C. The protein 
concentration of the supernatant was determined using Bradford assay. Samples with equal 
amounts of protein, 30 μg, were analyzed using the following primary antibodies: mouse anti-tubulin 
(1:200, DSHB), mouse anti-actin (1:250, Abcam) goat anti-AP2γ (1:250, Abcam), rabbit anti-PAX6 
(1:2000, Chemicon), rabbit anti-SOX2 (1:500, Chemicon) and rabbit anti-TBR2 (1:500, Abcam). 
Secondary antibodies were purchased from BioRad (anti-mouse, 1:10.000; anti-rabbit, 1:10.000) 
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and Santa-Cruz Biotechnologies (anti-goat, 1:5000). Membranes were developed using ECL Clarity 
reagent (BioRad) an developed in ChemiDoc XRS System from BioRad. After developing, images 
were quantified using ImageLabTM Software, BioRad. ".  
Luciferase Assay 
Expression plasmids for luciferase reporter assays were constructed using full-length cDNA of mouse 
Sox2 clone into the pCAG vector, Pax6 cloned into the pMXIG vector and the full-length cDNA of 
Mash1, Ngn1, Ngn2 and Ngn3 cloned into the pcDNA expression vector. The promoters of Tbr2, 
NeuroD and AP2γ were cloned into the pGL3 vector (Promega) as previously described20. We used 
mouse embryonic carcinoma P19 cells (0.5x105 cells/cm2) and assays were performed according to 
the manufacturer’s instructions (Promega). 
 
Electrophysiological studies 
Electrophysiological recordings were obtained from anesthetized Wt, AP2γ+/- cKO and AP2γ-/- cKO 
mice (sevoflurane 2.5%; 800 mL/min). Mice rectal temperature was maintained at 37°C by means 
of a homoeothermic blanket (Stoelting, Ireland). A surgical procedure was used to carefully insert 
platinum/iridium concentric electrodes (Science Products, Germany) in the target positions as 
described previously29 following the mouse brain atlas (from Paxinos): medial pre-frontal cortex 
(mPFC, prelimbic region; coordinates, 1.22 mm anterior to bregma, 0.4 mm lateral to the midline, 
1.7 mm below bregma); ventral hippocampus (vHIP; coordinates, 3.2 mm posterior to bregma, 3.1 
mm lateral to the midline, 2.5 mm below bregma). 
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LFP signals obtained from the mPFC and vHIP were amplified, filtered (0.1–3000 Hz, LP511 Grass 
Amplifier, Astro-Med, Germany), acquired (Micro 1401 mkII, CED, UK) and recorded running Signal 
Software (CED, UK). Local field activity was recorded at the sampling rate of 1000 Hz during 100s. 
At the end of the electrophysiological protocols, a biphasic 1 mA stimulus was delivered to electrodes 
in order to mark the local of recording. Afterwards, mice were deeply anesthetized with sodium 
pentobarbital, brains carefully removed, immersed in paraformaldehyde (PFA) 4% for 48h and 
sectioned (50 µm) in the vibratome apparatus. Next, brain slices containing the mPFC and vHIP 
were staining with Cresyl Violet for determination of the recording site. Animals with recording 
positions outside at least in one of the two regions under study were excluded from analysis (n= 5 
animals per group for each experimental condition). 
Coherence analysis was based on multi-taper Fourier analysis. Coherence was calculated by custom-
written MATLAB scripts, using the MATLAB toolbox Chronux (http://www.chronux.org)47. Coherence 
was calculated for each 1 s long segments and their mean was evaluated for all frequencies from 1 
to 90 Hz. The power spectral density (PSD) of each channel was calculated through the 10 × log of 
the multiplication between the complex Fourier transform of each 1s long data segment and its 
complex conjugate. The mean PSD of each channel was evaluated for all frequencies from 1 to 90 
Hz29. Both coherence and PSD measurements were assessed in the following frequencies: theta (4–
12Hz); beta (12–20Hz); low gamma (20–40Hz). 
Behavioral analysis 
Elevated-Plus Maze (EPM) 
Anxiety-like behavior was examined through the EPM test, in a 5 min. session, as previously 
described48. The percentage of time spent in the open-arm was used as an index of anxiety-like 
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behavior and the number of entries in the closed-arms was taken as an indicator for locomotor 
activity. Trials were video-recorded and analyzed using ethovision software (Noldus). 
Open field test (OF) 
The open field (OF) test was used to evaluate locomotor performance and exploratory activity. The 
open field apparatus consisted of a brightly illuminated square arena of 43.2 X 43.2 cm closed by a 
wall of 30.5 cm high. Mice were placed individually in the center of the open field arena and their 
movement was traced, for 5 minutes, using a two 16-beam infrared system. The resulting data was 
analyzed using the Activity Monitor software (Med Associates, Inc.), considering two previously 
defined areas: a central and an outer area. Due to the thigmotaxic exploratory activity of rodents, the 
ratio between the time spent in the center and in the periphery of the open field arena can also be 
indicative of anxiety-like traits49. Therefore, both distance travelled and time spent in each of the 
zones were recorded and analyzed. Average velocity was also determined for each group. 
Forced Swimming Test (FST) 
Learned-helplessness was assessed through the FST. Assays were conducted in a single trial, by 
placing the mice in transparent cylinders filled with water (25ºC; 50 cm of depth) during 5 min. 
According to the methodology already described50, the first three minutes were considered as an 
habituation period and the last two minutes as the test period. Therefore, only the last two minutes 
were considered for behavioral analysis. Trials were video-recorded and the immobility time was 
measured through the Etholog (vs.2.2) software. 
Water Maze Tasks 
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Water maze tests were used to test the performance in spatial reference and behavioral flexibility 
tasks as described previously48. Briefly, these tests were conducted in a circular black pool (170 cm 
diameter) filled with water at 22ºC to a depth of 34 cm in a room with extrinsic clues (triangle, 
square, cross and horizontal stripes) and dim light. An invisible platform was placed in one of four 
quadrants. In the reference memory task the platform position was maintained in the same quadrant 
for 4 days. At the fifth day, the behavioral flexibility performance of animals was tested by positioning 
the platform in a new (opposite) quadrant. Animals were tested in four trials. Besides the time of 
escape latency, the time spent in both new and old quadrants were recorded.  
To confirm that differences observed in the escape latency were not due to distinct locomotor 
performance, we measured the average swimming velocities during trials. 
Data collection and analyses of Morris Water Maze spatial reference trials were performed using a 
video tracking system (Viewpoint, Champagne au mont d’or, France). Search strategies were defined 
as previously described26,28. Quantitative analyses and strategy classification was performed with 
data collected by the Viewpoint software, using an algorithm that we developed for automatic 
strategy attribution based on the following main parameters: (i) thigmotaxis (Tt): >70% of swim 
distance within the outer ring area (8 cm from the pool border); (ii) random swim (RS): >80% of 
swim distance within the inner circular area; balanced quadrant exploration (all quadrants explored 
with a percentage of swim distance not >50% for none of the quadrants); non-circular trajectory; (iii) 
scanning (Sc): >80% of swim distance within the inner circular area; balanced quadrant exploration 
(all quadrants explored with a percentage of swim distance not >50% for none of the quadrants); 
non-circular trajectory; percentage of swim distance in the platform corridor area  (funnel shaped 
area centered along the imaginary axis connecting the start position and platform position) ≤60%; 
(iv) chaining (Ch): >80% of swim distance within the inner circular area; balanced quadrant 
exploration (all quadrants explored with a percentage of swim distance not >50% for none of the 
quadrants); percentage of swim distance in the platform corridor area ≤60%; circular trajectory (v) 
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directed search (DS): >80% of swim distance within the inner circular area; percentage of swim 
distance in the platform corridor area >60% with shifts in the trajectory direction (vi) focal search 
(FS): percentage of swim distance in the perimeter of the escape platform (30 cm perimeter) > 50%; 
(vii) direct swim (DSw): >80% of swim distance within the inner circular area; percentage of swim 
distance in the platform corridor area >90% with no shifts in the trajectory direction (“direct 
trajectory”).    
For strategy blocks analysis, we defined two blocks of strategies: Block1, comprising the “non-
hippocampal dependent strategies” (Thigmotaxis, Random Swim and Scanning) and Block2, 
comprising the “hippocampal dependent strategies” (Directed Search, Focal Search and Direct 
Swim). Strategy blocks were defined as a sequence of at least three trials with the strategies from 
the same class. For block lengths, a maximum of two-trial interruptions were tolerated but not 
counted: for example, in the following strategies sequence ”DS-DS-FS-DS-Sc-DS-FS-FS”, the block 
length for Block2 was scored 8, despite the presence of one trial in which the attributed strategy 
belongs to Block1 (Sc). Independent analysis was performed for both Wt, AP2γ+/- and AP2γ-/- cKO 
mice 
Contextual Fear Conditioning (CFC) 
Contextual Fear Conditioning  was conducted in white acrylic chambers with internal dimensions of 20 
cm wide, 16 cm deep and 20.5 cm high (Med Associates), with an embedded light bulb mounted directly 
above the chamber to provide illumination. Each chamber contained a stainless steel shock grid floor 
inside a clear acrylic cylinder, where animals were placed. Animals were subjected to two probes, a 
context probe and a cue (light) probe. The CFC procedure was conducted over 3 days (see Fig. 5), 
as follows: 
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Day 1.  Mice were placed in the conditioning white chamber (Context A) and received 3 pairings between 
a light (20 s) and a coterminating shock (1 s, ≈0.5 mA). The interval between pairing was set as 180 s, 
and the first tone presentation commenced 180 s after the mouse was placed into the chamber. After 
three light shock pairings, freezing behavior was measured during 3 minutes, in order to determine 
whether Wt and AP2γ cKO had similar baseline freezing values during the conditioning trials. Freezing 
was defined as the complete absence of motion, including motion of the vibrissae, for a minimum of 1s. 
At the end of the three pairings, mice remained in the chamber for a further 30 s before being returned to 
their home cage. The chambers were cleaned with 10% ethanol solution between each trial.   
Day 2.  For the context probe, animals were placed in the white chamber (Context A), where they were 
originally shocked, 24h after the light-shock pairings. Freezing behavior was measured during 3 minutes. 
Two hours later, animals were put in a modified version of the chamber (Context B) that was sheeted with 
a black plasticized cover that was previously sprayed with vanilla oil, in order to alter both spatial and odor 
references; the ventilation fan was not operated; the experimenter wore a different style of gloves and lab 
coat. Again, freezing was measured during 3 minutes. 
Day 3.  For the cue probe, test settings for Context B were maintained and animals were placed inside 
the chamber 24h after the context probe. After 3 minutes, a light was turned on during 20 s and freezing 
behavior was subsequently measured during 1 minute. 
  
Data analysis and Statistics 
Statistical analyses were done using SPSS software. After confirmation of homogeneity, data was 
subjected to appropriate statistical tests. ANOVA repeated measures was used to analyze cognitive-
learning tasks performance. One-way ANOVA was used to evaluate the remaining behavioral and 
molecular results. F-values and P-values derived from the between groups ANOVA analyses are 
i i  213
properly indicated along the text. Differences between groups were determined by Bonferroni’s post-
hoc multiple comparison test, and the corresponding P-values are indicated in the figures. A t-test 
was used two evaluate differences between two groups where appropriate. Statistical significance 
was accepted for P<0.05. 
Power Spectrum Density (PSD) of the mPFC and vHIP as well as the mPFC-vHIP coherences were 
obtained by the recording of LFP signals during 100 s. Each measure was applied on 1 s long 
segments and the average of all segments was considered for statistical group analysis. Values were 
obtained using custom-written MATLAB-based programs (MathWorks, Natick, MA). 
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FIGURE 1 
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Figure 1. AP2γ expression in the adult mouse brain. (a) In situ hybrization (ISH) of AP2γ in the adult subependymal 
zone (SEZ) (left panel) and hippocampal dentate gyrus (DG) (right panel). (b) The left panel shows the combination of 
ISH of AP2γ with immunolabelled BrdU+ cells in the SEZ. The right panel shows ISH of AP2γ in the DG, with 
immunolabelled BrdU+ (in red) and Tbr2+ cells (in green). (c-e) Immunohistochemical quantification of the percentage 
of AP2γ+ cells co-labelled with BrdU, Tbr2 or DCX in the SEZ (c) and the DG (d,e). Error bars represent s.e.m. Scale 
FIGURE 2 
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Figure 2. In vitro and in vivo deletion of AP2γ. (a-e) In vitro viral-mediated deletion of AP2γ in NSCs 
primary cultures (a) with quantification of the percentage of pure neuronal (PC), mixed neuronal and non-
neuronal (MC) and non-neuronal clones (NC) (b) and average clone size (c) in adult SEZ NSCs primary 
cultures. Similar analysis of clone type (d) and average size (e) was performed in adult DG NSCs primary 
cultures, n=10, Student’s t test, ** P ≤ 0.01,*** P ≤ 0.001. Error bars represent s.e.m. (f-h) Tamoxifen was 
administered to adult mice obtained after crossing Glast::CreErt2//Z/EG mice with mice containing AP2γ 
flanked by loxP sites (AP2γfl/fl), in order to promote AP2γ deletion in Glast expressing cells, and animals 
were sacrificed after 1 week (f). Quantification of the percentage of GFP-positive cells co-labelled with DCX 
or GFAP in the SEZ (g), and in the hippocampal DG (h) (n=6). Student’s t test, * P ≤ 0.05,** P ≤ 0.01. Error 
bars represent s.e.m. Scale bars represent 20µm.
FIGURE 3 
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Figure 3. Viral-mediated overexpression of AP2γ in the post-natal neurogenic niches. (a-b) Adult mice were injected 
with retrovirus containing AP2γIRES-GFP or simply IRES-GFP as an experimental control, either in the dorsal 
hippocampus or in the subependymal zone (SEZ) (a) and sacrificed either 1 week post-injection or 4 weeks post-
injection. (c) High magnification images showing GFP-positive transfected cells in the SEZ (left panels) and in the 
hippocampal dentate gyrus (DG, right panels) in sections immunolabelled to doublecortin (DCX, in red, left and mid 
panels) or NeuN (in red, right panels). (d-f) Quantification of the percentage of GFP-positive cells co-labelled with 
NeuN, DCX, GFAP or BrdU in the SEZ, 1 week post-injection (d), and in the hippocampal DG, 1 week (e) and 1 
month post-injection (f). n=10, Student’s t test, * P ≤ 0.05,** P ≤ 0.01. Error bars represent s.e.m. Scale bars 
represent 50µm. 
FIGURE 4 
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Figure 4. Regulation of glutamatergic determinants by AP2γ. (a-b) Histograms depicting the luciferase luminescence 
intensity normalized to Renilla intensity from embryonic carcinoma P19 cells transduced with the firefly or Renilla 
luciferase constructs (Fluc or Rluc, respectively) using either AP2γ (a) or NeuroD and Tbr2 promoters (b). Values were 
normalized to the pMXIG empty vector containing only GFP (4 independent experiments; Student’s t test, * P ≤ 0.05,** P 
≤ 0.01, ***P ≤ 0.001). (c) For western-blot analysis, 2month-old AP2γ cKO (AP2γfl/fl//Glast::CreErt2) animals were 
injected with tamoxifen, tested 21 days after and subsequently sacrificed; (d) Western-blot analysis of AP2γ, Sox2, Pax6 
and Tbr2 in adult hippocampal protein extracts from Wt, AP2γ+/- cKO and AP2γ-/- cKO mice (n=5-6; Student’s t test, * P ≤ 
0.05,** P ≤ 0.01). (e) Illustration depicting different regulatory functions of AP2γ in the adult hippocampus; both upstream 
transcription factors, Sox2 and Pax6 induce the expression of AP2γ, whereas the last presents self-regulatory activity and 
regulates the expression levels of Pax6, Tbr2 and NeuroD. Error bars represent s.e.m.
FIGURE 5 
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Figure 5. Hippocampal neurogenesis and dendritic morphology in adult AP2γ cKO (AP2γfl/fl//Glast::CreErt2) mice. 
(a) Dorsal hippocampal coronal section stained for BrdU (in green) and DCX (in red). Double-stained BrdU and 
DCX are indicated by white arrows. (b) Representative 3D morphometric reconstruction of a DG granular neuron. 
(c,d) Cell counts of BrdU-positive cells (c) and BrdU/DCX double-positive cells (d) in the hippocampal DG, n=6, 
Student’s t test, * P ≤ 0.05,** P ≤ 0.01. (e,f) Dendritic length (e) and spines density and morphology of hippocampal 
granular neurons (f),  n=10, Student’s t test, * P ≤ 0.05,** P ≤ 0.01. Error bars represent s.e.m. Scale bars represent 
50 µm. Abbreviations: T, Thin Spines; Tk, Thick Spines; M, Mushroom Spines; R, Ramified Spines. 
FIGURE 6 
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Figure 6. Behavioral analyses of AP2γ cKO mice (a-e) AP2γ cKO animals were tested in different behavioral 
paradigms. (a,b) Anxious-like behavior was tested both in the open-field test (a) and in the elevated plus maze (b). (c) 
The presence of depressive-like behavior was assessed in the Forced Swimming Test .  (d-h) In addition, animals were 
tested in a contextual fear conditioning paradigm, n=10, Student’s t test, * P ≤ 0.05,** P ≤ 0.01. Abbreviations: OF, 
open field; EPM, elevated plus maze; OA, open arms; FST, forced swimming; CFC, contextual fear conditioning; error 
bars represent s.e.m.
FIGURE 7 
 
i i  226
Figure 7. Cognitive strategies during water maze learning in AP2γ-/- cKO mice. (a-h) Spatial reference memory was 
evaluated as the average escape latency in each test day. A schematic representation and color code for each strategy (b) 
and the average prevalence of each strategy by trial number are shown both for Wt (c) and for AP2γ-/- cKO animals (d). 
The prevalence of each strategy-block along trials (Block 1: “Non-hippocampal dependent strategies”; Block 2: 
“Hippocampal dependent strategies”), the distribution of strategies-block boundaries and overall block length is shown 
for Wt (e) and AP2γ-/- cKO animals (f); graphical comparison of these parameters is shown in (g) and (h). (i,j) 
Furthermore, animals were tested in a working memory task (i) and in reversal learning task (j).  n=10, Student’s t test, 
* P ≤ 0.05,** P ≤ 0.01; error bars represent s.e.m.
FIGURE 8 
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Figure 8. AP2γ deficiency decreases spectral coherence between the ventral hippocampus (vHIP) and the medial 
prefrontal cortex (mPFC) and neuronal activity within each region. (a) Upper panel depicting LFP recording sites and 
depiction of the electrode positions; lower panel shows representative LFP signals. (b) Spectral coherence between 
vHIP and mPFC of Wt and AP2γ cKO mice (left panel); Group comparison of the coherence values for each frequency 
band (right panel). (c) Power spectral density (PSD) measured in the vHIP (left panel); group comparison of the PSD 
values for each frequency band (right panel). (d) PSD measured in the mPFC (left panel); group comparison of the PSD 
values for each frequency band (right panel). In the spectrograms each horizontal line in the Y-axis represents the 
spectrogram of an individual mouse (3 representative mice from each group are shown). ; n=5, One-way ANOVA, * P ≤ 
0.05,** P ≤ 0.01.; error bars represent s.e.m. 
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